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The Gram-positive lactic acid bacteria (LAB) that are represented by specific species of the genera 
Lactococcus, Lactobacillus, Leuconostoc, Streptococcus, Pediococcus, Bifidobacterium and 
Carnobacterium play an important role in the food industry due to their fermentative capacities (McKay 
and Boldvin, 1990). They strongly determine the flavour, texture and, frequently, the nutritional value of 
food and feed products. When ingested, LAB, especially Lactobacillus and Bifidobacterium sp., can have 
a beneficial (probiotic) effect on the treatment and prevention of specific pathological conditions (Rolfe, 
2000). In addition, they can function as biopreservatives in food products, preventing spoilage by 
pathogenic microorganisms through acidification, competition for essential nutrients and the production of 
antimicrobial peptides, the so-called bacteriocins (Stiles, 1996). 
LACTOCOCCAL PROTEINASES 
L. lactis is the main component of the starter cultures used for cheese making. Its main activity during 
milk fermentation is the conversion of lactose to lactic acid, which results in the lowering of the pH in the 
product. L. lactis, like many other lactic acid bacteria, is a multiple amino acid auxotroph and needs an 
extracellular source of essential amino acids (Chopin, 1993). However, the amount of free amino acids 
and small peptides in fresh milk is low. L. lactis has a complex proteolytic system to degrade caseins, the 
major milk proteins, into small peptides and free amino acids that are subsequently used for cell growth 
(Christensen et al., 1999). Proteolysis is a cascade process that involves many components, such as i) 
extracellular proteinase for initial degradation of casein into peptides, ii) transport systems for uptake of 
peptides and amino acids, and iii) various intracellular peptidases for degradation of peptides into amino 
acids (reviewed by Kunji et al., 1996).
PrtP
The initial breakdown of caseins is carried out by the cell wall-bound extracellular proteinase (CEP) PrtP. 
PrtP is a serine proteinase. C-terminally truncated but active PrtP (Mw of about 135-145 kDa) can be 
isolated from the cell wall by treating cells with a Ca2+-free buffer (reviewed by Exterkate, 1995). 
In many lactococcal strains, but not all (Niessen-Meyer et al., 1992), the gene for the proteinase is 
located on plasmids (for a review see Kok, 1990). The prtP genes of several lactococcal strains have 
been cloned and sequenced (Kok et al., 1985; Kok et al., 1988; de Vos et al., 1989; Kiwaki et al., 1989). 
Although their deduced amino acid sequences are over 98% identical, the specificity of the proteinases 
towards caseins is quite different. On basis of their caseinolytic properties, the proteinases are divided 
into two major groups: the PrtPI-type enzymes preferentially degrade E-casein but hardly DS1- and N-
casein, and the PrtPIII-type enzymes, degrading DS1-, N-, and E-casein, but the latter with a specificity 
different from that of PrtPI (Visser et al., 1989). 
For the production of an active proteinase, the product of a divergently transcribed prtM is required. 
This so-called maturase is a lipoprotein anchored to the cell membrane (Haandrikman et al., 1991). PrtM 
plays a role as extracellular chaperone, inducing the pro-proteinase to adopt the conformation in which it 
is able to autoproteolitically cleave off its own pro-region (Kok et al., 1990). 
Proteinase production in a number of lactococcal strains is inhibited in growth medium that is 
peptide-rich e.g. contains casitone, a tryptic digest of casein (Exterkate, 1985; Marugg et al., 1995; 1996; 
Miladinov et al., 2001; this thesis, Chapter 6). Expression is highest in media containing low 
concentrations of peptides. Both prtP and prtM are controlled in a similar way and at the transcriptional 
level (Marugg et al., 1995; 1996; this thesis, Chapter 6). The transcriptional repressor CodY, found to be 
involved in regulation of expression of a number of peptidases e.g. PepN, PepC and oligopeptide uptake 
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(Guedon et al., 2001b), was shown to be also responsible for the repression of prtP/prtM transcription in 
peptide-rich media (this thesis, Chapter 6). 
A comparative in silico analysis of the amino acid sequences of known PrtPs and a number of 
CEPs from different lactic acid bacteria showed that PrtP has a modular, multidomain structure (Fig. 1)
(Siezen, 1999). The N-terminal part, with the pre-pro domain (PP) containing signals for secretion and 
activation (Kok et al., 1985; Kok et al., 1988; de Vos et al., 1989; Kiwaki et al., 1989), is followed by the 
subtilisin-like serine proteinase domain (PR) (Siezen et al., 1991; Siezen and Leunissen, 1997) and two 
large central domains (A and B) that are thought to have regulatory and stabilising functions (Siezen, 
1999). The C-terminal part of PrtP consists of (i) a helical spacer (H), followed by (ii) a hydrophobic 
Gly/Thr/Asp-rich putative cell wall spacer (attachment) domain (W) that can span the peptidoglycan layer 
and, (iii) a cell wall anchoring domain (AN). The cell wall spacer domain (60 amino acid residues) is 
duplicated in PrtPIII of L. lactis SK11 (de Vos et al., 1989) and PrtPI BGMN1-5 (this thesis, Chapter 4) 
suggesting that this proteinase may be placed further outward of the cell. Recently it was shown that the 
duplicated cell wall spacer domain of PrtP can interact with other duplicated cell wall spacer domain 
present on other lactococcal cells through protein-protein interaction, thereby causing sedimentation of 
the cells (this thesis, Chapter 4).
Figure 1. Schematic representation of the predicted domains in lactococcal PrtP. PP: pre-pro domain; PR: protease 
domain; I: insert domain; A: A-domain; B: B-domain; H: helical domain; W: cell-wall domain; AN: anchor domain; 
Black dot represents LPXTG motif. Adopted from Siezen, 1999. 
The cell wall anchoring domain of PrtP contains the pentapeptide motif LPXTG, that is conserved 
among many surface proteins of Gram-positive bacteria (Fischetti et al., 1990), followed by a stretch of 
hydrophobic amino acids and a short tail of positively charged residues that remains in the cytoplasm 
(Schneewind et al., 1993). After translocation, the LPXTG sequence is cleaved between the threonine 
and glycine residues after which the threonine residue is covalently coupled via an amide-linkage to the 
peptide cross-bridge in the peptidoglycan of the cell wall (Navarre and Schneewind, 1994). The gene 
encoding the sortase SrtA of Staphylococcus aureus, a transpeptidase that performs this coupling 
reaction, has been cloned and sequenced (Sarkis et al., 1999). Removal of the C-terminus of PrtP (AN, 
W and H domains) leads to a fully active truncated proteinase of unaltered specificity that is secreted into 
the medium (Kok et al., 1989; Bruinenberg et al., 2000). 
HtrA
Besides PrtP and NisP, which is involved in the cleavage of the precursor molecule of the lantibiotic nisin 
into its active form (van der Meer et al., 1993), HtrA is a third lactococcal extracellular proteinase (Poquet 
et al., 2000). HtrA of L. lactis IL1403, a homologue of E. coli HtrA/DegP, is a trypsin-like serine protease 
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containing a Ser, His and Asp catalytic triad. It is predicted to be a membrane-bound enzyme with most 
of the protein including the catalytic site exposed on the cell surface. HtrA is unique housekeeping 
surface proteinase of L. lactis, which degrades fusion proteins and cell-surface located or secreted 
misfolded proteins (Poquet et al., 2000). HtrA was also shown to be responsible for the cleavage of the 
precursor peptide of the lactococcal bacteriocin LsbA to yield the active antimicrobial peptide (this thesis, 
Chapter 2). 
BACTERIOCINS
The LAB have been used for centuries in the fermentation of food, not only for flavour and texture 
development, but also to prevent the growth of spoilage and pathogenic microorganisms, either by the 
acidification of the growth medium, the production of organic acids, or the production of bacteriocins 
(Stiles, 1996). A number of bacteriocins produced by LAB have already been tested for their 
biopreservation potential in food systems (reviewed by Stiles, 1996). However, the only LAB bacteriocin 
to date that is allowed to be used as a food additive (in more than 45 countries) is nisin (Delves-
Broughton, 1990). 
Bacteriocins are ribosomally synthesised antimicrobial peptides produced by bacteria. They are 
defined as extracellular bioactive peptides or peptide complexes that are bacteriocidal, due to the 
combined action of the bacteriocin and the host autolysin (Martinez-Cuesta et al., 2000), or bacteriostatic 
against other species, usually closely related to the producer strain. In some cases, they are also active 
against more distant species (Klaenhammer, 1993; Jack et al., 1995). Recent developments in 
biochemical and molecular biological techniques have led to the elucidation of several aspects of the 
regulation, production, processing, secretion, structure and mode of action of bacteriocins.
Bacteriocins produced by LAB are classified into three main classes based on their genetic and 
biochemical characteristics (Nes et al., 1996; Nissen-Meyer and Nes, 1997). 
Class I: Lantibiotics. These small (<5 kDa), post-translationally modified peptides contain one or 
more unusual amino acids such as lanthionine, E-methyllanthionine and the dehydrated residues 
dehydroalanine and dehydrobutyrine (Mc Auliffe et al., 2001). Based on structural and functional features, 
lantibiotics are subdivided into type-A and type-B lantibiotics (Jung, 1991). Type-A lantibiotics (e.g. nisin, 
subtilin and epidermin) are elongated, cationic peptides with a conserved arrangement of lanthionine-
bridges. These peptides primarily act by disrupting the membrane integrity of the target organism. Type-B 
peptides (e.g. mersacidin, duramycin and actagardine) are globular and smaller (up to 19 amino acid 
residues) and act by disrupting enzyme functions (e.g. inhibition of cell wall biosynthesis) (Mc Auliffe et
al., 2001). 
Class II: Small (<10 kDa), heat-stable unmodified membrane active peptides. Although a small 
number of these class II bacteriocins are translated with a sec-dependent leader sequence, most 
possess a double glycine-type leader (Gly-2-Gly-1). The mature bacteriocins are predicted to form 
(amphipathic) helices with variable hydrophobicity and E-sheet structures. They are moderately (100°C) 
to highly (121°C) heat-stable (Sablon et al., 2000). So far, more than 50 class II bacteriocins from LAB 
have been isolated and characterised. On the basis of some conserved features, this class can be further 
divided into at least 3 subclasses, although three additional subclasses have been suggested. The 
subgrouping of class II bacteriocins does not seem straightforward, since an increasing number of new 
bacteriocins can not be classified according to the established subclasses (Diep and Nes, 2002). 
Class IIa: Pediocin-like bacteriocins. This is the largest and most extensively studied subclass 
(Stoddard et al., 1992; Cintas et al., 1997). The peptides display a strong anti-listerial activity and have a 
high overall sequence identity (40-70%). The most striking structural feature is the conserved YGNGVXC-
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motif in the hydrophilic N-terminal part of the protein.
Class IIb: Two-peptide bacteriocins. These bacteriocins require the combined action of two 
peptides for full antimicrobial activity. In most cases the separate peptides exert bacteriocin activity, but 
this activity is highly stimulated by the presence of the second peptide (Allison et al., 1994; Jimenez-Diaz 
et al., 1995; Anderssen et al., 1998). The lactococcin G and lactococcin 705 peptides do not have 
antimicrobial activity on their own and, therefore, are exceptions to this rule (Nissen-Meyer et al., 1992; 
Cuozzo et al., 2000).
Class IIc: sec-dependent bacteriocins. These bacteriocins are exported across the cytoplasmic 
membrane by the general sec-dependent secretory pathway (e.g. acidocin B, divergicin A, bacteriocin 31, 
enterocin P, listeriocin 743A) (Leer et al., 1995; Worobo et al., 1995; Tomita et al., 1996; Cintas et al.,
1997; Kalmokoff et al., 2001).
Class IId: Bacteriocins without a leader sequence. Unlike other bacteriocins, they are synthesised 
without an N-terminal leader peptide or signal sequence. This subclass contains the two-component 
bacteriocin enterocin L50 and the single peptide bacteriocin enterocin Q, produced by Enterococcus
faecium L50 (Cintas et al., 1998; 2000), aurocin A70 produced by Staphylococcus aureus A70 (Netz et
al., 2001) and LsbB of L. lactis BGMN1-5 (this thesis, Chapter 2). 
Class IIe: Cyclic peptide bacteriocins. Unlike linear bacteriocins, these bacteriocins are cyclised by 
a head-to-tail peptide bond formation (e.g AS-48, gassericin A, circularin A) (Mendoza et al., 1998; Kawai 
et al., 1998; Kemperman et al., submitted). 
Class IIf: Other unmodified bacteriocins. This group contains the remaining class II bacteriocins that 
do not contain the structural features or conserved motifs that are unique to any of the other subclasses. 
Class III: Large (>30 kDa), heat-labile proteins. Only very few bacteriocins belonging to this class 
have been identified (e.g. helveticin J, helveticin V, acidophilucin A, lactacins A and B) (Joerger and 
Klaenhammer, 1990; Vaughan et al., 1992; Toba et al., 1991). 
Class II bacteriocins 
Genetic organisation 
Class II antimicrobial peptides of LAB can either be plasmid or chromosomally encoded. The synthesis 
and export of these bacteriocins involve four or more different genes organised in a gene cluster, which 
usually consist of a number of operons (e.g. LcnA, Holo et al., 1991; van Belkum et al., 1991a) that are 
not necessarily transcribed in the same direction. This gene cluster is comprised of one or two structural 
genes (the latter in the case of class IIb bacteriocins), encoding the prebacteriocin(s), and a specific 
immunity gene, which (in the majority of cases) is located next to the structural gene(s) and in the same 
transcriptional unit. Furthermore, it includes genes encoding a dedicated ABC-transporter and an 
accessory protein (except in the case of class IIc), both of which are needed for the externalisation of the 
bacteriocin concomitant with the processing of the leader (Venema et al., 1995a; Håvarstein et al., 1995). 
In most cases, these two genes are closely linked (Nes et al., 1996). In addition to the four basic genes, 
regulatory genes are associated with the genetic determinants of several class II bacteriocins (Diep et al.,
1994; 1996; Axelsson and Holck, 1995; Quadri et al., 1995; Brurberg et al., 1996). They specify three-
component regulatory mechanisms consisting of a small induction peptide (IP), a histidine protein kinase 
(HPK) and a response regulator (RR). The secreted IP functions as a peptide pheromone, which is 
recognized by an HPK. This recognition event triggers an autophosphorylation reaction within the HPK, 
after which this phosphate is transferred to the cognate RR. The phosphorylated RR then acts as a 
transcriptional activator of the bacteriocin gene cluster (Kleerebezem et al., 1997). Bacteriocin production 
provides a selective advantage on the producing organism over its closely related natural competitors. 
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This so-called cell density-dependent regulation of bacteriocin production (quorum sensing) enables the 
producing organism to switch on antimicrobial production when the competition for nutrients is likely to 
become more severe. 
Structural features of class II bacteriocins 
In general, class II bacteriocins are small (37 to 58 amino acids) cationic peptides with pI’s varying from 8 
to 11. They contain a relatively high number of small amino acids such as glycine and alanine, giving 
them a high degree of conformational freedom (Kaiser and Montville 1996). They are amphipathic in two 
respects: i) their hydrophobicity increases gradually from the N-terminal to the C-terminal part of the 
molecule, but slightly decreases at the C-terminus, ii) the hydrophobic residues within the Į-helical
structure appear on one surface whereas the hydrophilic residues occupy the opposite side of the 
molecule (Moll et al., 1999).
Biosynthesis of class II bacteriocins 
Bacteriocins are mainly synthesised as precursor peptides with an N-terminal leader sequence. This 
leader i) prevents the bacteriocin from being biologically active while being inside the producing strain, 
and ii) directs the bacteriocin to the dedicated transport protein. Upon externalisation, the leader peptide 
is removed, thus releasing the mature bacteriocin from the cell (Nes et al., 1996). The export of 
bacteriocins can be mediated by dedicated ATP-binding cassette (ABC) transporters and their accessory 
proteins, or by the general sec-dependent secretory pathway. 
The primary translation product of most non-lantibiotics and some lantibiotics contains a leader 
peptide of the so-called double-glycine-type (Gly-2-Gly-1). This type of leader is amphipathic and varies in 
length from 14 to 30 residues (Klaenhammer, 1993; Håvarstein et al., 1994). Only the glycine residue at 
position –2 is fully conserved. These leader peptides have several conserved characteristics, including 
hydrophobic residues at positions –4, –7, –12 and –15 and hydrophilic residues at position –8, –9, and –
11 (Fremaux et al., 1993; Håvarstein et al., 1994; Nes et al., 1996). The high similarities between the 
double-glycine leaders may allow heterologous expression of multiple bacteriocins by a strain that 
possesses one single processing and transport system (van Belkum et al., 1991a; 1992; Allison et al.,
1995).
Secretion and proteolytic activation of bacteriocin precursors 
ATP dependent translocation and processing 
The secretion of bacteriocins with a double glycine leader is mediated by a dedicated transmembrane 
translocator belonging to the ATP-binding cassette (ABC) superfamily and an additional (accessory) 
protein, which together form a specific transport system (Håvarstein et al., 1995; Franke et al., 1996). The 
ABC transporter is encoded by a gene in the same operon or an operon adjacent to that specifying the 
bacteriocin (Sablon et al., 2000). All ABC-transporters contain a hydrophobic integral membrane domain 
and a cytoplasmic carboxy-terminal domain harbouring the highly conserved hydrophilic ATP-binding 
domain with Walker A and B motifs (Higgins, 1992). ABC transporters responsible for the translocation 
and proteolytic activation of bacteriocins with a double glycine leader contain a cytoplasmic N-terminal 
proteolytic domain of approximately 150 amino acids that is involved in the processing of the pre-
bacteriocin (Venema et al., 1995a; Håvarstein et al., 1995). The energy needed for the translocation 
process is provided by the hydrolysis of ATP. Two conserved amino acid stretches 
QX4D/ECX2AX3MX4Y/FGX4I/L (Motif 1; in which X represents any amino acid) and HY/FY/VVX10I/LXDP 
(Motif 2) are found exclusively in the N-terminal extensions of these bacteriocin ABC transporters 
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(Håvarstein et al., 1995). Replacement of the conserved Cys13 in Motif 1 of the ABC transporter by an 
alanine residue results in complete loss of proteolytic activity, indicating that this residue is part of the 
active site, and that the proteolytic domain belongs to the family of cysteine protease (Håvarstein et al.,
1995).
Remarkably, the ABC transporters involved in the secretion of the lantibiotics nisin, epidermin and 
subtilin are devoid of a conserved N-terminal proteolytic domain. Instead, subtilisin-like proteases are 
involved in maturation of these bacteriocins (Schnell et al., 1992; van der Meer et al., 1993). 
In contrast to the above mentioned dedicated transport proteins, the secretion of two bacteriocins 
from L. lactis BGMN1-5, LsbA, synthesised with an N-terminal extension, and leaderless LsbB was 
shown to be mediated by an ATP-binding-cassette-type multidrug resistance transporter protein, LmrB 
(this thesis, Chapters 2 and 3). 
Accessory proteins 
Although the exact function of the accessory transport proteins in Gram-positive bacteria is unknown, 
they are required for the secretion of class II bacteriocins. They generally consist of about 460 amino 
acids, and are homologous to HlyD, the accessory protein of the E.coli haemolysin A secretion apparatus 
(Fath and Kotler, 1993; Marugg et al., 1992; Axelsson and Holck, 1995; Fremaux et al., 1995; Venema et
al., 1995a; Diep et al., 1996; Quadri et al., 1997a; O’Keeffe et al., 1999; Franz et al., 2000; Varcamonti et
al., 2001). These proteins are encoded by a gene adjacent to the ABC transporter gene. Except for a 
single N-terminal transmembrane domain that anchors the protein to the cytoplasmic membrane, these 
proteins are hydrophilic (van Belkum and Stiles, 1995). The N-terminal part of LcnD, the accessory 
protein of the L. lactis lactococcin secretory system, is located in the interior of the cell, while the (major) 
C-terminal part is on the extracellular side of the cytoplasmic membrane (Franke et al., 1996). LcnD and 
the dedicated bacteriocin transporter LcnC were shown to interact in the bacterial membrane (Varcamonti 
et al., 2001). It is hypothesised that these accessory proteins in Gram-negative bacteria may connect the 
inner and outer membranes to facilitate the passage of substrates through both membranes. They belong 
to a recently identified, novel class of export proteins designated as the membrane fusion proteins (Dinh 
et al., 1994; Sablon et al., 2000). Counterparts of these accessory proteins have not yet been reported in 
lantibiotic operons.
Secretion of sec-dependent bacteriocins 
While most class II bacteriocins are secreted by the ABC transporter system, a few bacteriocins (e.g. 
acidocin B, divergicin A, bacteriocin 31, enterocin P, listeriocin 743A) are exported by the general sec-
dependent secretory pathway (Leer et al., 1995; Worobo et al., 1995; Tomita et al., 1996; Cintas et al.,
1997; Kalmokoff et al., 2001). The bacteriocin precursor contains a canonical sec signal peptide 
consisting of a positively charged N-terminus, a hydrophobic core, and a defined cleavage site that is 
removed by a specific signal peptidase during translocation (Pugsley, 1993; von Heijne, 1983). In all 
cases, production was shown to be dependent on the expression of a single operon comprising the 
structural and (putative) immunity genes, without the need for dedicated secretion and maturation 
proteins.
Mechanism of action of bacteriocins 
In general, bacteriocins of Gram-positive bacteria are primarily active against other closely related Gram-
positive species, although in some cases (e.g. nisin), activity against Gram-negatives has also been 
observed when the outer membrane was permeabilised (Stevens et al., 1991). Type-A lantibiotics and 
some of the class II bacteriocins have been shown to be membrane-active peptides that destroy the 
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integrity of the cytoplasmic membrane via the formation of membrane pores. Thus, they affect the 
membrane permeability causing leakage of low molecular mass metabolites or dissipation of the proton 
motive force (PMF) (Fig. 2). The PMF is the electrochemical gradient over the cytoplasmic membrane 
composed of membrane potential ('\) and the pH gradient (pH), which drives ATP synthesis and 
accumulation or extrusion of ions and other metabolites (Konings et al., 1989). Collapse of the PMF, 
induced by bacteriocin action, leads to cell death through cessation of energy-requiring reactions. Low 
intracellular levels of ATP, the inability to carry out active transport of nutrients, and the inability to 
maintain sufficient concentration of cofactors, such as K+ and Mg2+, are all a direct result of PMF collapse 
and will contribute to growth inhibition and cell death (Venema et al., 1995b; Montvile and Chen, 1998). 
Upon membrane insertion, class II bacteriocins are thought to form a barrel-stave like pore (Fig. 2).
According to the corresponding model, the lateral oligomerisation of bacteriocin monomers or the 
complementation of two class IIb peptides that form two-component poration complexes, occurs with the 
hydrophobic side of peptides facing the fatty acid chains of the membrane lipids. The hydrophilic sides of 
D-helical peptides form the inside wall of the water-filled pore (Ojcius and Young 1991). Amphipathic 
structures are essential for this process and the D-helix formed by each bacteriocin monomer must at 
least consist of twenty amino acid residues in order to be able to completely span the membrane (Lear et
al., 1988). The diameter of these pores may vary depending of the number of bacteriocin monomers 
involved (van Belkum et al., 1991b; Chikindas et al., 1993; Venema et al., 1993; Tahara et al., 1996). 
Figure 2. Model of barrel-stave pore formation by peptides.
Immunity and resistance towards bacteriocins 
A bacteriocin producer is insensitive to the bacteriocin it produces thanks to the action of one or 
more immunity proteins. The immunity protein of most of the non-lantibiotic bacteriocins is encoded by a 
gene located immediately downstream of, and in the same operon as, the bacteriocin gene(s) (Nes et al.,
1996). The immunity gene of enterocin B is located downstream of, but in the opposite orientation to the 
bacteriocin structural gene (Franz et al., 1999), while the immunity gene of CbnA is also encoded in 
opposite orientation but not in close proximity to the structural gene (Franz et al., 2000). Although two-
component bacteriocins require the combined action of both peptides for full antimicrobial activity, they 
have only one dedicated immunity protein whose gene is linked to the two bacteriocin structural genes 
(van Belkum et al., 1991a; Diep et al., 1996). Strains that produce multiple bacteriocins produce different 
immunity proteins specific to each of the bacteriocins (Van Belkum, 1994; Diep et al., 1996; Quadri et al.,
1997b). The immunity protein is expressed concomitantly with bacteriocin but, in contrast to bacteriocin 
biosynthesis, it does not require the bacteriocin transport and processing system. 
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Immunity proteins usually have a high pI (Diep et al., 1996) and those associated with one peptide 
bacteriocins consist of 51 to 113 amino acid residues, which adopt an D-helical structure with, normally, 
one or two hydrophobic putative membrane spanning domains (van Belkum et al., 1991a; 1992; Marugg 
et al., 1992; Tichaczek et al., 1993; Venema et al., 1994; Quadri et al., 1994; Axselsson and Holck, 1995; 
Eijsink et al., 1998; Franz et al., 2000). Some immunity proteins are devoid of apparent transmembrane 
helices. Immunity proteins that exert immunity to two-peptide bacteriocins are generally larger, consisting 
of 110 to 154 amino acids. They also contain several putative transmembrane helices (van Belkum et al.,
1991b; Allison and Klaenhammer, 1996). Lately, a new class of immunity proteins was reported: the 
immunity proteins of bacteriocins produced by Lb. plantarum C11 consist of 247 to 257 residues and are 
predicted to span the cytoplasmic membrane seven times (Diep et al., 1996).
The homology observed between some immunity proteins is surprisingly low considering the 
similarity between the bacteriocins to which they give immunity (Aymerich et al., 1996; Nes et al., 1996). 
This is exemplified by Lb. sakei Lb706 and Lb. curvatus LTH1174: they produce the identical bacteriocins 
sakacin A and curvacin A, respectively, while their respective immunity proteins lack any apparent 
similarity (Tichaczek et al., 1992; Axelsson and Holck 1995). However, as more bacteriocin loci are being 
characterised, it has become apparent that many of the identified immunity proteins do exhibit significant 
similarity to other immunity proteins, particularly in their C-terminal regions (Quadri et al., 1995; Aymerich 
et al., 1996; Cintas et al., 1997; Franz et al., 2000). It has been speculated that, in addition to providing 
total immunity against the cognate bacteriocin, immunity protein may also allow a certain level of cross 
protection of the bacterial cell against other closely related bacteriocins. Franz et al. (2000) have shown 
that the immunity genes of CnbA and enterocin B can be exchanged to confer cross protection against 
the corresponding bacteriocins. 
Although the lactococcin A immunity protein LciA is the only immunity protein studied in detail (Fig.
3), it seems that an important group of immunity proteins like LciA exert their activity at the level of the 
cytoplasmic membrane (Nissen-Meyer et al., 1993; Venema et al., 1994; Quadri et al., 1995). Cell-
fractionation studies with purified LciA showed that approximately 50% of the protein is located in or at 
the cell membrane, with the remainder present in the cytoplasm (Nissen-Meyer, 1993; Venema et al.,
1994). Computational analysis of LciA suggests that it contains a putative D-amphiphilic helix (residues 
29 to 47), which could span the cytoplasmic membrane, whereas the C-terminal part of the protein is 
located outside of the cell (Venema et al., 1994). LcnA acts on intact cells and membrane vesicles but not 
on liposomes (lacking proteins and non-lipid constituents), suggesting that a specific membrane 
receptor(s) is involved in the recognition process between host and bacteriocin (van Belkum et al.,
1991b). The D-amphiphilic helix of LciA is believed to interact with and block the bacteriocin receptor. 
Although LcnA can still bind to the LciA-occupied receptor, bound LciA prevents LcnA from inserting into 
the membrane and forming pores (Venema et al., 1994). The cellular localisation and mode of action of 
class IIa immunity proteins without apparent membrane-spanning helices is not yet known (Quadri et al.,
1995; Eijsink et al., 1998), although membrane association of such proteins can not be excluded. This 
seems to be supported by the finding that membrane vesicles derived from cells producing the pediocin 
immunity protein are highly resistant to pediocin (Chickindas et al., 1993). 
Chapter 1 
18
Besides the immunity that is genetically linked to bacteriocin production, which exerts the strongest 
level of insensitivity, bacteriocin resistance i) can occur as the appearance of spontaneous mutations 
following selection in the presence of bacteriocin, or ii) can be conferred by a gene that is not genetically 
linked with bacteriocin production. Increased tolerance of the foodborne pathogen Listeria
monocytogenes to nisin has been related to cell wall changes (Davies et al., 1996) and alteration in both 
the fatty acid and the phospholipid content of the bacterial membranes (Mazzotta and Montville, 1997; 
Verheul et al., 1997). In spontaneous L. monocytogenes mutants with high-level resistance to class IIa 
bacteriocins an increased expression of two putative E-glucoside-specific PTS genes, EIIBgl and a 
phospho-E-glucosidase homologue was observed and all strains no longer synthesised the MptA subunit 
from a mannose-specific PTS, EII tMan (Gravesen et al., 2000; 2002). Lactococcal strains producing 
proteinase PrtP, are more resistant against lactococcins, because the proteinase degrades them (this 
thesis, Chapter 4). 
Besides NisI, the nisin immunity protein (Kuipers et al., 1993) NisF, NisE, and NisG were shown to 
confer an insensitive phenotype (Siegers and Entian, 1995). The NisE and NisG proteins are both 
predominantly hydrophobic with six transmembrane domains, while NisF contains two potential 
consensus ATP-binding sites. Based on homology with E.coli MalFGK and HisMQP transporters and 
SpaFG and MsbFE, which are involved in resistance against subtilin and microcin B17, respectively, it 
was proposed that NisE and NisF constitute an ATP-dependent translocator (Siegers and Entian, 1995). 
NisG was predicted to have a similar function in resistance to nisin as colicin immunity proteins (Siegers 
and Entian, 1995). A comparable gene cluster epiFEG encoding proteins with a similar function has been 
described for the lantibiotic epidermin produced by Staphylococcus epidermidis (Peschel and Götz, 
1996).
Resistance towards two lactococcal bacteriocins LsbA and LsbB produced by L. lactis BGMN1-5 is 
mediated via a single protein, LmrB. LmrB is an ATP-binding-cassette-type multidrug resistance 
transporter protein with 6 putative D-helical transmembrane segments in the N-terminus. LmrB is likely to 
be active as a homodimer (this thesis, Chapters 2 and 3). It mediates resistance towards LsbA and LsbB 
most likely by extruding the two polypeptides from the cytoplasmic membrane (this thesis, Chapters 2 
and 3). Apart from conferring insensitivity towards antimicrobial peptides produced by bacteria, LmrB can 
also confer resistance towards a number of eukaryotic antimicrobial peptides e.g. magainin II and 
cecropin P1 and to several organic drugs and antibiotics (this thesis, Chapter 3). 
Figure 3. Model for the mode of
action of LciA, the lactococcin A
immunity protein, according to
Venema et al. (1994). The
putative bacteriocin receptor (R)
is depicted as a transmembrane
protein. The amphiphilic helix in
LciA (black area) is located in the
cytoplasmic membrane. It
interacts with a hydrophilic area
in the receptor (light grey area).
LciA prevents insertion of LcnA
into membrane, although binding
of LcnA to the receptor still
occurs. N, N-terminus. See the
text for more details.
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Antimicrobial peptides of eukaryotes 
Ribosomally synthesised antimicrobial peptides are also produced by mammals, birds, amphibia, insects 
and plants (Diamond, 2001; Zasloff, 2002). So far, more than 500 different peptides have been isolated 
(an online catalogue of these molecules can be found at http://www.bbcm.univ.trieste.it/~tossi/
antimic.html). In mammals, the antimicrobial peptides are expressed in phagocytes and mucosal 
epithelial cells (Lehrer et al., 1993; Boman, 1995). Bacterial infection in insects induces the release of 
antimicrobial peptides from blood cells and the insects fat body (the functional counterpart of the 
mammalian liver) into haemolymph (Boman, 1995). Frogs produce antimicrobial peptides in glands in the 
skin (Zasloff, 1984). These antimicrobial peptides are the key effector molecules of the host defence 
system commonly referred to as “innate immunity”. In contrast to bacteriocins, which have relatively 
narrow inhibitory spectra, many of eukaryotic antimicrobial peptides show activity against bacteria (Gram+
and Gram-), yeast, fungi, and even certain enveloped viruses and protozoa (Lehrer et al., 1993; Martin et
al., 1995). 
All eukaryotic antimicrobial peptides are derived from larger precursors containing a signal 
sequence. Post-translational modifications can include proteolytic processing, glycosylation (Bulet et al.,
1993), carboxy-terminal amidation, amino acid isomerisation (Simmaco et al., 1998), or halogenation. 
Although they form a diverse group of peptides on basis of their primary structures, they are amphiphilic 
and often cationic due to the over-representation of the basic amino acids arginine and lysine. The 
African clawed frog’s magainin is an D-helical linear peptide (Zasloff et al., 1987). The pig leukocyte 
peptide protegrin (Fahrner et al., 1996) and human defensins (D and E) (Selsted et al., 1985) are 
molecules that contain a relatively rigid anti-parallel E-sheet which is stabilised by two or three conserved 
disulfide motifs, respectively. The structural principle underlying eukaryoric antimicrobial peptides is their 
ability to adopt a shape in which clusters of hydrophobic and cationic amino acids are spatially organised 
in discrete sectors of the molecule (Zasloff, 2002). The nature of the peptides (cationic and hydrophobic) 
is important for the initial interaction with bacterial membranes.
The activity of most eukaryotic antimicrobial peptides can be explained by the Shai-Matsuzaki-
Huang model (SMH), which includes the formation of holes in the membrane (Matsuzaki, 1999; Shai, 
1999; Yang et al., 2000). The model proposes the interaction of the positively charged peptide with the 
negatively charged bacterial phospholipid-containing membrane. This interaction is followed by i) 
displacement of lipids, ii) “worm hole” formation, iii) alteration of membrane structure, and in certain cases 
entry of the peptide into the interior of the target cells. In general, peptides operating by the SMH 
mechanism kill microbes at micromolar concentrations. In contrast, their bacterial counterparts (e.g. the 
lantibiotic nisin, which binds with high affinity to lipid II) operate at nanomolar concentrations (Breukink et
al., 1999). 
MULTIDRUG RESISTANCE (MDR) 
Bacteria have developed various mechanisms to resist the toxic effect of antibiotics and other drugs. 
They either enzymatically degrade or inactivate them (Davies, 1994) or the targets of the drugs can be 
altered through mutation or enzymatic modification (Spratt, 1994). In addition, the highly impermeable 
outer membrane of Gram-negative bacteria prevents entrance of a variety of toxic compounds into the 
cell (Nikaido, 1994). A mechanism that ensures a significant level of drug resistance is the active efflux of 
drugs by specialised membrane proteins. In contrast to specific drug transporters, which are fairly specific 
for a given drug or class of drugs, the so-called multidrug transporters can handle a wide variety of 
compounds with different chemical structures and cellular targets (Lewis et al., 1997). On the basis of 
bioenergetic and structural criteria, multidrug transporters can be divided into two major classes (Fig. 4):
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i) secondary multidrug transporters - utilising the transmembrane electrochemical gradient of 
protons or sodium ions; 
ii) ABC transporters - using the free release of phosphate bond-energy by ATP hydrolysis. 
Figure 4. Schematic representation of (1) secondary multidrug transporter and (2) ABC-type multidrug transporter 
Secondary multidrug transporters 
These transporters mediate the extrusion of toxic compounds from the cell in a coupled exchange with 
protons (reviewed by: Paulsen et al., 1996; Putman et al., 2000a). On the basis of their size and 
similarities in primary and secondary structures, secondary multidrug transporters can be divided into 3 
distinct families. Representatives of each family are listed in Table 1. 
I Major facilitator superfamily (MFS). These transporters are found in bacteria as well as in lower 
and higher eukaryotes. They are involved in the symport, antiport, or uniport of various substrates such 
as sugars, Krebs cycle intermediates, phosphate esters, oligosaccharides and antibiotics (Marger and 
Saier, 1993). Hydropathy and phylogenetic analyses of the resistance-conferring drug efflux proteins 
revealed that these proteins can be divided into two separate clusters, with either 12 or 14 
transmembrane segments (TMS) (Paulsen and Skurray, 1993).
II Small multidrug resistance family (SMR). Multidrug transporters belonging to this family are the 
smallest secondary drug efflux proteins known. They generally consist of about 110 amino acid residues 
that are predicted to form 4 TMS. Their small size has led to propose that SMR proteins may function as 
homo-oligomeric complexes (Paulsen et al., 1995). In contrast, EbrAB and YkkCD of B. subtilis are 
composed of two dissimilar but homologous subunits (Masaoka et al., 2000; Jack et al., 2000). One 
member of each pair is short (105 to 106 amino acids), while the other is longer (111 to 117 amino acids) 
(Jack et al., 2000). 
III Resistance-nodulation-cell division family (RND). Hydrophaty analyses and alignments of 
conserved motifs of the RND-type efflux proteins revealed that these proteins consist of 12 TMS with two 
large external loops situated between TMS 1 and 2 and TMS 7 and 8 (Saier et al., 1994). In Gram-
negative bacteria RND proteins interact cooperatively with a membrane fusion protein and an outer 
membrane protein to allow drug transport across both the inner and outer membrane of the cell envelope. 
Multidrug transporters of MFS and SMR families have been found in both Gram-positive and Gram-
negative bacteria while, so far, RND-type multidrug transporters have only been identified in Gram-
negative bacteria. Some bacteria, e.g. B. subtilis, E.coli and S. aureus contain several multidrug 
transporters from different families. 
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Table 1. Secondary multidrug transporters in bacteria 
Multidrug
transporter family 
Protein           Organism           Reference 
MFS family    
 12-TMS cluster NorA Staphylococcus aureus Yoshida et al., 1990 
 Bmr B. subtilis Neyfakh, 1992 
 LmrP L. lactis Bolhuis et al., 1995 
 Bcr E.coli Bently et al., 1993 
 EmrD E.coli Noroditskaya et al., 1993 
 MdfA E.coli Edgar and Bibi, 1997 
 Tap Mycobacterium fortium
M. tuberculosis
Ainsa et al., 1998 
 14-TMS cluster QacA Staphylococcus aureus Rouch et al., 1990 
 QacB Staphylococcus aureus Paulsen et al., 1996 
 Bmr3 B. subtilis Ohki and Murata, 1997 
 EmrB E.coli Lomovskaya and Levis, 1992 
    
SMR family EmrE E.coli Morimyo et al., 1992 
 Mmr M. tuberculosis De Rossi et al., 1998 
 Smr Staphylococcus aureus Grinius et al., 1992 
 QacE Klebsiella aerogenes Paulsen et al., 1993 
 EbrA B. subtilis Masaoka et al., 2000 
 EbrB B. subtilis Masaoka et al., 2000 
 YkkC B. subtilis Jack et al., 2000 
 YkkD B. subtilis Jack et al., 2000 
    
RND family MexB Pseudomonas aeruginosa Poole et al., 1993
 MexD Pseudomonas aeruginosa Poole et al., 1996
 MexF Pseudomonas aeruginosa Kohler et al., 1997 
 MexY Pseudomonas aeruginosa Mine et al., 1999 
 AcrB E. coli Ma et al., 1993 
 AcrF E. coli Klein et al., 1991 
 YhiV E. coli Ma et al., 1995 
Energetics of drug transport by secondary multidrug transporters 
Drug transport of the secondary multidrug transporters is driven by the PMF of the transmembrane 
electrochemical proton gradient. Based on the sensitivity of drug transport to the ionophores nigericin and 
valinomycin, which selectively dissipate the 'pH, it is assumed that secondary drug transporters function 
as drug/proton antiporters. Transport experiments in the presence of valinomycin and/or nigericin showed 
that both 'pH and '< provide driving force of LmrP mediated transport (Bolhuis et al., 1996a; Putman et
al., 1999), consistent with an electrogenic exchange of one lipophilic cation for two or more protons. 
Electrogenic drug nH+ (nt2) antiport was also observed for NorA, QacA and Smr. This appears to be a 
general feature of multidrug transporters of the MFS and SMR family and may also be the mechanism for 
the RND-type multidrug transporters. 
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ATP-dependent multidrug transporters 
ABC multidrug transporters utilise the ' free energy from ATP hydrolysis to pump drugs out of the cell. In 
general, they consist of four distinct domains: two highly hydrophobic domains, usually consisting of 6 
putative D-helical transmembrane segments, and two hydrophilic nucleotide-binding domains (NBDs). 
The latter contain the features of an ABC-type ATPase: the ABC signature sequence and the Walker A 
and B motifs (Higgins, 1992). 
Most bacterial ATP-dependent drug transporters known to date mediate the export of specific 
antibiotics (Ross et al., 1990; Guilfolie and Hutchinson, 1991; Fath and Kolter, 1993; Linton et al., 1994; 
Olano et al., 1995). In contrast to secondary multidrug transporters, which are widely distributed in 
bacteria, LmrA and LmrB of L. lactis are so far the only ABC-type multidrug transporters identified and 
characterised in bacteria (van Veen et al., 1996; this thesis, Chapter 3). LmrA of L. lactis MG1363 is a 
590-amino-acid membrane protein with an N-terminal hydrophobic domain with 6 putative 
transmembrane helices, and a C-terminal hydrophilic domain containing the ATP-binding site (van Veen 
et al., 1996). It shares significant sequence similarity with members of the P-glycoprotein family of ABC 
transporters, most notably the human multidrug resistance P-glycoprotein (34% sequence identity, 50% 
similarity with each of the two halves of P-glycoprotein), which is one of the causes of failure of 
chemotherapeutic treatment in human cancers (Endicott and Ling, 1989; Borst and Elferink, 2002). Like 
many eukaryotic ABC transporters, P-glycoprotein has two transmembrane and two ATP-binding 
domains fused into a single polypeptide. This monomeric, four-domain protein was shown to be a 
functional unit (Higgins et al., 1997; Rosenberg et al., 1997). In contrast, LmrA appears to be a half-
transporter, suggesting that it functions as a homodimer. This was confirmed by several observations. 
First, studies of the expression of covalently linked dimers composed of i) wild-type LmrA units, ii) 
mutated LmrA units containing an inactivated nucleotide-binding domain and iii) combinations of wild-type 
and mutated LmrA, showed that only the wild-type dimeric form of LmrA retained full ATPase activity and 
the ability to transport ethidium bromide from the cell (van Veen et al., 2000). Secondly, co-reconstitution 
into proteoliposomes of wild-type and mutated LmrA demonstrated the negative dominance of mutated 
over wild-type units (van Veen et al., 2000). Thirdly, electron microscopic analysis of purified and 
functionally reconstituted LmrA (dimer) revealed small and uniform particles with a diameter of 8.5 nm by 
5 nm (S. Scheuring, A. Margolles, H.W. van Veen, W.N. Konings and A. Engel, unpublished data), similar 
to those previously observed for monomeric P-glycoprotein (Rosenberg et al., 1997). From the above 
observations it was concluded that the dimeric state is a prerequisite for function. 
Interestingly, LmrA is not only a structural, but also a functional homologue of P-glycoprotein. When 
expressed in humans lung fibroblast cells, it was targeted to the plasma membrane and conferred 
multidrug resistance in these human cells, indicating that this type of efflux pump is conserved from 
bacteria to man (van Veen et al., 1998). Besides eukaryotic multidrug transporters, LmrA is also 
homologous to prokaryotic ABC transporters such as the hop-resistance protein HorA in Lactobacillus
brevis (Sami et al., 1997) and ABC proteins in B. subtilis, E.coli (van Veen and Konings, 1998). Recent 
studies of major human pathogens have revealed the presence of lmrA-like genes in the genomes of S.
aureus, S. epidermis, Streptococcus pneumoniae, Enteroccocus faecalis, Mycobacterium tuberculosis
and several others. As an exceptionally broad range of antibiotics is transported by LmrA e.g. 
aminoglycosides, lincosamides, macrolides, quinolones, streptogramins, tetracyclines and 
chloramphenicol (Putman et al., 2000b), it has been suggested that ABC-type multidrug transporters may 
play a role in antibiotic resistance development in human bacterial pathogens.
The lactococcal bacteriocin LsbB is a substrate for LmrA and LmrB (this thesis, Chapter 3). When 
LsbB is added together with antibiotic e.g. minocycline (class: tetracyclines), azytromycin (class: 
macrolides) to lactococcal cells expressing LmrB, this leads to increased sensitivity of the cells to the 
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antibiotic compared with the situation when no bacteriocin was added (this thesis, Chapter 3). These data 
suggest that LsbB or analogues thereof might be able to sensitise multi-antibiotic resistant bacterial 
strains in those cases where resistance is based on multidrug resistance transporter proteins. 
Drug extrusion 
Although the substrates that interact with multidrug transporters have variable structures, they share 
physical characteristics such as high hydrophobicity, amphiphilic nature and positive or neutral charge. 
These characteristics allow partitioning of the molecules into the phospholipid bilayer and it seems likely 
that they are transported from the membrane (Higgins and Gottesman, 1992; Speelmans et al., 1996; 
Ueda et al., 1997) rather than from the cytoplasmic aqueous phase (Altenberg et al., 1994). Two models 
exist that try to incorporate all available literature data (Fig. 5): multidrug transporters bind the 
amphiphatic substrates within the cytoplasmic (inner) leaflet of the membrane and transport them across 
the membrane 1) directly into the external water phase (vacuum cleaner model) (Raviv et al., 1990; 
Bolhuis et al., 1996b), or 2) into the exoplasmic (exterior) leaflet of the membrane from which they would 
diffuse into the external water phase (flippase model) (Higgins and Gottesman, 1992). 
Figure 5. Molecular models for extrusion of hydrophobic drugs by multidrug transporters. (1) vacuum cleaner model, 
(2) flippase model. 
Although recognition of the drugs within the membrane has been shown in several studies, these 
observations do not discriminate between the vacuum cleaner or flippase models. The most convincing 
evidence for drug efflux from the membrane to the aqueous phase, however, was provided by transport 
studies using the fluorescent compounds Hoechst 33342 and TMA-DPH, which are fluorescent only in 
hydrophobic environments but essentially not-fluorescent in an aqueous phase. Transport of these 
compounds can be followed as a decrease of fluorescence in time. Schapiro and Ling (1997) have shown 
that the initial rate of P-glycoprotein-mediated Hoechst 33342 transport is directly proportional to the 
concentration of Hoechst 33342 in the membrane, indicating that P-glycoprotein removes drugs from the 
membrane. 1-[4-(trimethylamino) phenyl]-6-phenylhexa-1,3,5-triene (TMA-DPH) is an amphiphilic, 
cationic and hydrophobic membrane probe, which displays a biphasic interaction with membranes: fast 
entry of the probe into the outer leaflet, followed by a slower transbilayer movement to the inner leaflet of 
the membrane. The initial rate of extrusion of TMA-DPH by LmrA, observed by a decrease in 
fluorescence, increases with increasing concentrations of TMA-DPH in the inner leaflet of the membrane 
(Bolhuis et al., 1996b). These data demonstrate that TMA-DPH is only recognised after partitioning into 
the inner leaflet and is directly exported to the exterior. Interestingly, similar results have been obtained 
for LmrP (Bolhuis et al., 1996a) and QacA (Mitchell et al., 1999) demonstrating that multidrug 
transporters of the ABC, MFS and RND family extrude toxic compounds from the inner leaflet of the 
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cytoplasmic membrane to the aqueous extracellular medium (Fig. 5). Thus, despite differences in energy 
coupling, ATP- and PMF-driven multidrug efflux pumps share similarities in the way they extrude 
compounds from the cytoplasmic membrane. 
Based on vinblastine equilibrium binding experiments, photoaffinity labelling experiments and drug 
transport assays, it has been proposed that homodimeric LmrA mediates drug transport by a two-cilinder
engine mechanism (van Veen et al., 2000). According to this transport model, in a complete drug 
transport cycle, the LmrA dimer exposes four drug-binding sites in two pairs of two sites via an alternating 
two-sites mechanism. This alternating two-site transport mechanism may also apply to P-glycoprotein 
and other ABC transporters. 
Besides the compounds with the features mentioned above, two ribosomally synthesised, 
unmodified linear antimicrobial peptides, LsbA and LsbB produced by L. lactis BGMN1-5, are also 
substrates for bacterial LmrA and LmrB and for human P-glycoprotein (this thesis, Chapters 2 and 3). 
Outline of this thesis 
This thesis deals with the in-depth characterisation of three plasmid-encoded bacteriocins and an 
extracellular cell wall-bound proteinase, PrtP, produced by the L. lactis strain BGMN1-5. Chapter 2 
describes the sequence of, processing of, secretion of and resistance against bacteriocins LsbA and 
LsbB. Secretion and resistance are shown to be mediated by LmrB, a multidrug resistance transporter 
protein. As described in Chapter 3, LmrB confers not only resistance to the bacteriocins LsbA and LsbB, 
but also to eukaryotic antimicrobial peptides. Furthermore, this chapter focuses on the functional 
conservation between LmrB and its eukaryotic counterpart P-glycoptotein. The nucleotide sequence of 
the third bacteriocin produced by L. lactis BGMN1-5, LcnB, its medium-dependent production and its 
sensitivity to lactococcal proteinase PrtP with the PI-type caseinolytic specificity, is described in Chapter 
4. In Chapter 5 the expression of the divergently oriented proteinase and maturase genes (prtP and 
prtM), with respect to the peptide concentration in the growth media was studied. The repressor CodY 
was shown to be responsible for proteinase repression in peptide-rich media. Chapter 6 deals with the 
function of 60-amino-acids-long C-terminal cell wall spanning domain (CWS) of PrtP. A natural 
duplication of this domain causes sedimentation of lactococcal cells due to protein-protein interaction of 
the extracellularly exposed CWS on the cells.
References
References are listed in Chapter 9. 
25
Chapter 2
Novel mechanism of bacteriocin secretion and 




A natural isolate of Lactococcus lactis was shown to produce two narrow spectrum 
class II bacteriocins, designated LsbA and LsbB. The cognate genes are located on a 
5.6-kb plasmid within a gene cluster specifying LmrB, an ATP-binding-cassette-type 
multidrug resistance transporter protein. LsbA is a hydrophobic peptide that is initially 
synthesised with an N-terminal extension. The housekeeping surface proteinase HtrA 
was shown to be responsible for the cleavage of precursor peptide to yield the active 
bacteriocin. LsbB is a relatively hydrophilic protein synthesised without an N-terminal 
leader sequence or signal peptide. The secretion of both polypeptides was shown to 
be mediated by LmrB. An L. lactis strain deficient in the LmrB homologue LmrA is 
unable to secrete either of the two bacteriocins. Complementation of the strain with an 
active LmrB protein resulted in restored export of the two polypeptides across the 
cytoplasmic membrane. When expressed in an L. lactis strain that is sensitive to LsbA 
and LsbB, LmrB was shown to confer resistance towards both bacteriocins. It does so, 
most likely, by extruding the two polypeptides from the cytoplasmic membrane. This is 
the first report in which a multidrug transporter protein is shown to be involved in both 
secretion and immunity of antimicrobial peptides. 
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Bacteriocins are ribosomally synthesised antimicrobial peptides produced by a large variety of bacteria 
(Tagg et al., 1976; Klaenhammer, 1993). This group of antibacterial compounds is also found in plants 
(e.g. thionins: Broekaert et al., 1995) and animals (e.g. defensins, magainins and cecropins: Zasloff, 
2002). The eukaryotic antimicrobials share a number of structural similarities with bacterial bacteriocins 
such as a very small size and considerable amphiphilicity. 
Most bacteriocins produced by the Gram-positive lactic acid bacteria (LAB) characterised to date 
are small (less than 6 kDa), cationic and amphiphatic membrane permeabilizing peptides (Klaenhammer, 
1993). They can be classified into three main groups (Nissen-Meyer and Nes, 1997). Group I comprises 
the lantibiotics, which contain post-translationally modified amino acids, such as lanthionine and E-
methyllanthionine and the dehydrated residues dehydroalanine and dehydrobutyrine (Jung, 1991; Sahl et
al., 1995). Group II, consisting of the unmodified heat-stable peptide bacteriocins (the nonlantibiotics) can 
be further divided into: IIa) the pediocin-like bacteriocins (Stoddard et al., 1992; Cintas et al., 1997), IIb) 
the two-peptide bacteriocins, which require the complementary action of two peptides for full antimicrobial 
activity (van Belkum et al., 1991; Hayema et al., 1991) and IIc) other unmodified bacteriocins. Group III 
contains larger and heat-labile bacteriocins. Bacteriocins are mainly synthesised as precursor peptides 
with an N-terminal leader sequence (Nes et al., 1996). The primary translation product of most 
nonlantibiotics and some lantibiotics contains a leader peptide of the double-glycine-type (Gly-2-Gly-1),
which is cleaved off during export across the cytoplasmic membrane by dedicated ATP-binding cassette 
(ABC) transporters and their accessory proteins (Franke et al., 1996; Håvarstein et al., 1995). Some 
bacteriocins e.g. divergicin A, enterocin P and listeriocin 743A (Cintas et al., 1997; Kalmokoff et al., 2001) 
are exported across the cytoplasmic membrane by the general secretory pathway (Worobo et al., 1995). 
They contain canonical sec signal peptides consisting of a positively charged N-terminus, a hydrophobic 
core, and a defined cleavage site that is removed by a specific signal peptidase during translocation. 
Some bacteriocins produced by Enterococcus faecium e.g. enterocin L50A and L50B, and enterocin Q 
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have recently been shown to be synthesised without an N-terminal leader sequence or signal peptide 
(Cintas et al., 1998; 2000).
All bacteriocin producers are insensitive to the bacteriocin(s) they produce. The genetic 
determinants proposed or confirmed to confer immunity are frequently found downstream of the 
bacteriocin structural gene(s) in the bacteriocin operon (Klaenhammer, 1993; Nes et al., 1996). These 
immunity proteins usually have a high pI and those that are associated with one-peptide bacteriocins are 
generally small in size (51 to 113 aa) and contain no or only a few (one to two) potential transmembrane 
helices (van Belkum et al., 1991a; Venema et al., 1994; Nes et al., 1996). 
Here, we report the characterisation of two novel and highly different bacteriocins, LsbA and LsbB, 
produced by Lactococcus lactis. The cognate genes were cloned and sequenced and their transcription 
was analysed. Also, the processing mechanism of LsbA, the secretion of both bacteriocins, as well as the 
resistance mechanism against both peptides were studied. Both secretion and immunity were found to 
rely on the activity of a single multidrug resistance (MDR) transporter protein. 
Results
Sequence analysis of the locus responsible for bacteriocin production in L. lactis BGMN1-5
L. lactis subsp. lactis BGMN1-5 has been previously shown to produce two class II bacteriocins, Bac513 
and Bac501 (Gajic et al., 1999). By means of plasmid curing, derivatives of L. lactis BGMN1-5 have been 
obtained that lack one or more of the five resident plasmids. Bac513 has been shown to be only 
produced when a 5.65-kb plasmid (pMN5) was present. The genetic information for the production of 
Bac501 is located on a 80-kb plasmid (Gajic et al., 1999) and will not be further discussed. Subcloning of 
the two EcoRI fragments of pMN5 revealed that the genetic information for the production of and 
immunity towards Bac513 is located on the 3.28kb EcoRI fragment of pMN5 (Fig. 1A). Three open 
reading frames (ORF’s) could be discerned in the nucleotide sequence of this region (Fig. 1C). The first 
ORF could encode a peptide of 67-amino-acid residues witha calculated molecular mass of 7.8 kDa. The 
ATG start codon is preceded by a potential ribosome binding site (GAGGA), but no obvious -35 and -10 
consensus promoter regions were present. Two 12-bp inverted repeats separated by 4 nucleotides are 
present immediately downstream of this ORF, which could form a stable stem-loop structure with an 
estimated 'Gº of 15.2 kcal/mol (-63.6 kJ/mol) and could serve as a bidirectional rho-independent
transcription terminator (Platt, 1986). The divergently oriented ORF could specify a 30-amino-acid 
peptide with a calculated molecular mass of 3.4 kDa. The gene is preceded by a strong potential 
ribosome binding site (AGAAAGGAAG). The third ORF could encode a protein of 567 amino acid 
residues with a calculated molecular mass of 63.8 kDa. This ORF is preceded by a potential ribosome
binding site (AAAGGAAG) and is located immediately downstream of the oppositely oriented second 
ORF. Both genes are separated by a 96-bp intergenic region.
The deduced amino acid sequences of the two small ORFs do not share mutual similarity, nor do 
they show homology with any entry in the protein databases. The product of the large ORF shares 34% 
sequence identity with the multidrug transporter protein LmrA of L. lactis MG1363 (van Veen et al., 1996) 
and, like LmrA, is a half size version of the human multidrug resistance P-glycoprotein (Gottesman et al.,
1995). Based on this homology the gene was labelled lmrB. LmrB is homologous to many pro- and 
eukaryotic ABC transporters and to the hop resistance protein HorA of the beer-spoilage bacterium 
Lactobacillus brevis (Sami et al., 1997). 
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  1 ataagtattt acagttggaa cttgatggaa atgtaaaaaa aggattttgg aaaaatttat ttaatttcaa aaaatagaga 
       RBS 
 81 gttaatgagg atatttaaaa tgataattgt aggaattata tttttgttcg tatttttagc tataacaata ggtttatctt 
          M  I  I   V  G  I  I   F  L  F   V  F  L   A  I  T  I   G  L  S  
      lsbA Æ
161 ttgaagtctt taagaaaaag aaaagaaata ttggaacctt tgtgtttttt gctatagcat tattttgtac tgtcatgttt 
     F  E  V   F  K  K  K   K  R  N   I  G  T   F  V  F  F   A  I  A   L  F  C   T  V  M  F 
241 gcctatttgt tattgactaa tcaatatgtt ccaattgatt ataatgtacc aagatatgca taataaaaac tgcaactatt 
      A  Y  L   L  L  T   N  Q  Y  V   P  I  D   Y  N  V   P  R  Y  A   * 
301 gttgcagttt ttccttaata gcttaagctt ttccacgttc ccatggatag ccgccagttt tctttttatg actagcaata 
                            *  A  K   G  R  E   W  P  Y  G   G  T  K   K  K  H   S  A  I  D 
                                                     RBS                   -10 
381 tcgtagccag caacaaaacg taggattgtt ttcataggtt tacttccttt ctatcaagat acaataataa tatcataaaa 
      Y  G  A   V  F  R   L  I  T  K   M 
Å lsbB
       -35     -35            -10           RBS 
461 attagaaaat gtgatattct gttaataata aaaaaaggaa gtgataaatt tatgaaattt
                                                              M  K  F
lmrB Æ
Figure 1. (A) Linear map of pMN5. Positions and orientation of genes are indicated by the block arrows, promoters 
by vertical arrows and putative terminator structures by ball-and-stick symbols. The DNA fragment of which the 
sequence is presented in Figure 1C is boxed. (B) Analysis of transcription of lsbA.The products obtained by PCR 
amplification of reverse transcribed (RT) mRNA using the oligonucleotides located within repA (lane 2) and at the 5’-
end of repA and within lsbA (lane 4). PCR amplification of the control samples, without RT reaction (lanes 1 and 3). 
The sizes of the products are indicated in the right margin. In the left panel the location of the PCR products on the 
map in panel A is shown. (C) Nucleotide sequence of a 530-bp DNA fragment from pMN5 containing the structural 
genes of LsbA and LsbB and the start of lmrB. The deduced amino acid sequences are shown below the DNA 
sequence. Putative ribosomal binding sites (RBS) and –35 and –10 promoter sequences are overlined. Start codons 
are indicated in bold face. The horizontal arrows indicate a potential rho-independent transcription terminator 
sequence. The cleavage site in pre-LsbA is indicated by a vertical arrow.
Bac513 activity is a mixture of two bacteriocins 
The L. lactis BGMN1-5 plasmid pMN5 has been shown to specify bacteriocin activity, which has been 
named Bac513 (Gajic et al., 1999). In order to investigate which of the two small ORFs carried by the 
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lactococcal expression vector, downstream of the nisin-inducible promoter PnisA (Kuipers et al., 1998). 
The two plasmids pNZLsbA and pNZLsbB, carrying the 67-codon and the 30-codon ORFs, respectively, 
were introduced in L. lactis NZ9000. The supernatants of both strains were shown to inhibit the growth of 
L. lactis subsp. lactis IL1403, indicating that the gene products of both ORFs had antimicrobial activity. 
The two peptides do not act synergistically, since the titre of a mixture of both was the same as the sum 
of the individual titres. Hereafter, the gene products are designated LsbA and LsbB for the 67- and the 
30-residues peptides, respectively.
Neither LsbA nor LsbB inhibits the growth of strains of the Grampositive species Lactobacillus,
Leuconostoc, Bacillus, Enterococcus and Staphylococcus or that of several Gramnegative bacteria 
tested (E. coli C600, Salmonella thyphimurium LT2, Pseudomonas sp.). In fact, only closely related L.
lactis strains are inhibited, showing that both bacteriocins exhibit a very narrow antibacterial spectrum.  
Analysis of transcription of the bacteriocin encoding genes 
No consensus promoter sequence is present immediately upstream of lsbA. In accordance with this 
observation, no transcription initiation start site could be determined by primer extension mapping. A 
promoter sequence (P1) is present upstream of the preceding gene, that of the plasmid replication protein 
RepA (Fig. 1A). Primer extension analysis confirmed the position of this postulated promoter, 80 nt 
upstream of the repA start codon (data not shown). RT-PCR on total RNA isolated from L. lactis (pMN5) 
with a primer located within lsbA and one immediately upstream of repA gave a product of the expected 
size (1457 bp; Fig. 1B). An equal amount of total RNA sample was amplified with the same primers 
without a prior RT-PCR to confirm that no contaminating DNA material was present. These data indicate 
that lsbA and repA are located in one operon and form a transcriptional unit. 
The region between lsbB and lmrB contains two putative promoters P2 and P3 (Fig. 1A). Gene lsbB
is preceded by possible –35 (ATCACA) and –10 (TATTAT) sequences that are 17nucleotides apart. The 
-35 and -10 promoter sequences upstream of lmrB (TTAGAA and AATAAT, respectively, with a spacing 
of 16 nucleotides), could constitute promoter P3 (Fig. 1C). A DNA fragment carrying the expression 
signals of the divergently transcribed lsbB and lmrB genes was inserted, in two orientations, between the 
two promoterless reporter genes in pGKH10 in such a way that translational fusions were created. The 
reporter genes in pGKH10 encode E.coli E–galactosidase and Cyamopsis tetragonoloba D-galactosidase
(Haandrikman, 1990). The lmrB and lsbB genes were shown to be mainly expressed during the 
exponential growth phase (Fig. 2). By comparing E–galactosidase activity levels it was shown that the 
expression signals of lsbB are about 2.5-fold stronger than those of lmrB. Taken together these results 
show that lsbB and lmrB are both actively transcribed. 
Figure 2. Analysis of transcription of lsbB::lacZ (in 
pGKH1) and lmrB::lacZ (in pGKH2) transcriptional 
fusions. Specific E-galactosidase activity of L. lactis
MG1363 carrying pGKH1 (Ÿ) or pGKH2 (Ɣ) during 
growth in GM17 containing the fluorescent 
substrate trifluoromethyl umbelliferyl E-D-
galactopiranoside. Optical density of MG1363 
(pGKH1) (ǻ) and MG1363 (pGKH2) (ż) was 
measured at 595 nm. Specific E-galactosidase
activity was calculated as arbitrary fluorescence 
units divided per time and optical absorbance 






































LsbA is processed by HtrA 
LsbA and LsbB were purified from the supernatant of L. lactis NZ9000 containing either pNZLsbA or 
pNZLsbB, respectively, and the purified peptides were subjected to N-terminal amino acid sequencing. 
The molecular weight of the secreted form of LsbA, estimated after SDS-20% PAGE, was approximately 
3 kDa (Fig. 3), indicating that LsbA is synthesised as a pre-protein. The first five amino acids obtained by 
Edman degradation were Leu-Phe-Lys-Lys-Lys, indicating that the bacteriocin is processed between the 
two putative membrane spanning domains, leaving a highly positive charge on the N-terminus of the 
mature protein (Fig. 1C).
No consensus signal peptidase I or II cleavage site is present in the deduced amino acid sequence 
of LsbA. Instead, the region of cleavage shows similarity with the cleavage site of the housekeeping 
protease HtrA (Kolmar et al., 1996). The production of LsbA was examined in a lactococcal strain in 
which the chromosomally located htrA gene was inactivated by single cross-over homologous 
recombination. As can be seen in Fig. 4A, no active LsbA was present in the supernatant, showing the 
involvement of HtrA in LsbA processing during or after its translocation across the cell membrane.
The amino acid sequence Met-Lys-Thr-Ile-Leu-Arg-Phe-val-Ala-Gly was obtained after Edman 
degradation of purified LsbB. Apparently, the product of lsbB is secreted without N-terminal processing 
(Fig. 1C). 
Figure 3. Detection of purified LsbA and LsbB and 
their activities in an SDS 20% polyacrylamide gel. 
(A) Coomassie briliant blue staining. (B) Bacteriocin 
activity as visualised by an activity overlay assay 
using L. lactis IL1403 as the indicator strain. 15 Pl
of a 10-fold concentrated supernatant of a nisin-
induced culture of L. lactis NZ9000 (pNZLsbA) 
(lanes 1) or L. lactis NZ9000 (pNZLsbB) (lanes 2) 
were applied. Molecular masses (in kDa) of
reference proteins are shown on the left. 
Figure 4. Detection of LsbA and LsbB activities 
using an agar-well diffusion assay. (A) Activity of
LsbA in L. lactis strains NZ9000 and NZ9000'htrA.
(B) LsbB activity of L. lactis strains NZ9000, 
NZ9000'lmrA and NZ9000'lmrA, all carrying 
pNZLsb2-LmrB. The indicator strain used was L.
lactis IL1403.
Lmr-mediated bacteriocin secretion and immunity
31
LmrB renders cells resistant to LsbA and LsbB 
Hydropathy analysis of LmrB suggests the presence in the N-terminus of six putative D-helical
transmembrane segments and a C-terminal, highly conserved hydrophilic nucleotide binding domain. 
This latter domain contains features diagnostic for ABC-type ATPases, such as the ABC signature 
sequence and the Walker A and B motifs (Higgins, 1992). LmrB was shown to be an active MDR 
transporter protein (Gajic, unpublished data). In order to visualise the protein in situ, LmrB was N-
terminally fused to GFP and overexpressed from the nisin inducible PnisA promoter (Kuipers et al., 1998). 
After nisin induction the GFP::LmrB fusion protein was shown to be distributed all along the cytoplasmic 
membrane by fluorescence microscopy (Fig. 5A). In contrast, when expressed alone, GFP was present in 
the cytoplasm (Fig. 5B). 
To examine the possible involvement of LmrB in immunity against LsbA and LsbB, a histidine 
(His6)-tagged variant of the protein was overexpressed in L. lactis by using the nisin controlled gene 
expression system (Kuipers et al., 1998). His6-LmrB was of the expected molecular size (65.4 kDa) in 
Western blotting using monoclonal antibodies directed against the histidine tag (data not shown). L. lactis
strain IL1403 is very sensitive for LsbA and LsbB (data not shown). A derivative of this strain, L. lactis
JIM7049 containing the nisRK genes needed for nisin induction of PnisA was used as the host for His6-
LmrB expression. L. lactis JIM7049 (pNHLmrB) became resistant to both LsbA and LsbB when His6-
LmrB expression was induced with nisin. Moreover, expression in L. lactis JIM7049 of two other 
lactococcal multidrug transporter proteins, LmrA and LmrP, (van Veen et al., 1996; Bolhuis et al., 1995) 
also resulted in resistance against both bacteriocins. These findings demonstrate that resistance to LsbA 
and LsbB can be accomplished via all three MDR proteins. 
LmrA and LmrP are not expressed in L. lactis IL1403 
In contrast to L. lactis IL1403, the growth of L. lactis subsp. cremoris NCDO712 or its plasmid free derivative 
MG1363 is not inhibited by LsbA and LsbB. Strain MG1363 produces both MDR proteins, LmrA and LmrP (van 
Veen et al., 1996; Bolhuis et al., 1995). The lmrA gene is also present in the chromosome of L. lactis IL1403 
(Bolotin et al., 2001) but it is preceded by a nucleotide sequence that is different from that of the region preceding 
lmrA in MG1363. The gene in strain IL1403 is preceded by a potential ribosome binding site (AAAGGAAG), but 
no obvious -35 and -10 consensuspromoter regions could be discerned. Possibly, lmrA is in an operon with the 
upstream-located yhbF, encoding a hypothetical protein. However, two 14-bp inverted repeats separated by 15 
nucleotides are present immediately upstream of the RBS and could form a stable stem-loop structure with an 
estimated 'Gº of 14.9 kcal/mol (-62.3 kJ/mol). This structure could serve as a rho-independent transcription 
terminator blocking transcription of lmrA. Also, the -35 and -10 consensuspromoter regions of the lmrP genes of 
L. lactis strains MG1363 and IL1403 are different. In MG1363, lmrP is preceded by possible –35 (TTGACT) and –
10 (TATAAA) sequences with a spacing of 16 nucleotides (Bolhuis et al., 1995). The putative -35 and -10 
promoter sequences upstream of lmrP in strain IL1403 (TTGCAG and TTTAAA, respectively), most likely do not 
constitute an active promoter. Immediately downstream of both lmrP’s, the oppositely orientedsipX is located. 
Figure 5. Fluorescence microscopy analysis of L.
lactis NZ9000 cells expressing (A) GFP::LmrB 
fusion protein or (B) GFP. Fluorescence was 
visualised using a Zeiss Axiophot microscope (Carl 
Zeiss, Thorns wood, USA) and an Axion Vision 
camera (Axion Technologies, Houston, USA). 
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Northern analysis of the lmr genes in both strains after hybridisation with an lmrA-specific probe 
revealed a transcript of 1.8 kb only in RNA isolated from MG1363. A transcript of 1.3 kb was observed 
with the same RNA when an lmrP-specific probe was used. No transcripts were detected in RNA isolated 
from strain IL1403 with either of the two probes (Fig. 6). These findings demonstrate that, although lmrA
and lmrP are present on the chromosome of IL1403, they are not transcribed.
LmrB is involved in bacteriocin secretion 
The secretion of both bacteriocins by L. lactis was not affected by the addition of 2 mM azide, a known 
inhibitor of the sec translocation pathway in B. subtilis (Klein et al., 1994), to the growth medium (data not 
shown). Next, we examined whether the secretion of both bacteriocins is mediated by LmrB. To this end, 
His6-LsbB was overexpressed in either an lmrA- or lmrP-deficient lactococcal strain. The experiments 
could not be done in an lmrA, lmrP double mutant as such a strain is, apparently, not viable. Lack of 
active LmrP did not have any effect on the secretion of LsbB (data not shown). In contrast, no secretion 
of LsbB was observed in L. lactis NZ9000 ('lmrA) (Fig. 4B). Upon disruption of the cells, active LsbB was 
shown to be present intracellularly by an SDS PAA gel overlay assay (data not shown). The function of 
LmrA could be complemented by LmrB, as was shown by the introduction of pNZLsbB-LmrB in NZ9000 
('lmrA): nisin-induced co-expression of LsbB and LmrB from this plasmid resulted in the secretion of 
active LsbB (Fig. 4B). The same observations were made with respect to the secretion of LsbA (data not 
shown). Taken together these findings show that the multidrug transporter proteins LmrA and LmrB are 
directly involved in the secretion of LsbA and LsbB, while LmrP is not.
Discussion
The data presented here show that L. lactis BGMN1-5 produces three bacteriocins. The antimicrobial 
activity that had previously been labelled Bac513 (Gajic et al., 1999) is, in fact, the result of the concerted 
action of two distinct bacteriocins, LsbA and LsbB. Although LsbB is smaller than LsbA (30 instead of 44 
amino acid residues) and possesses less pronounced cationic and hydrophobic properties, both 
bacteriocins share the characteristic physico-chemical properties of LAB bacteriocins (size, molecular 
weight, isoelectric point, and hydrophobicity) (Klaenhammer, 1993). They are not post-translationally 
modified, since problems typically encountered when determining the amino acid sequence of proteins 
containing residues such as didehydroalanine, didehydrobutyrine, lanthionine and E-methyllanthionine
(Jung, 1991; Sahl et al., 1995) were not observed. Both peptides contain a stretch of 4 to 5 positively 
charged amino acid residues. These are located at the N-terminus of LsbA and in the middle of LsbB. 
LsbA and LsbB are apparently one-peptide bacteriocins since each is active on its own and no additional 
Figure 6. Northern analysis of lmrA and lmrP
transcription. Total RNA (5 Pg) isolated from L.
lactis MG1363 (lane 1) or L. lactis IL1403 (lane 2) 
was hybridised with (A) an lmrA-specific probe or
(B) an lmrP- specific probe.
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bacteriocin encoding genes could be discerned on pMN5. Based on the features described above LsbA 
and LsbB can be regarded as members of LAB bacteriocin group IIc. 
Most bacteriocins are synthesised as precursor peptides containing an N-terminal leader peptide 
with two conserved glycine residues at positions -1 and –2 relative to the cleavage site (Håvarstein et al.,
1995). Translocation across the cytoplasmic membrane and the subsequent removal of the leader 
peptide during maturation is carried out by a dedicated ABC transporter (Håvarstein et al., 1994; 1995; 
Venema et al., 1995). Only a few LAB bacteriocins described to date contain a typical signal peptidase 
cleavage site (von Heijne, 1983) and are secreted by the general secretory pathway (Cintas et al., 1997; 
Worobo et al., 1995; Kalmokoff et al., 2001; Leer et al., 1995). Comparing the amino acid sequence of 
purified LsbA with the deduced amino acid sequence revealed that the bacteriocin is first produced as a 
precursor peptide. Instead of a leader peptide of the double-glycine-type (Håvarstein et al., 1995), or a 
consensus signal peptidase cleavage site (von Heijne, 1983) a possible HtrA cleavage site could be 
discerned in pre-LsbA (Kolmar et al., 1996). HtrA is a surface housekeeping protease in L. lactis, which 
was shown to have a dual function: it acts as a chaperone and as a protease. It is responsible for both 
the degradation and maturation of exported proteins (Poquet et al., 2000). The activation of LsbA by HtrA 
during or after translocation of the bacteriocin across the cellular membrane is a mechanism of 
processing that is distinctly different from that of all other known bacteriocins (Håvarstein et al., 1995; von 
Heijne, 1983).
For most non-lantibiotics, the gene encoding bacteriocin immunity is usually located immediately 
downstream of, and in the same operon as, the bacteriocin structural gene(s) (Klaenhammer et al., 1993; 
Nes et al., 1996). LsbA and LsbB are exceptions to this rule. The gene conferring immunity, lmrB, is 
located immediately downstream of, and in the opposite orientation to lsbB. LmrB is a member of the 
ABC protein superfamily. It is homologous to LmrA of L. lactis MG1363 (van Veen et al., 1996), to 
prokaryotic ABC transporters of B. subtilis, Staphylococcus aureus, E. coli, Campylobacter jejuni and 
Haemophilus influenzae and to the hop resistance protein HorA of the beer-spoilage bacterium 
Lactobacillus brevis (Sami et al., 1997). LmrB is also homologous to eukaryotic ABC transporters, e.g. 
human multidrug resistance P-glycoprotein (Gottesman et al., 1995). LmrB and the other two MDR 
proteins of L. lactis, LmrA and LmrP, were shown here to confer immunity to LsbA and LsbB. In contrast 
to LmrB and LmrA, LmrP is a protone motive force driven-transporter (Bolhuis et al., 1995). These three 
MDR proteins do not render cells resistant to other lactococcal bacteriocins e.g. lactococcins A, B, M/N or 
nisin. They are rather specific for LsbA and LsbB. Bacterial strains that produce multiple bacteriocins also 
produce different bacteriocin specific immunity proteins (Nes et al., 1996; Diep et al., 1996). Here, we 
report that immunity against two distinct bacteriocins relies on the activity of only one protein. The exact 
mechanism(s) by which immunity proteins function is not clear. Those predicted to have transmembrane 
helices, e.g. LciA, are envisaged to interact with and block the receptor for the bacteriocin. By binding to 
the receptor, LciA prevents lactococcin A (LcnA) from inserting into the membrane, although binding of 
LcnA to the receptor still occurs (Venema et al., 1994). In the case of LsbA and LsbB, the protein that is 
responsible for immunity is a multidrug transporter protein. The common feature of most MDR proteins is 
their ability to extrude a wide range of hydrophobic and amphiphilic compounds from the cytoplasmic 
membrane (Gottesman et al., 1995). As both bacteriocins are hydrophobic molecules, it seems likely that 
all three lactococcal multidrug transporters mediate bacteriocin resistance by extruding them from the 
cytoplasmic membrane. Besides conferring immunity, we show that LmrB carries out secretion of both 
bacteriocins. This route of secretion is different from that of all other known bacteriocins and also 





Bacterial strains, plasmids and media
Bacterial strains and plasmids used in this study are listed in Table 1. L. lactis was grown at 30qC in chemically defined 
medium CDM (Mierau et al., 1994), M17 (Difco, West Molesey, United Kingdom) or ½ M17 broth (containing 0.95% E-
glycerophosphate, Sigma Chemicals Co., St. Louis, Mo) as standing cultures, and on M17 agar plates containing 1.5% or 
0.75% (wt/vol) agar. All media contained 0.5% (wt/vol) glucose, while 5 Pg/ml chloramphenicol (Sigma Chemicals Co.) or 
5 Pg/ml erythromycin (Roche Molecular Biochemicals, Mannheim, Germany) were added when needed. 5-bromo-4-
chloro-3-indolyl-E-D-galactopiranoside (Sigma) was used at a concentration of 1 mM.  
DNA techniques and transformation
Molecular cloning techniques were performed essentially as described by Sambrook et al. (1989). Restriction enzymes, 
T4 DNA ligase and ExpandTM High Fidelity DNA polymerase (Roche) were used according to the instructions of the 
supplier. Synthetic oligonucleotides were obtained from Life Technologies B.V. (Breda, the Netherlands). The High pure 
PCR product purification kit (Roche) was used to purify PCR products. For nucleotide sequence analysis the dideoxy 
chain termination method (Sanger et al., 1977) was used with [D-35S]-dATP and the T7 sequencing kit (Amersham 
Pharmacia Biotech, Roosendal, the Netherlands). L. lactis was transformed by electroporation using a gene pulser (Bio 
Rad Laboratories, Richmond, Calif.) as described by Leenhouts and Venema (1993).
Plasmid construction
The lmrB gene was amplified from pMN5 by PCR with oligonucleotides LMRB1 (5’-TCTAGACCACCATGGGGCATCAC
CATCACCATCACGATGACGATGACAAAGCCGAAAGAGG), introducing the underlined NcoI restriction enzyme site 
upstream of the hexa-histidine tag (italic), and LMRB2 (5’-ATATCTAGAGTTAATTGATTCTGAAC), introducing the 
underlined XbaI restriction enzyme site downstream of the stop codon (italic) of lmrB. The purified 1764-bp PCR product 
was digested with NcoI and XbaI and ligated into the corresponding sites in pNZ8048, resulting in pNHLmrB. The lsbB
gene was amplified with oligonucleotides LSBB-1 (5’-CCGGTCATGAAAACAATCCTACG) and LSBB-2 (5’-CTGGTCTAG 
ATTAAGCTTTTCCACG) by using pMN5 as a template. An RcaI and XbaI (underlined) digested PCR product was ligated 
into the NcoI and XbaI sites of pNZ8048, resulting in pNZLsbB. Oligonucleotides LSBA-1 (5’-CCGGTCATGATAATTGTA 
GGAATTATATTTTTG) and LSBA-2 (5’-CTGGTCTAGATTATGCATATCTTGGTAC) were used to amplify lsbA gene from 
plasmid pMN5. The PCR product was digested with RcaI and XbaI (underlined) and ligated into the NcoI and XbaI sites of 
pNZ8048, resulting in pNZLsbA. In order to make an lmrB-lsbB operon, lmrB was amplified by PCR using oligonucleotides 
LMRB3 (5’-CCGGAGCTCTAAAAAGGAAGTGATAAATTTATG) and LMRB2. SacI and XbaI (underlined) digested PCR 
product was ligated into the corresponding sites in pNZLsbB, resulting in pNZLsbB-LmrB. To construct an in frame N-
terminal fusion with the green fluorescent protein (GFP), lmrB was amplified by PCR using LMRB4 (5’-CCGGAATTCATA 
TGAAATTTTTGAAAGACAAATC) and LMRB2 as oligonucleotides. The PCR product was digested with EcoRI and XbaI
(underlined) and ligated into the corresponding restriction enzymes sites of pGFPmut1, containing gfp-mut1 downstream 
of the nisA promoter (PnisA), resulting in pNZGfp-LmrB. All plasmids were introduced in L. lactis NZ9000 to enable nisin 
induction. Nisin induction of PnisA in the pNZ8048 derivatives was performed as described by de Ruyter et al. (1996).
To investigate the transcription of lsbB and lmrB the DNA fragment containing the expression signals of the 
divergently transcribed lsbB and lmrB genes was amplified from pMN5 by PCR using oligonucleotides P1 (5’-CTCG 
TGATCATAGGTTTACTTCCTTTC) and P2 (5’-CAGGTGATCATAAATTTATCACTTCC) containing BclI restriction sites 
(underlined) that overlap the lsbB and lmrB initiation codons. BclI digested PCR product was ligated into the BamHI site of 
pGKH10, resulting in pGKH1 and pGKH2. In plasmid pGKH1, the lacZ gene is under the control of the LsbB promoter, 
whereas the lmrB promoter directs the transcription of the D-galactosidase gene. The promoter fragment is present in the 
reverse orientation in pGKH2. 
Construction of an lmrA deletion strain
The non-autonomously replicating vector pORI280 (Leenhouts et al., 1996) was used to construct an lmrA replacement 
plasmid. The 1561-bp EcoRV fragment encoding the N-terminal portion of LmrA, was deleted from pAPL2 (K. Venema, 
unpublished). The resulting plasmid pAPL3 was digested with ScaI and BamHI yielding a 3.234-kb fragment with the lmrA
deletion and its flanking regions. This fragment was ligated into corresponding sites in pORI280. The resulting plasmid, 
pORILmr, was used to transform L. lactis LL108, which carries the repA gene on the chromosome, thereby allowing the 
pORI280 derivative to replicate. pORILmr isolated from this strain was introduced together with pVE6007 into L. lactis
NZ9000. As this strain does not contain the repA gene, selection for growth in the presence of erythromycin and increased 
temperature (37qC) forces pORILmr to integrate into the chromosome by homologous recombination. A number of 
integrants were subsequently grown for about 30 generations under nonselective conditions allowing a second 
recombination event to occur, which results in either the deletion or the wild-type gene lmrA. The 'lmrA mutation was 
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confirmed by PCR as well as Southern hybridisation experiments.  
Table 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant phenotype or genotype Source or reference 
Strains 
L. lactis subsp. cremoris
MG1363 Plasmid–free derivative of NCDO712  Gasson, 1983  
MG1363'lmrP MG1363 derivative with chromosomal deletion in lmrP Bolhuis et al., 1995 
NZ9000 MG1363 pepN::nisRK Kuipers et al., 1998 
NZ9700 Nisin producing transconjugant containing the nisin-sucrose 
transposon Tn5276
Kuipers et al., 1993 
NZ9000'lmrA NZ9000 derivative with chromosomal deletion in lmrA This work 
NZ9000'acmA 'htrA NZ9000 derivative containing chromosomal deletions in acmA and 
htrA
Leenhouts, unpublished 
LL108 MG1363 derivative carrying the pWV01 repA gene downstream of 
the promoter P23 in its chromosome 
Leenhouts et al., 1996 
L. lactis subsp. lactis 
BGMN1-5 Wild type strain, Bac501+, Bac513+  Gajic et al., 1999 
BGMN1-596 Bac501-, Bac513-; Plasmid-free derivative of BGMN1-5 Gajic et al., 1999 
IL1403 Plasmid-free strain Chopin et al., 1984
JIM7049 IL1403 his::nisR nisK Dronault et al., 2000 
Plasmids
pNZ8048 Cmr, inducible expression vector carrying PnisA  Kuipers et al., 1998 
pNHLmrA his6-lmrA of L. lactis MG1363 behind PnisA Margolles et al., 1999 
pHLP5 his6-lmrP of L. lactis MG1363 behind PnisA Putman et al., 1999 
pORI280 Emr , ori+ of pWV01, replicates only in strains carrying repA in trans Leenhouts et al., 1996 
pMN5 Plasmid carrying lmrB, lsbA and lsbB Gajic et al., 1999 
pNZLsbA Cmr, pNZ8048 carrying lsbA  This work 
pNZLsbB Cmr, pNZ8048 carrying lsbB  This work 
pNHLmrB Cmr, pNZ8048 containing his6-lmrB  This work 
pNZLsbB-LmrB Cmr, pNZLsbB derivative containing lmrB in an operon structure 
with lsbB
This work 
pNZGFP-LmrB Cmr, pGFP-mut1 derivative containing lmrB fused C-terminally to 
gfp
This work 
pGFP-mut1 Cmr, pNZ8048 containing gfp mut1 Campo, unpublished 
pNZ9530 Emr, pIL252 derivative carrying nisRK Kleerebezem et al., 1997 
pVE6007 Cmr, Ts replication derivative of pWV01 Maguin et al., 1992 
pAPL2 Apr, pUC19 carrying a 6063-bp lactococcal chromosomal DNA 
fragment with lmrA gene 
Venema, unpublished 
pAPL3 Apr, pAPL2 with 1561-bp EcoRV deletion This work 
pORILmr pORI280 carrying 3.234-kb ScaI/BamHI fragment from pAPL3, 
containing lmrA deletion and its flanking regions 
This work 
pGKH10 Emr, Cmr, contains promoterless genes for D-Gal and E-Gal Haandrikman, 1990 
pGKH1 Emr, Cmr, contains genes for D-Gal and E-Gal controlled by PlmrB
and PlsbB, respectively 
This work 
pGKH2 Emr, Cmr, contains genes for D-Gal and E-Gal controlled by PlsbB 
and PlmrB, respectively 
This work 
Emr, Cmr Apr, resistance to erythromycin, chloramphenicol and ampicillin, respectively. PlsbB: lsbB promoter, PlmrB: lmrB
promoter, PnisA: nisin inducible nisA promoter, Gal-galactosidase, GFP: green fluorescent protein 
Assay of E-galactosidase activity 
The activity of E-galactosidase was measured during growth of L. lactis in a 96 well microtiter plate (Greiner Bio-One B.V., 
Alphen, the Netherlands) using the GENios microtiterplate reader and Mage4lan software (Tecan, Grödig, Austria). ҏ E-
galactosidase activity was measured by conversion of T657 substrate (trifluoromethylumbelliferyl-E-D-galactopyranoside;
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Molecular probes, Leiden, the Netherlands) into T659 fluorescent product. Fluorescence was followed usiong 
excitation and emission wavelengths of 360 and 535 nm, respectively. Culture optical densities (OD) were measured at 
595 nm. Specific E-galactosidase activity was calculated as arbitrary fluorescence units divided per time and optical 
absorbance (AFU x min-1 x OD595-1).
Bacteriocin activity assays 
Bacteriocin activity was detected using an agar-well diffusion assay (Tagg et al., 1976). To this end, wells made in the 
lawn of soft agar with an indicator strain (106 cells/ml), which was poured onto agar plates, were filled with 50 Pl
aliquots of supernatant. To detect bacteriocin activity on SDS polyacrylamide (PAA) gels, an overlay assay was used 
(Bhunia et al., 1987). The supernatant of a nisin-induced culture of a bacteriocin producer (2 ml) was concentrated 20-
fold by phenol/ether extraction (Sauyé et al., 1995), after which 15 Pl was loaded onto an SDS-20% (wt/vol) PAA gel. 
After electrophoresis the gel was treated twice for 30 min with a mixture of isopropanol (20%) and acetic acid (10%), 
washed with several changes of demineralised water and overlaid with soft agar containing 106 cells/ml of an indicator 
strain, followed by overnight incubation at 30ºC. 
Bacteriocin purification and N-terminal amino acid sequence determination 
LsbA and LsbB were purified from 50 ml of nisin-induced cultures of L. lactis NZ9000 carrying pNZLsbA or pNZLsbB, 
respectively. Cells were removed by centrifugation, after which the supernatant was concentrated 20-fold by 
phenol/ether extraction (Sauyé et al., 1995). The supernatant was dialysed against several changes of demineralised 
water at 4qC, using cellulose ester membranes with a molecular weight cut–off of 1 kDa (Spectra, Por£ CE, Spectrum 
Laboratories, USA). Quantification of protein was done by the method of Bradford, using bovine serum albumin (BSA) 
as a standard. The purified sample was subjected to SDS 20% (wt/vol)-PAA gel electrophoresis (Laemmli, 1970) using 
the Rainbow pre-stained low range molecular weight protein marker (Amersham Pharmacia Biotech) as a size 
reference. The protein band corresponding to active bacteriocin was excised from a Coomassie brilliant blue stained 
SDS-PAA gel and destained for 1 h at RT in a solution of 45% methanol, 10% acetic acid. The purified protein was 
subjected to N-terminal amino acid sequencing (Eurosequence, Groningen, the Netherlands) by means of Edman 
degradation on an automated sequenator (Model 477A, Applied Biosystems) using protocols, chemicals and materials 
from Applied Biosystems (Foster City, CA, U.S.A.). 
RNA analysis 
Primer extension analysis. RNA was isolated from exponentially growing L. lactis cells as described by van 
Asseldonk et al. (1993). Synthesis of cDNA was performed using SUPERSCRIPT transcriptase (Life Technologies). 
mRNA (3.5 Pg) was reverse transcribed using 25 ng of synthetic oligonucleotide REP1 ((5’-
AATTAAGATAGCCTAACTCC), which anneals at the 5’ of the repA), or LSBA ((5’-GTACAAAATAATGCTATAGC), 
which anneals at the 5’ of lsbA) and dATP, dGTP, dTTP, and [D-P32]dCTP (Amersham Pharmacia Biotech). Reaction 
mixtures were incubated for 10 min at 42qC, after which an excess in cold dCTP was added and incubation was 
continued for another 10 min at 42qC. The reaction products were separated by electrophoresis on a 6% 
polyacrylamide urea gel and analysed by autoradiography.
RT-PCR. First strand cDNA synthesis with reverse transcriptase was carried out with the First strand cDNA synthesis 
kit for RT-PCR (AMV) from Roche. mRNA (2 Pg) was reversely transcribed with 50 ng of synthetic oligonucleotide 
LMRB (5’-CTATATTGATACCTTGAC). The cDNA thus obtained was subsequently amplified by PCR using REP2 (5’-
GAAATTGGCAACAACG) in combination with REP3 (5’-CCCAATTCCAAATCGC), or LSBA-3 (5’-GT 
ACAAAATAATGCTATAGC). The size of the obtained PCR products was checked on a 1% (wt/vol) agarose gel. 
Northern hybridisation. RNA for Northern blot analysis was fractionated on a 1 % formaldehyde agarose gel 
(Sambrook et al., 1989). The RNA size marker (0.5 – 9 kb) was from Ambion (Austin, Texas, USA). Purified PCR 
products obtained with the oligonucleotides i) LMRA1 (5’-TGATTGGGATTGTGGCTGG) and LMRA2 (5’-
CAAAACCAATTTGACTCCGCC), containing the 5’ end of lmrA or ii) LMRP1 (5’-CAATGATTTTTGGAAGTGGGC) and 
LMRP2 (5’-CTCATCAACTTTGACTGTGG), containing the 5’end of lmrP, were used as probes. Labelling of probes 
and transcript detection were performed with the ECL detection system (Amersham Pharmacia Biotech) according to 
the manufacturer’s instructions. 
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Multidrug resistance (MDR) is one of the causes of failure of chemotherapeutic 
treatment in human cancers, as exemplified by the action of the human P-
glycoprotein (Chen et al., 1986; Endicott and Ling, 1989; Borst and Elferink, 2002). 
Here we show that LmrB, a novel multidrug transporter protein of Lactococcus lactis,
mediates multidrug resistance by extruding amphiphilic compounds from the 
cytoplasmic membrane. In addition, LmrB confers resistance to the lactococcal linear 
antimicrobial peptides LsbA and LsbB, as well as to the eukaryotic peptides magainin 
II and cecropin P1. Its eukaryotic homologue P-glycoprotein, reconstituted in insect 
cells, is also capable of transporting LsbB across the membrane. LsbA and LsbB are 
shown to compete with compounds that are substrates for transport by both LmrB 
and P-glycoprotein. Moreover, they have the ability to decrease the resistance of cells 
expressing LmrB to clinically relevant macrolides and to tetracyclines. Since 
homologs of LmrB are ubiquitous in pathogenic bacteria, these antimicrobial 
peptides are good candidates for the development of new non-toxic compounds to 
sensitise MDR-based multiantibiotic resistant bacteria.
MDR proteins of eukaryotic cells play a major role in the resistance against cytostatic drugs during 
cancer chemotherapy. However, a physiological function, apart from protecting cells from certain drugs 
and toxic compounds, has not yet been described to the best of our knowledge. Here, we report on 
natural peptide transport by LmrB, an ATP-driven multidrug transporter protein produced by the Gram-
positive bacterium Lactococcus lactis BGMN1-5. LmrB shares 34% sequence identity with LmrA from L.
lactis MG1363 (van Veen et al., 1996; 1998) and is homologous to many pro- and eukaryotic ABC 
transporters. It is a half-size version of the human P-glycoprotein (Higgins, 1992).
A 65.4-kDa histidine-tagged LmrB (His6-LmrB) was expressed from a plasmid in an LmrA-
deficient L. lactis strain (NZ9000'lmrA). By using anti-His6 tag monoclonal antibodies the protein was 
shown to be localised in the cytoplasmic membrane (data not shown). These His6-LmrB-expressing 
cells showed a 40-fold increased resistance to the toxic agent ethidium bromide. The concentration of 
ethidium bromide was measured indirectly by monitoring the fluorescence of the intracellular ethidium-
polynucleotide complex. The accumulation of ethidium bromide in the glucose-energised cells 
overexpressing His6-LmrB was significantly lower than in the control strain NZ9000'lmrA (Fig. 1A), 
showing that LmrB functions as an MDR protein. Extrusion of the compound across the cytoplasmic 
membrane is the underlying mechanism of the observed resistance. This was shown by monitoring the 
transport of Hoechst 33342 using inside-out vesicles of L. lactis (Fig. 1B). This amphiphilic compound 
inserts in the membrane and is fluorescent when present in the lipid environment of biomembranes 
(Shapiro and Ling, 1995). As compared to the control strain, accumulation of Hoechst 33342 was 
reduced in cells expressing His6-LmrB in the presence of ATP. The efflux was inhibited by the Rauwolfia
alkaloid reserpine and the phenylalkylamine verapamil, two classic inhibitors of drug transport by P-
glycoprotein (Endicott and Ling, 1989). 
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Figure 1. Fluorometric analysis of His6-LmrB activity. (A) Accumulation of ethidium bromide in whole cells of L.
lactis: (1) NZ9000'lmrA and (2) NZ9000'lmrA expressing His6-LmrB. Cells were pre-energised for 3 min with 25 
mM glucose after which ethidium bromide (2 PM) was added. Upon the addition of reserpine (50 PM end 
concentration) at the time point indicated by the arrow, LmrB-mediated extrusion of ethidium bromide was inhibited. 
C. Deduced amino acid sequences of mature LsbA (calculated molecular mass of 5.227 Da) and LsbB (3.410 Da). 
Cationic amino acids (+) are indicated. (B, D, E) Hoechst 33342 transport in inside-out membrane vesicles of L.
lactis NZ9000 expressing His6-LmrB. The assay was performed in 50 mM potassium Hepes buffer (pH 7.4), 
containing 2 mM MgSO4, 8.5 mM NaCl, 0.1 mg/ml creatine kinase and 5 mM phosphocreatine at 30 ºC. His6-LmrB 
was present in the membrane vesicles at a concentration of 0.5 mg/ml. 2 PM Hoechst 33342 was used. At the time 
point indicated by the arrow, verapamil (50 PM) was added (panel B) to inhibit LmrB-mediated extrusion of Hoechst 
33342. LsbA and LsbB (panel E and C, respectively) were added at 0.1, 0.25 and 0.5 Pg. Mg-ATP (2) and Mg-
AMP-PNP (1) were used at 2 mM. Fluorescence intensities are presented as arbitrary units (a.u.). 
The gene encoding LmrB is located on a small plasmid in a gene cluster specifying two 
antimicrobial peptides (bacteriocins), designated LsbA and LsbB. LsbA and LsbB are ribosomally 
synthesised membrane active linear peptides of 44 and 30 amino acid residues, respectively (Fig. 1C) 
and have antimicrobial activity against some specific lactococcal strains. They neither share mutual 
amino acid similarity nor have homology with any entry in the protein databases. LsbA is rich in leucine 
and valine residues. In addition to their overall hydrophobic and cationic nature, they share a stretch of 4 
and 5 positively charged amino acid residues located at the N-terminus in LsbA, and in the middle of 
LsbB, respectively. Together with the other cationic amino acids in the peptides, these residues are 
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arranged in such a way that they are likely to form an amphipathic structure (Zasloff, 2002). These 
properties allow antimicrobial peptides to insert into the lipid phase of the membrane leading to pore 
formation (Breukink et al., 1999; Brotz and Sahl, 2000). When expressed in L. lactis IL1403, a strain that 
is sensitive to LsbA and LsbB, LmrB was shown to confer resistance towards both peptides (data not 
shown). As most substrates of MDR proteins are recognised at the membrane level (Homolya et al.,
1993; Bolhuis et al., 1996), and amphiphilic bacteriocins intercalate into lipid bilayers (Breukink et al.,
1999; Brotz and Sahl, 2000), it is very likely that LmrB mediates bacteriocin resistance by extruding the 
peptides from the cytoplasmic membrane. Beside its role in resistance, LmrB is also involved in 
secretion of the bacteriocins from the cytosol to the outside of the cell (not shown). In order to be able to 
follow the transport of LsbB, the residue Ser15 of the peptide was changed into Cys. The modification 
did not affect the antimicrobial activity (data not shown). Purified LsbB-Cys15 was labelled with 
maleimide and added to the outside of inside-out membrane vesicles of lactococcal cells expressing 
His6-LmrB. Upon addition of ATP, the peptide was transported across the cytoplasmic membrane, as 
solubilisation of the vesicles with 4 % SDS revealed that all maleimide-labelled LsbB-Cys15 was present 
in the lumen (Fig. 2A). 
Various (modified) hydrophobic peptides, of which many are rich in leucine and/or valine, can be 
substrates for P-glycoprotein. The structures of these compounds range from simple synthetic amidated 
linear tripeptides to more complex cyclic structures (Sharom et al., 1995; 1996; 1998). It has been 
shown that P-glycoprotein has a very high affinity for cyclic peptide-like compounds of microbial and 
fungal origin (e.g. beauvericin, valinomycin and cyclosporine A) and a relatively low affinity for synthetic 
leucine rich tripeptides such as ALLM (N-acetyl-leucyl-leucyl-methioninal), ALLN (NAc-Leu-Leu-
norleucinal) and leupeptin (Nac-Leu-Leu-arginal) (Sharom et al., 1998). To study whether LsbA and 
LsbB can be substrates for human P-glycoprotein, the MDR1 gene was expressed in recombinant 
baculovirus-infected Spodoptera frugiperda insect cells (Vaughn et al., 1977). When maleimide-labelled 
LsbB-Cys15 was added to inside-out membrane vesicles of infected insect cells (Sf21), the peptide was 
transported across the cytoplasmic membrane to the lumen (Fig. 2B). Transport was dramatically 
inhibited by 50 PM verapamil, an inhibitor of P-glycoprotein. No transport of LsbB-Cys15 was observed 
when using inside-out membrane vesicles of the Sf21 insect cell line infected with baculoviruses 
expressing E-glucuronidase (not shown). This finding demonstrates a remarkable conservation of 
Figure 2. (A) LsbB-Cys15 transport in inside-out
membrane vesicles of L. lactis NZ9000'lmrA expressing
His6-LmrB. Membrane vesicles were energised with 2 mM
Mg-ATP (1), or 2 mM Mg-AMP-PNP (3). Verapamil was
used at 50 PM (2). After transport in the presence of Mg-
ATP, vesicles were solubilised and separated by
centrifugation into a lumen (L) (4) and membrane fraction
(M) (5). (B) LsbB-Cys15 transport across the membranes
of vesicles isolated from insect cell line Sf21 expressing
MDR1 in the presence of 4 mM Mg-ATP (1), or 4 mM Mg-
AMP-PNP (3). Lumen content (L) (5) was separated by
centrifugation from the membrane fraction (M) (4).
Verapamil was used at 50 PM (2). In both, A and B,
maleimide-labelled LsbB-Cys15, was detected upon the
SDS-PAGE by UV excitation and visualised with a Lumi-
Imager.
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function and of substrate specificity between bacterial LmrB and human P-glycoprotein.
Antimicrobial peptides that have a similar mode of action and share a number of structural 
similarities with bacterial bacteriocins, are also found in eukaryotes (Huang, 2000; Zasloff, 2002). They 
belong to a host defense system commonly referred to as “innate immunity”. Like their bacterial 
counterparts, the structural principle underlying this class of peptides is their ability to adopt a shape in 
which clusters of hydrophobic and cationic amino acids are spatially organised in discrete sectors of the 
molecule (Zasloff, 2002). The silk moth’s cecropin (Steiner et al., 1981) and the African clawed frog’s 
magainin (Zasloff, 1987) are linear peptides. These compounds kill bacterial cells at micromolar 
concentrations by causing i) a fatal depolarisation of bacterial membranes by interacting with negatively 
charged phospholipid headgroups (Westerhoff et al., 1989), or ii) a change in membrane permeability 
followed by the formation of physical holes that cause cellular contents to leak out (Yang et al., 2000). L.
lactis IL 1403 cells are sensitive to magainin II and cecropin P1. The in vivo susceptibility of L. lactis
IL1403 cells expressing His6-LmrB to these eukaryotic antimicrobial peptides was studied in liquid 
cultures. Strikingly, His6-LmrB expression resulted in resistance to magainin II and cecropin P1 (Fig. 3). 
These data indicate that both magainin II and cecropin P1 are substrates for LmrB, and, thus, that LmrB 
renders the lactococcal cells resistant to the activity of these antimicrobials. 
The potential of LsbA and LsbB to act as antagonists for MDR-mediated drug efflux was shown by 
monitoring Hoechst 33342 transport into energised His6-LmrB-expressing cells in the presence or 
absence of LsbA or LsbB. The Hoechst 33342 accumulation in membranes was increased in those 
instances in which LsbB was added prior to the transport assay (Fig. 1D). These results clearly show 
that LmrB-mediated efflux of Hoechst 33342 is inhibited by LsbB. LsbB may thus act as an inhibitor of 
Hoechst 33342 transport by occupying the drug-binding site(s) on LmrB. The same observation was 
made when LsbA was used in the competition assay (Fig. 1E).
Figure 3. Effect of (A) magainin II and (B)
cecropin P1 on growth in liquid microtiterplate 
cultures of L. lactis IL1403 expressing (circles) or
not expressing (squares) His6-LmrB. Growth in the 
presence (closed symbols) or absence (open 
symbols) of 5 PM magainin II (Bachem, 
Bubendorf, Switzerland) or 5 PM cecropin P1 
(Sigma-Aldrich, St Louis, Missouri, USA) was 
followed in a microtiterplate reader (Tecan, Grödig, 
Austria) by measuring the optical density (OD) at 
595 nm. All strains were grown in the presence of
a subinhibitory concentration of nisin (2 nM) to 




An increasing number of pathogenic microorganisms is resistant to multiple antibiotics, causing a 
major problem in the treatment of patients with hospital- or community-acquired infections caused by 
bacteria, yeasts, or fungi (Berkelman et al., 1994; Levy, 1998). One of the mechanisms that these 
microorganisms utilize to resist the toxic effects of antibiotics is drug expulsion mediated by membrane-
associated efflux pumps. The LmrB homolog, LmrA, was shown to confer resistance to eight classes of 
clinically relevant, structurally unrelated broad-spectrum antibiotics e.g. aminoglycosides, lincosamides, 
macrolides, quinolone, streptogramines, tetracyclines and chloramphenicol (Putman et al., 2000b). As 
LsbB competes with MDR substrates for transport by LmrB, we examined the effect of the presence of 
LsbB on the susceptibility of L. lactis IL1403 cells for certain clinically relevant antibiotics. A nanomolar 
concentration of minocycline was shown to be toxic for wild type IL1403 cells (Fig. 4A). When the cells 
expressed His6-LmrB, an 8-fold increase in the resistance of lactococcal cells to the antibiotic was 
observed (Fig. 4B). This MDR-mediated resistance, however, was abolished in the presence of 1 Pg/ml
of LsbB, as His6-LmrB expressing IL1403 cells were as sensitive to minocycline as the wild type cells 
(Fig. 4C). Similar observations, but with a less drastic effect, were made when azytromycine was used 
(data not shown). 
To our knowledge, this is the first report showing that natural, ribosomally synthesised linear 
peptides can be substrates for both bacterial and human MDR proteins. We also show that bacteria can 
employ MDR-type proteins that are present in many species, to gain resistance against typical innate 
Figure 4. Effect of LsbB on micocycline 
sensitivity of L. lactis IL1403 expressing (B, C) or
not expressing (A) His6-LmrB. Growth in the 
presence of minocycline (Sigma-Aldrich) was 
followed in a microtiterplate reader (Tecan) by 
measuring the optical density (OD) at 595 nm. 
LsbB was used at 1 Pg (C). All strains were 
grown in the presence of a subinhibitory 
concentration of nisin (2 nM) to induce the PnisA
promoter that drives the expression of his6-lmrB.
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immunity antimicrobial peptides such as magainin and cecropin. This study points to the possibility that 
certain endogenous eukaryotic peptides may rely on MDR proteins for their secretion. If this would be 
the case, secretion of these (possibly antimicrobial) peptides might be inhibited by the administration of 
cytostatic drugs, thereby reducing the innate immunity. Another important implication of this work is that 
LsbA and LsbB, which are natural linear peptides produced by the food grade microorganism L. lactis,
or genetically engineered analogues thereof, may be used to sensitise multiantibiotic resistant bacteria, 
in those cases where resistance is based on MDR proteins. 
Experimental procedures 
Genetic manipulations 
The lmrB gene was amplified by PCR with oligonucleotides LMRB1 (5’-TCTAGACCACCATGGGGCATCACCATCAC
CATCACGATGACGATGACAAAGCCGAAAGAGG) and LMRB2 (5’-ATATCTAGAGTTAATTGATTCTGAAC), introducing 
the underlined NcoI and XbaI restriction enzyme sites upstream of the hexa-His tag (italic) and downstream of the lmrB
stop codon (italic), respectively. The fragment was cloned in pNZ8048 (Kuipers et al., 1998), thereby placing lmrB under 
the control of the nisin inducible promoter PnisA. The lsbB gene was amplified with oligonucleotides LSBB-1 (5’-CCGGTC 
ATGAAAACAATCCTACG) and LSBB-2 (5’-CTGGTCTAGATTAAGCTTTTCCACG), digested with RcaI/XbaI (underlined) 
and ligated into NcoI/XbaI digested pNZ8048. A gene encoding LsbB-Cys15 was obtained by oligonucleotide-directed 
mutagenesis. The lsbB gene was amplified with oligonucleotides LSBB-2 and LSBB-3 (5’-CTGGTCTAGATTAAGCTTTT 
CCACGTTCCCATGGATAGCCGCCAGTTTTCTTTTTATGACAAGCAATATCG). The RcaI/XbaI (underlined) digested 
product was ligated in the corresponding restriction enzyme sites of pNZ8048. Oligonucleotides LSBA-1 (5’-CCGGTC 
ATGATAATTGTAGGAATTATATTTTTG) and LSBA-2 (5’-CTGGTCTAGATTATGCATATCTTGGTAC) were used to 
amplify lsbB. The PCR product was digested with RcaI/XbaI (underlined) and ligated into the NcoI/XbaI sites of 
pNZ8048. The template for all PCR reactions was plasmid pMN5 DNA. An lmrA deletion variant of L. lactis strain NZ9000 
was constructed by using the gene replacement vector pORI280 (Leenhouts et al., 1996), containing truncated lmrA (5’-
end) together with its flanking regions. The chromosomal copy of lmrA was replaced by the mutated version by 
homologous recombination (Leenhouts et al., 1996). 
Bacteriocin purification 
LsbA, LsbB and LsbB-Cys15 were purified from 50 ml of nisin-induced cultures of L. lactis NZ9000 harbouring pNZ8048 
carrying either lsbA, lsbB or lsbB-Cys15, respectively. Cells were removed by centrifugation, after which the supernatant 
was concentrated 20-fold by phenol/ether extraction (Sayé et al., 1995). The samples were dialysed against several 
changes of demineralised water at 4qC, using cellulose ester membranes with a molecular weight cut–off of 1 kDa 
(Spectra, Por£ CE, Spectrum Laboratories, USA). The quantity of purified proteins was determined according to 
Bradford, using bovine serum albumin (BSA) as a standard. 
Labelling of LsbB-Cys15 with maleimide 
Purified LsbB-Cys15 was dissolved in 50 mM HEPES buffer, pH 7.4, and mixed with fluorescein-5-maleimide (Molecular 
Probes, Europe BV, Leiden, Netherlands) at a final concentration of 100 PM. The suspension was incubated for 10 min 
at 30qC, after which the labelling reaction was stopped with DTT (final concentration 5 mM). Labelled LsbB-Cys15 was 
extensively dialysed at 4qC against HEPES buffer. 
Ethidium bromide transport in whole cells 
The accumulation of ethidium bromide in L. lactis cells was measured by fluorometry as described (van Veen et al.,
1996). Fluorescence was monitored with a Perkin-Elmer LS 50B fluorometer, using excitation and emission wavelengths 
of 500 and 580 nm, respectively. The excitation and emission band widths were 5 and 10 nm, respectively. 
Hoechst 33342 and maleimide-labelled LsbB-Cys15 transport in membrane vesicles
Inside-out membrane vesicles from cells expressing either His6-LmrB or His6-LmrA were prepared from 1 l of culture 
(Margolles et al., 1999). Total membrane protein was assayed according to Lowry in the presence of 0.5% SDS, using 
BSA as a standard. Fluorometric transport assays with Hoechst 33342 (Molecular Probes Europe BV) were performed 
(Margolles et al., 1999) in the presence of 2 mM Mg-ATP, or Mg-AMP-PMP (Roche). The intensity of fluorescence was 
followed for 15 min (Perkin-Elmer LS 50B fluorometer), using excitation and emission wavelengths of 355 nm and 457 
nm, respectively, and slit widths of 3 nm each. Purified LsbA and LsbB (0.25 Pg, 0.5 Pg or 1 Pg) were added prior to the 
transport assay, upon dilution of the membrane vesicles in the potassium-Hepes buffer.
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Maleimide-labelled LsbB-Cys15 (1 Pg) was incubated with membrane vesicles from cells expressing His6-LmrB (1 
mg of protein) in 50 Pl of 50 mM potassium Hepes buffer (pH 7.4) containing 2 mM MgSO4, 8.5 mM NaCl, 0.1 mg/ml 
creatine kinase and 5 mM phosphocreatine at 30 ºC for 15 min. Mg-ATP or Mg-AMP-PNP were used at a concentration 
of 2 mM, and verapamil was used at 50 PM. After incubation and subsequent washing with ice-cold phosphate-buffered 
saline (PBS), membrane vesicles were solubilised by adding SDS sample buffer. The lumen content of the vesicles was 
separated from the membrane fraction by centrifugation at 125,000xg for 30 min at 4qC. Samples were subjected to 
tricine-SDS-20% PAGE. Maleimide-labelled LsbB-Cys15 was detected by UV excitation and visualised with a Lumi-
Imager F1 (Roche).
Transport studies with Sf21 insect cells 
Recombinant baculoviruses containing either the human MDR1 gene or the E–glucuronidase gene (Life Technologies, 
Breda, the Netherlands) were used for transfection of the insect cell line Sf21 (Vaughn et al., 1977). Plasma membrane-
enriched fractions were isolated by sucrose gradient centrifugation (Muller et al., 1994). Membrane vesicles (1 mg of total 
protein) were incubated with 1 Pg maleimide-labelled LsbB-Cys15 in a total volume of 50 Pl in the presence of 4 mM Mg-
ATP, 10 mM MgCl2, 10 mM creatine phosphate, 100 Pg/ml of creatine kinase, 250 mM sucrose and 10 mM Tris HCl (pH 
7.4) at 37qC for 15 min. In the control experiments, ATP was replaced by 4 mM Mg-AMP-PNP. Verapamil was used at 50 
PM. After incubation and washing with ice-cold PBS, membrane vesicles were fractionated and maleimide-labelled LsbB-
Cys15 was detected as described above.  
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Chapter 4
Dual regulation of lactococcin production by 
proteolytic activity of the cell wall proteinase PrtP 




Lactococcus lactis BGMN1-5 produces a small, hydrophobic, positively charged 
bacteriocin named lactococcin B (LcnB). The cognate immunity gene and the genes 
encoding the secretion machinery are located on a large plasmid of approx. 80-kb. 
This plasmid also carries the genetic information for the production of the cell wall-
anchored proteinase, PrtP. The expression of lcnB was found to be transcriptionally 
regulated. By fusing the lcnB promoter region to a promoterless E-galactosidase
reporter gene, lcnB expression was shown to be high in medium with a high (4% 
casitone) peptide concentration, and repressed (up to 3.5–fold) in medium with a low 
(0.5% casitone) amount of peptides. Upon secretion into the medium, LcnB is 
substrate of proteolytic degradation by PrtP whose production is high in low casitone 
and decreases with increasing the casitone concentration in medium. This 
degradation is also dependent on the caseinolytic specificity of the proteinase. 
Whereas LcnB is broken down by proteinases with type I, III and intermediate 
specificities, LcnA is only degraded by type I but hardly by the intermediate and type III 
proteinase. These results implicate that bacteriocin production is particularly 
increased in nitrogen-rich medium, where competition with other lactococci is severe. 
Introduction
Bacteriocins are ribosomally synthesised antimicrobial peptides produced by a large variety of bacteria 
(Tagg et al., 1976; Klaenhammer, 1993). Most characterised bacteriocins produced by the Gram-positive 
lactic acid bacteria (LAB) are small (< 6 kDa), cationic and amphiphatic membrane permeabilising 
peptides (Klaenhammer, 1993). They can be classified into three groups (Nissen-Meyer and Nes, 1997). 
Group I comprises the lantibiotics containing post-translationally modified amino acid residues, such as 
lanthionine, E-methyllanthionine and the dehydrated residues dehydroalanine and dehydrobutyrine (Jung, 
1991; Sahl et al., 1995). The unmodified heat-stable peptide bacteriocins (the non-lantibiotics) that form 
group II can be further divided into: IIa) the pediocin-like bacteriocins (Stoddard et al., 1992; Cintas et al.,
1997), IIb) the two-peptide bacteriocins that require the complementary action of two peptides for full 
antimicrobial activity (van Belkum et al., 1991a; Diep et al., 1996) and IIc) the other unmodified 
bacteriocins. Group III contains the large, heat-labile bacteriocins.
Lactococcus lactis produces several lactococcins that belong to bacteriocin group II. The plasmid 
located genes of the two one-peptide bacteriocins LcnA and LcnB and the two-peptide bacteriocin 
LcnM/N have been cloned and sequenced (van Belkum et al. 1991a; 1992). LcnA was also shown to be 
produced by two other lactococcal strains (Holo et al., 1991; Stoddard et al., 1992). These lactococcins 
are synthesised as precursor peptides with a leader peptide of the double-glycine-type (Gly-2-Gly-1). This 
leader is cleaved off during export across the cytoplasmic membrane by the dedicated ATP-binding 
cassette (ABC) transporter (LcnC) and its accessory protein (LcnD) (Håvarstein et al., 1995; Franke et
al., 1996). Both proteins were shown to be embedded in the bacterial membrane (Varcamonti et al.,
2001). The lcnC and lcnD genes are located in an operon in close vicinity to the lactococcin structural 
and immunity genes (Stoddard et al., 1992). L. lactis IL1403, a plasmid free strain, is capable of 
producing and externalising active lactococcins when provided solely with the structural genes, as it 
contains genes on its chromosome that are highly homologous to lcnC and lcnD (Venema et al., 1996). 
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The production of most bacteriocins is growth-phase dependent, often restricted to the mid-or late 
exponential growth phase or the stationary phase. After the cessation of growth, the bacteriocin 
concentration usually decreases. This decrease might be caused by proteolytic degradation, aggregation 
and/or adsorption to the cells (de Vuyst et al., 1996; Lejeune et al., 1998). Environmental parameters 
such as pH, temperature and nutrition can also affect bacteriocin production (Brurberg et al., 1997; Blom 
et al., 1997). As lactic acid bacteria are fastidious with respect to nutrient requirements, a rich medium 
with yeast extract and protein hydrolysates is required for good growth and bacteriocin production 
(Parente and Hill, 1992; Daba et al., 1993; de Vuyst and Vandame, 1993; de Vuyst et al., 1996). The 
production of LcnB is high in rich M17 medium, and production is even higher in 2-fold concentrated M17 
(Venema et al., 1997). 
Here, we report on regulation of LcnB production by L. lactis BGMN1-5. The cognate gene was 
cloned and the influence of the peptide concentration of the medium on the transcription was analysed. 
Moreover, the sensitivity of LcnB to proteolytic degradation by the lactococcal proteinase with different 
specificities was studied. The production of the proteinase itself is also dependent on the peptide 
concentration in the medium, proving an additional level of regulation for bacteriocin production. 
Results
L. lactis BGMN1-5 produces LcnB
L. lactis subsp. lactis BGMN1-5 has previously been shown to produce at least two peptides with 
antimicrobial activity, Bac513 and Bac501 (Gajic et al., 1999). By means of plasmid curing, derivatives of 
L. lactis BGMN1-5 were obtained that lacked one or more of five cryptic plasmids. The activity previously 
assigned to Bac513 was found to be a mixture of the bacteriocins LsbA and LsbB (Gajic et al., submitted; 
this thesis, Chapter 2). Bac501 was only produced when a large plasmid of approximately 80-kb is 
present that also carries the genetic information for proteinase production (Gajic et al., 1999).
Total DNA of L. lactis BGMN1-501 and that of the plasmid-free derivative L. lactis BGMN1-596 was 
used in a hybridisation experiment using DNA probes for the lactococcins LcnA, LcnB and the two-
peptide bacteriocin LcnM/N. No signals were obtained for L. lactis BGMN1-596. An lcnB-specific signal 
was obtained for L. lactis BGMN1-501, indicating that Bac501 is similar to LcnB (data not shown). Using 
probes for lcnC and lcnD, specifying the secretion machinery for lactococcins, it was shown that both 
genes are also located on the same, approximately 80-kb plasmid.
Sequence analysis of subcloned plasmid DNA fragments harbouring the bac501 operon revealed 
the presence of two open reading frames (ORFs) that could specify peptides of 68 and 91 amino acids, 
respectively. The deduced amino acid sequences were identical to LcnB and the immunity protein LciB 
(van Belkum et al., 1991a). Therefore, Bac501 was renamed LcnB. Its structural gene is located 
immediately downstream of lcnD. Both genes are separated by a 73–bp intergenic region containing two 
18–bp inverted repeats. These sequences with dyad symmetry can form a structure with an estimated 
'G° of -13 kcal/mol (-54.4 kJ/mol) (Fig. 1). The lciB gene is located immediately downstream of lcnB, with 
a spacing of 26 nucleotides. Downstream of the UAA stop codon of lciB, an inverted repeat (estimated 
'Gº of –19.6 kcal/mol (–82 kJ.mol)) is present that could act as a rho-independent terminator (Platt, 
1986). The promoter region upstream of BGMN1-5 lcnB contains two mismatches as compared to the 
equivalent sequence of L. lactis subsp. cremoris 9B4. It is identical to that upstream of lcnA of strain 9B4 
(Fig. 1). The transcription initiation site of lcnB of BGMN1-5 was determined by primer extension mapping 
and was found to be an A residue 20 nucleotides upstream of the proposed AUG start codon (Fig. 1). 








Figure 1. (A) Schematic representation of the lcnC/lcnD and lcnB/lciB operon of L. lactis BGMN1-5. The orientation 
of the genes is indicated by block arrows, promoters by vertical arrows and putative terminator structures by 
lollipops. (B) Nucleotide sequence of the lcnB promoter region. Differences between the lcnA- and lcnB upstream 
regions are depicted in lower case. The putative ribosome binding site (RBS) and –10 (P-10) and –35(P-35) promoter 
sequences are overlined. Transcription start site ( ) is indicated. Arrows represent inverted repeats that overlap the 
promoter.
The production of LcnB is medium dependent 
LcnB production by L. lactis BGMN1-501 was analysed during growth in rich medium (M17) and CDM 
medium containing different amounts of casitone. This pancreatic digest of casein mainly consists of 
small peptides and amino acids in a ratio of about 4:1 (Marugg et al., 1995). As judged from an agar well 
diffusion assay, a considerable increase in LcnB production could be obtained by increasing the casitone 
concentration in CDM (from 0.5% to 4%) (Fig. 2). 
LcnB is degraded by PrtP 
L. lactis BGMN1-501 also produces the cell wall-bound extracellular proteinase PrtP with a PI-type 
caseinolytic specificity (Gajic et al., submitted). PrtP production by strain BGMN1-501 was also shown to 
be regulated by the peptide concentration of the growth medium (Gajic et al., submitted; this thesis, 
Chapter 6). Interestingly, the production of PrtP is inversely proportional to that of LcnB, being high at low 
casitone concentration and low at high concentrations of casitone. Therefore, it was examined whether 
LcnB is a substrate for proteolytic degradation by PrtP. LcnB of L. lactis BGMN1-501 was incubated with 
the proteinase isolated from the same strain and with an isolate from a derivative of L. lactis BGMN1-5 
that had lost the prtP/prtM genes (BGMN1-5'prtP/prtM, Gajic et al., submitted). Upon incubation with the 
isolated proteinase (released fraction), bacteriocin activity decreased drastically, as judged from halo 
sizes in an agar well diffusion assay (Fig. 3). No difference in halo sizes was observed when an isolate 
from L. lactis BGMN1-5'prtP/prtM was used, indicating that the degradation is caused by the action of 
PrtP (Fig. 3).
Figure 2. LcnB activity of L. lactis BGMN1-501 
after growth in CDM with 0.5% and 4% casitone 
and in rich M17 medium as determined by an agar-
well diffusion assay. 50 Pl of cell free supernatant 
of an overnight culture was applied in the wells. L.
lactis IL1403 was used as an indicator strain.
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In a similar experiment using L. lactis strains IL1403 (pMB553) and IL1403 (pMB225), which 
produce LcnA and LcnM/N, respectively, it was shown that these lactococcins are also degraded (data 
not shown). 
Lactococcin degradation is dependent on the caseinolytic specificity of PrtP 
In order to test whether bacteriocin degradation is dependent on the caseinolytic specificity of the 
proteinase, L. lactis MG1363 cells producing type I, III or hybrid I/III proteinases PrtPI, PrtPIII or PrtPI/III 
were spotted next to L. lactis IL1403 cells producing either LcnA or LcnB. As a control, a strain was used 
producing an inactive form of PrtPI due to a mutation in the active site Asp-30 ÆAsn-30 residue 
(Haandrikman et al., 1991). As judged from the ’semi-moon’ halo formation around the spots of the 
bacteriocin producers, LcnB was broken down by all three types of PrtP. The strongest effect was 
observed with PrtPIII (Fig. 4). LcnA was degraded by PrtPI proteinase but hardly by PrtPIII and PrtPI/III 
indicating that the susceptibility of lactococcins for degradation by PrtP differs and is dependent on the 
caseinolytic specificity of the proteinase.
Figure 4. Proteolytic degradation of LcnA and LcnB by PrtPs with different caseinolytic specificities. Bac (right spot) - 
bacteriocin producing strains IL1403(pMB553; LcnA+) or IL1403(pMB580; LcnB+); PrtP (left spot) - strain producing: 
*- cell wall-anchored PrtP with a mutation in the active site Asp-30 residue (MG1363/pGKV1552); I- PrtPI 
(MG1363/pGKV552); III- PrtPIII (MG1363/pGKV552abc); I/III- PrtPI/III (MG1363/pGKV552ac). L. lactis IL1403 was 
used as indicator strain. 
The PrtP sensitivity of the two other bacteriocins produced by L. lactis BGMN1-5, LsbA and LsbB 
was also examined. Neither of them was degraded by PrtP, indicating that the breakdown might be 
specific for lactococcins (data not shown). 
Figure 3. LcnB activity after incubation with: (A) PI-type PrtP 
of L. lactis BGMN1-501 and (B) isolate from L. lactis BGMN1-
5'prtP/prtM. 50 Pl of cell free supernatant of an overnight 
culture of the LcnB producer L. lactis IL1403 (pMB580) was 
incubated with 20 Pl of isolated proteinase for 15 (1), 30 (2) 
and 60 minutes (3). +: non-treated LcnB sample. The
indicator strain used was L. lactis IL1403. 
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The lcnB promoter is subject to medium-dependent regulation
Medium-dependent production of LcnB was also observed in L. lactis BGMN1-5'prtP/prtM (data not 
shown). In other words, the disappearance of LcnB in low casitone media cannot be fully explained by an 
increase in proteolytic capacity. Therefore, the regulation of lcnB was studied in more detail. The lcnB
promoter region, together with the 5’-end of lcnB, was cloned upstream of promoterless lacZ in pIL252. 
The construct was introduced in the proteinase deficient L. lactis IL1403 and E-galactosidase production 
was analysed during growth in CDM supplemented with 0.5% and 4% casitone. When the cells were 
grown in medium with a low (0.5%) casitone concentration, E-galactosidase activity was approximately 
3.5 times lower than the level obtained in medium containing 4% casitone (18 ± 2.5 nmol min-1 x mg of 
protein –1 and 64 ± 8 nmol min-1 x mg of protein –1, respectively).
The effect of the dipeptides Leu-Pro and Pro-Leu on the regulation of lcnB expression was tested, 
as they were shown to negatively regulate prtP/prtM transcription (Marugg et al., 1995; Guedon et al.,
2001a). The expression of the lcnB::lacZ fusion was analysed after the addition of either Leu-Pro or Pro-
Leu to the growth medium (final concentration 0.5 to 2 mM). Neither of the dipeptides had an influence on 
E-galactosidase activity indicating that lcnB regulation is distinct from that of prtP/M.
Discussion
The small heat-stable bacteriocin with a narrow antimicrobial spectrum that is specified by the 80-kb 
plasmid of L. lactis BGMN1-5 was shown to be LcnB. Sequencing of the cognate gene showed that it is 
100% identical to the corresponding region of the 60-kb plasmid p9B4 of L. lactis subsp. cremoris 9B4 
(van Belkum et al., 1992). From hybridisation experiments it could be concluded that, in contrast to p9B4, 
which caries the genetic information for the lactococcins LcnA, LcnB and LcnM/N (van Belkum et al.,
1991a; 1992), the 80-kb plasmid of strain BGMN1-5 only contains lcnB and the immunity gene lciB. The 
lcnA operon is located in between the lcnC/D operon and lcnB in L. lactis 9B4. However, lcnB is located 
immediately downstream of lcnC/D in L. lactis BGMN1-5. The promoter regions of three lactococcins only 
differ in a few basepairs. The lcnB promoter of BGMN1-5 is identical to that of L. lactis 9B4 lcnA and was 
shown to have the same transcriptional start as determined for lcnA (van Belkum et al., 1991a). The 
observed conservation is interesting from an evolutionary point of view. Although L. lactis p9B4 and 
BGMN1-5 were isolated independently with respect to source and geographical location, their plasmid-
located genetic information for bacteriocin production is highly conserved. This could mean that both 
strains have a common ancestor and that during their divergent evolution changes (base substitutions 
and deletions) have occurred. 
As has been observed for most bacteriocins, the production of LcnB by strain BGMN1-5 is growth-
phase dependent. It is produced during logarithmic growth, the highest activity being present in the early 
stationary phase (data not shown, Venema et al., 1997). In the later phase of stationary growth the 
activity declines, which is most likely due to aggregation and/or adsorption of the bacteriocins on the 
producer cells or to the effect of proteolytic degradation (de Vuyst et al., 1996; Lejeune et al., 1998). Total 
LcnB activity was also shown to be medium-dependent, the highest level being obtained in rich M17 
medium (Venema et al., 1997). Here we show that the production of LcnB increases with increasing 
concentrations of nitrogen sources (e.g. casitone) in the medium. By using the lacZ reporter gene fused 
to the lcnB promoter region, the transcription of the promoter was shown to be medium-dependent, being 
repressed in the presence of low casitone concentrations. Interestingly, LcnB production is thereby 
inversely correlated to the production of several components of the proteolytic system (e.g PrtP, the 
peptide transport systems and certain peptidases; Marugg et al., 1995; 1996; Guedon et al., 2001a, this 
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thesis, Chapter 5), which are negatively regulated by medium peptides and by the dipeptides Leu-Pro 
and Pro-Leu (Marugg et al., 1995; Guedon et al., 2001a). These two dipeptides do not have any effect on 
lcnB expression. The mechanisms underlying lcnB regulation are still unclear. Like the promoter region of 
the proteinase and maturase genes (prtP and prtM), that of lcnB contains an inverted repeat. As it 
overlaps the –10 sequence and the transcription start site, this palindromic region might be involved in 
the recognition or binding of a regulator. Peptides from the medium may directly or indirectly act as 
effectors of this regulator.
As most other bacteriocins that are produced by LAB, lactococcins are sensitive to digestion by 
endopeptidases such as trypsin, D-chymotrypsin, pepsin, pronase, proteinase K. We show here that 
lactococcins are also susceptible to hydrolysis by the cell wall-anchored proteinase of L. lactis. This 
degradation was shown to be dependent on the caseinolytic specificity of the proteinase. In addition to its 
role in the initial break down of the major milk protein casein, thereby providing the producing cell with 
small peptides and free amino acids necessary for growth (Kunji et al., 1996; Christensen et al., 1999) 
PrtP can also protect the cells against certain bacteriocins. This observation could have implications for 
the use of bacteriocins in fermentations, as its susceptibility to digestion by PrtP could decrease its 
activity range. 
Experimental procedures
Bacterial strains, plasmids and media 
The strains and plasmids used in this study are listed in Table 1. L. lactis was grown at 30qC in M17 broth (Terzaghi et al.,
1975) or on M17 agar plates containing 1.5% (wt/vol) agar. Chemically defined medium (CDM) (Mierau et al., 1994) 
containing 0.5% or 4% (wt/vol) casitone (Difco Laboratories, Detroit, Mich. USA) was used for the expression studies. All 
media contained 0.5% (wt/vol) glucose, while 5 Pg/ml chloramphenicol (Sigma-Aldrich, St. Luis, Missouri, USA) or 5 Pg/ml
erythromycin (Roche Molecular Biochemicals, Mannheim, Germany) were added when necessary. The chromogenic 
substrate 5-bromo-4-chloro-3-indolyl-E-D-galactopyranoside (X-Gal; Sigma-Aldrich) was used at a concentration of 1 mM. 
DNA techniques and transformation 
Molecular cloning techniques were performed essentially as described by Sambrook et al. (1989). Restriction enzymes, 
Klenow enzyme, T4 DNA ligase and ExpandTM High Fidelity DNA polymerase were used according to the instructions of 
the supplier (Roche Molecular Biochemicals). Synthetic oligo deoxyribonucleotides were obtained from Life Technologies 
B.V. (Breda, the Netherlands). PCR products were purified with the High pure PCR product purification kit (Roche 
Molecular Biochemicals). For nucleotide sequence analysis the dideoxy chain termination method (Sanger et al., 1977) 
was used with [D-35S]-dATP (Amersham Pharmacia Biotech, Roosendaal, the Netherlands) and the T7 sequencing kit 
(Amersham Pharmacia Biotech). L. lactis was transformed by electroporation using a gene pulser (Bio Rad Laboratories, 
Richmond, Calif.) as described by Leenhouts and Venema (1993). 
Plasmid constructions 
The lcnB promoter region of L. lactis BGMN1-5 was amplified by PCR with oligonucleotides Pr1 (5’-CGGAATTCGG
AAGAGGCAATCAGTAG) and Pr2 (5’-GCTCTAGATTTTTCATAATAATCTCC). The purified 114-bp PCR product was 
digested with EcoRI and XbaI (restriction sites are underlined in the oligonucleotide sequence), and ligated into the 
EcoRI/XbaI sites of pORI13, upstream of the promoterless E-galactosidase (lacZ) gene. The resulting construct 
(pORI13lcn) was introduced in L. lactis LL108 carrying the repA gene on the chromosome, thereby allowing the pORI13 
derivative to replicate. The region containing the lcnB promoter transcriptionally fused to lacZ, and the rest of lacZ was 
also cloned into pIL252. To this end, the EcoRI-digested PCR product obtained with oligonucleotides Pr1 and Pr3 (5’- 
CGGAATTCGAATCGCTAGTTCTAGG; annealing to the 3’-end of lacZ) on pORI13lcn as the template was cloned into the 
EcoRI site of pIL252. The resulting construct, pIL252lcn, was made in L. lactis IL1403. The orientation and integrity of the 
inserts was confirmed by nucleotide sequencing. 
Bacteriocin activity assays 
Bacteriocin activity was determined using an agar-well diffusion assay (Tagg et al., 1976). To this end, wells were made in a 
lawn of soft agar containing an indicator strain (106 cells/ml) on top of the agar plates, and filled with 50 Pl of supernatant, 
followed by overnight incubation. To analyse the proteolytic degradation of the bacteriocins, the colony overlayer assay, as 
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described by Venema et al. (1995), was used. Colonies of bacteriocin producers and proteinase producers were cultivated 
overnight on an M17 agar plate with an intercolony distance of about 1 cm. The colonies were treated with chloroform vapour 
for 15 min. After 30 min of exposure to air, the colonies were covered with soft agar containing approximately 106cells/ml of an 
indicator strain.
Table 1. Bacterial strains and plasmids used in this study. 
Strain or plasmid Relevant phenotype or genotype Source or reference 
Strains 
L. lactis subsp. cremoris
MG1363 Lac-; Prt- ; Plasmid–free derivative of NCDO712  Gasson, 1983 
LL108 Cmr, MG1363 derivative containing pWV01 repA gene in the 
chromosome
Leenhouts et al., 1998 
L. lactis subsp. lactis 
IL1403 Plasmid-free strain Chopin et al., 1984 
BGMN1-5 PrtP+, Bac501+ (LcnB), Bac513+ (LsbA, LsbB) Gajic et al., 1999 
BGMN1-5'prtP/M Prt-, derivative of BGMN1-5 lacking prtP/M genes (~5,6 kb) from 
a 80-kb proteinase plasmid 
Gajic et al., submitted 
BGMN1-501 PrtP+, Bac501+ (LcnB), Gajic et al., 1999 
BGMN1-596 PrtP-, Bac501- (LcnB), Bac513- (LsbA, LsbB), Plasmid-free 
derivative of BGMN1-5 
Gajic et al., 1999 
   
Plasmids
pORI13 Emr, Cmr, contains promoterless gene for E-gal (lacZ), repA- Sanders et al., 1998 
pORI13lcn Emr, Cmr, pORI13 derivative carrying lacZ fused to lcnB
promoter
This work 
pIL252 Emr, low copy number plasmid Simon and Chopin, 1988 
pIL252lcn Emr, pIL252 derivative carrying lacZ fused to lcnB promoter This work 
pGKV552 Emr, specifying cell wall-anchored proteinase of L. lactis Wg2 
(aPI)
Haandrikman et al., 1991 
pGKV1552 Emr, pGKV552 specifying cell wall-anchored Asp-30Asn-30 
proteinase mutant (aPI*) 
Haandrikman et al., 1991 
pGKV552abc Emr, specifying hybrid PI(Wg2)-PIII(SK11) proteinase (aPIabc)  Vos et al., 1991 
pGKV552ac Emr, specifying hybrid PI(Wg2)-PIII(SK11) proteinase (aPIac) Vos et al., 1991 
pMB553 Emr, specifying lactococcin A van Belkum et al., 1991a 
pMB580 Emr, specifying lactococcin B van Belkum et al., 1992 
pMB553 Emr, specifying lactococcin M/N van Belkum et al., 1991a 
Emr, Cmr resistance to erythromycin and chloramphenicol, respectively 
Proteinase isolation and activity assays 
Proteinases were isolated by release from the cells of L. lactis using Ca2+-free buffer as described by Vos et al. (1991). 
The concentration and purity of the proteinase samples were estimated by SDS-10% PAGE (Laemmli, 1997). Proteinase 
activity was determined by using the chromogenic peptide S2586 (Meo-Suc-Arg-Pro-Tyr-pNA; Cromatogenix AB, 
Sweden), as described by Mierau et al. (1996). LcnB-containing supernatant was incubated with the proteinases for 15, 30 
and 60 min at 30°C, after which bacteriocin activity was tested by using the agar well diffusion assay (Tagg et al., 1976). 
E-galactosidase activity assay 
The activity of E-galactosidase in cell-free extracts was determined by assaying the degradation of ortho-nitrophenyl-E-D-
galactopyranoside (ONPG; Sigma-Aldrich) at 30°C, essentially as described by Miller (1972). Cell-free extracts were 
prepared as described by van de Guchte et al. (1990) using a Bead Beater (Biospec products, Bartlessville, Oklahoma). 
The E-galactosidase activity of cells at the mid exponential growth phase (OD595~0.7) is expressed as the amount of 
substrate converted per minute per mg of protein (nmol x min-1 x mg–1). Protein concentrations were determined by the 
method of Bradford (1976), using bovine serum albumin as a standard. 
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Proteinase and maturase gene expression in 





Proteolysis of milk protein (casein) by Lactococcus lactis is initiated by the 
extracellular cell wall-bound proteinase (PrtP). PrtP requires the action of the maturase 
protein PrtM to become active. Transcription of the divergently oriented prtP and prtM
genes of L. lactis strains BGMN1-5 and E8 in response to the peptide concentration in 
the growth medium was analysed by fusing their intergenic regulatory regions with 
promoterless D- and E-galactosidase reporter genes. The expression of both prtP and 
prtM was shown to be controlled in an identical manner. prtP expression was high in 
medium with a low peptide concentration, and was repressed up to ten–fold by 
increasing the concentration of medium peptides. Expression of prtP was found to be 
higher than that of prtM, an observation that is in contradiction with previously 
published data. The transcriptional repressor CodY was shown to be responsible for 
repression of prtP/prtM transcription in peptide-rich media. Expression of both prtP
and prtM was derepressed in a CodY-deficient L. lactis strain. Using electrophoretic 
mobility shift assays, it was shown that CodY binds to the prtP/prtM intergenic region.  
Introduction
Lactococcus lactis, like other lactic acid bacteria, is a multiple amino acid auxotroph. It has a complex 
proteolytic system to break down the major milk protein casein into small peptides and free amino acids 
that are necessary for growth in this medium (Kunji et al., 1996; Christensen et al., 1999). Initial 
breakdown of casein is carried out by the extracellular cell wall-bound serine proteinase PrtP. Several 
lactococcal prtP genes have been cloned and sequenced (Kok et al., 1985; Kok et al., 1988; de Vos et
al., 1989; Kiwaki et al., 1989). Although they are over 98% identical on the amino acid sequence level, 
the proteinases can have quite different caseinolytic specificities (Visser et al., 1986). For the production 
of an active proteinase, the product of prtM, a gene that is in a back-to-back orientation with prtP, is 
required. The so-called maturase PrtM plays a role as an extracellular chaperone, inducing the pro-
proteinase to adopt a conformation in which it is able to autoproteolytically cleave off its pro-region (Kok, 
1990; Haandrikman, 1990). Peptides that are produced by the proteinase can be internalised by either 
one of three different transport systems. Oligopeptides are taken up by Opp, while DtpT and DtpP 
transport di- and three-peptides respectively (Tynkkynen et al., 1993; Foucaud et al., 1995). 
Intracellularly, the peptides are further hydrolysed into smaller peptides and amino acids by the action of 
over 15 different peptidases (Kunji et al., 1996; Christensen et al., 1999). 
Proteinase and maturase production is inhibited in peptide-rich medium (e.g. containing casitone, a 
tryptic digest of casein) in a number of lactococcal strains (Exterkate, 1985; Laan et al., 1993; Marugg et
al., 1995; Miladinov et al., 2001). As PrtP expression is not down-regulated in strains that lack the di- and 
tripeptide transporter DtpT, it was hypothesized that the internal concentration of small (di-tri) peptides, or 
amino acids derived thereof, are important in the regulation of proteinase production (Marugg et al.,
1995). The genetic information for proteinase regulation was shown to be present on a 90-bp 
subfragment of the prtP/prtM intergenic region encompassing the transcription start sites of both genes
(Marugg et al., 1996). Disruption of an inverted repeat that is present in this region resulted in 
derepression of the prtP and prtM promoters in medium with a high peptide concentration. Therefore, it 
was speculated that this palindromic sequence might be involved in the recognition or binding of a 
repressor protein, and that specific dipeptides may directly or indirectly act as effectors of this regulator 
(Marugg et al., 1996). 
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The expression of genes of other components of the proteolytic system of L. lactis is also affected 
by medium composition. The expression of OppA, DtpT and DtpP is increased when cells are grown in 
medium with a low peptide concentration (Detmers et al., 1998; Kunji et al., 1996; Foucaud et al., 1995). 
Moreover, the expression of the peptidases PepX and PepN in L. lactis MG1363 was shown to be 
regulated in a similar way (Meijer et al., 1996). Promoters of pepC, pepN, pepO1, and pepO2 were also 
reported to be more active in medium with amino acids than in peptide-rich medium (Guedon et al.,
2001a). In the same study, the prtP promoter was shown to be subject of a similar regulatory circuit. 
Recently, it was shown that the genes pepN, pepC and the opp-pepO1 operon are regulated by the 
pleiotropic repressor CodY. The signal controlling CodY-dependent repression was found to be present in 
dipeptides containing at least one of the branched-chain amino acids (Guedon et al., 2001b).
In this study, the medium-dependent regulation of the prtP/prtM promoters of the L. lactis strains 
BGMN1-5, E8 and two reference strains, SK11 and Wg2, was studied. In addition, it was shown that 
CodY can also directly regulate proteinase and maturase expression.
Results
The prtP/prtM intergenic regions of L. lactis BGMN1-5 and E8  
Two proteinases with different caseinolytic specificities have been characterised from L. lactis
strains BGMN1-5 (PI-type) (Gajic et al., submitted) and E8 (PI/III-type) (Kok, 1990), respectively. The prtP
and prtM genes of L. lactis BGMN1-5 are located on a large plasmid of approx. 80 kb (Gajic et al., 1999). 
The size of the PrtP+-plasmid of L. lactis E8 has not been determined. Using PCR, the prtP/prtM
intergenic regulatory regions of these two strains were amplified. Sequence analysis showed that the 
lengths of the prtP/prtM intergenic regions of BGMN1-5 and E8 are identical to that of L. lactis SK11, 
namely 330 bp. In L. lactis Wg2, a deletion of 5 bp is present (Fig. 1). Although there are some sequence 
differences between the three regions the overall homology is very high (t 96% identity). The regions are 
very A/T rich (t 75%) and contain several putative –35 and –10 consensus promoter sequences on both 
strands. As is the case for SK11 and Wg2, the prtP/prtM intergenic regions of BGMN1-5 and E8 contain 
an inverted repeat that could possibly form a structure of an estimated 'G° of –21.4 kcal/mol (-89.5 
kJ/mol) and –19.8 kcal/mol (-82.8 kJ/mol), respectively. The ribosome binding sites of prtP (GGAGGG) 
and prtM (AAGAG) of BGMN1-5 differ from those present upstream of the corresponding genes of the 
three other lactococcal strains (GGAGGA and AGGAG, respectively) (Fig. 1).
Determination of the transcription start sites 
The transcription initiation sites of prtP and prtM of L. lactis BGMN1-5, E8, and the two reference strains 
SK11 and Wg2 were determined by primer extension mapping. RNA was isolated from these strains 
grown in CDM with 0.2% casitone (see below) and annealed with a primer either specific for the 5‘-end of 
prtP or that of prtM. Our studies confirmed the position of the postulated promoters. Although the lengths 
of the prtP/prtM intergenic regions and the –35 and –10 sequences of BGMN1-5 and E8 are identical to 
that of SK11, the sites at which transcription starts are different in these strains. For both prtP and prtM,
of BGMN1-5 and SK11 two bands are visible on the autoradiogram (Fig. 2). For prtP, the upper band, 
having the highest intensity, corresponds to the transcription initiation site determined previously for prtP
of SK11 and Wg2 (Vos et al., 1991; van der Vossen et al., 1992) and is therefore designed as +1 (Fig. 1). 
The lower, less intense band is probably derived from a second, less efficient start site. The prtP
transcription start site of BGMN1-5 and E8 was found to be a C and a T, respectively, 85 and 84 
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The start site in prtM of BGMN1-5 and E8 was mapped at 232 bp (G) and 231 bp (A) upstream of the 
proposed AUG start, respectively (Fig. 1). 
Transcriptional regulation of the prtP and prtM promoters 
In order to study the regulation of proteinase and maturase production, fragments containing the 
prtP/prtM intergenic region of L. lactis strains BGMN1-5, E8, SK11 or Wg2, respectively, were cloned in 
between the promoterless Escherichia coli E-galactosidase (lacZ) and the Cyamopsis tetragonoloba D-
galactosidase (D-gal) genes of pGKH10. Thus, translational fusions of prtP and prtM with the two reporter 
genes were created, the AUG codons of prtP or prtM serving as a start codon for lacZ or D-gal (Fig. 3). In 
the resulting plasmids pGKB11, pGKE11, pGKS11 and pGKH11, lacZ is under the control of the prtP
promoter of BGMN1-5, E8, SK11 and Wg2, respectively. In these plasmids the prtM promoter directs the 
transcription of the D-gal gene. In the corresponding plasmids pGKB12, pGKE12, pGKS12 and pGKH12 
the respective fragments are present in the opposite orientation.
The plasmids were introduced in the proteinase-deficient L. lactis MG1363. For all prtP promoters, 
the highest E-galactosidase activities were observed in the cells grown in CDM containing a low 
concentration of casitone (0.2%). This pancreatic digest of casein mainly consists of small peptides and 
amino acids in a ratio of about 4 to 1 (Marrug et al., 1995). 
Figure 2. Determination of the 
transcription start sites of: (A) prtP
and (B) prtM of L. lactis BGMN1-5, 
SK11, E8 and Wg2 by primer
extension mapping. Lanes PE 
show the extended products using 
primers PrE (prtP) and PrF (prtM).
Nucleotide sequence ladders, 
obtained with the corresponding 
primers and template DNAs of
BGMN1-5 and Wg2 were run in 
parallel. The nucleotide sequences 
are given in the left- and right-hand 
margins. The 5’ ends of the prtP
and prtM transcripts are boxed. 
The differences between BGMN1-
5 with respect to the other three 
strains are indicated by asteriks.
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Figure 3. Nucleotide sequence of: (A) the DNA regions containing the initiation codons (boxed) of prtP and prtM.
Introduced BclI site is indicated in bold. Ribosomal binding sites (RBS) are overlined. (B) the DNA fragment 
surrounding the unique BamHI site (boxed) in pGKH10. The orientation of the D- and E-galactosidase genes is 
indicated. (C) DNA regions joined by the BamHI/BclI fusion in pGKM11 and pGKM12. Direction of transcription of the 
D- and E-galactosidase genes and the orientation of the expression signals from prtP (PP) and prtM (PM) are 
indicated. The 4 nucleotides that are duplicated as a consequence of the BamHI/BclI fusion, are shaded. 
The growth rates of the strains decreased dramatically at casitone concentrations lower than 0.1% (data 
not shown). As in 0.2% casitone growth reached the same optical densities as in rich medium, this 
casitone concentration was used for the expression studies. Although the E-galactosidase activities 
differed for the four lactococcal strains tested, a gradual increase in casitone concentration from 0.2% to 
2% resulted in a gradual decrease in E-galactosidase activity for all prtP promoters (data not shown, and 
Table 1).
When cells were grown in medium with a high (2%) casitone concentration, E-galactosidase levels 
were low during growth and were approximately two- to thirteen fold lower than the maximal levels 
obtained during growth in medium containing 0.2% casitone (Table 1).
Gene expression driven by the prtM promoter of strains BGMN1-5, E8, SK11 and Wg2 was 
analysed in the same way (Fig. 3). As was observed for prtP, E-galactosidase activities directed by the 
prtM promoters decreased with increasing concentrations of casitone from 0.2% to 2%. Activity of E-
galactosidase decreased approximately four- to ten fold in peptide-rich CDM (2% casitone) compared 
with that obtained in CDM containing 0.2% casitone (Table 1).
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Table 1. E-galactosidase activities of L. lactis MG1363 cells carrying pGKH10 derivatives harbouring 
prtP::lacZ and prtM::lacZ fusionsa.
                                          0.2% casitone                                2% casitone
Plasmid E-galactosidase      PprtP/PprtM E-galactosidase      PprtP/PprtM
                              activityb                     ratioc                 activityb                    ratioc            Repressiond
pGKB11 Pe 15.0 ± 2.0 5 2.5 ± 0.6 8.3   6 
pGKB12 M 3.0 ± 0.5  0.3 ± 0.1  10 
pGKE11 P 6.5 ± 1.0 1 0.5 ± 0.1 1.25 13 
pGKE12 M 6.5 ± 1.1  0.4 ± 0.1  16.25 
pGKS1 P 15.0 ± 2.5 2.5 4.0 ± 0.5 4   3.75 
pGKS12 M 6.0 ± 1.0  1.0 ± 0.2    6 
pGKH11 P 9.0 ± 1.5 1.6 3.5 ± 0.8 3.5   2.57 
pGKH12 M 5.5 ± 0.5  1.0 ± 0.2    5.5 
aStrains were grown in CDM with casitone concentrations as indicated 
bE-galactosidase activity as determined by fluorescence (calculated as arbitrary fluorescence units divided per time 
and optical density (AFU x min-1 x OD595-1))
cRatio between prtP and prtM promoter strengths for one strain under identical growth conditions 
dRatio between the E-galactosidase activities in CDM with 0.2% casitone and CDM with 2% casitone for one strain 
eP: prtP::lacZ; M: prtM::lacZ fusions 
These data indicated that the prtP and prtM promoters are regulated in a similar way. The 
expression signals of the prtP promoters of L. lactis BGMN1-5, SK11 and Wg2 were stronger than those 
of the corresponding prtM promoters in all media tested. The highest E-Gal expression ratio 
(PprtP::lacZ/PprtM::lacZ) under the same growth condition was found for the promoters of strain BGMN1-5. 
No significant differences were observed between both promoters of L. lactis E8 (Table 1). Similar data 
for the E-Gal expression ratios (PprtP::lacZ/PprtM::lacZ) at low (0.2%) and high (2%) casitone concentrations 
were obtained when D-galactosidase was measured (data not shown).
The above results are in contradiction with those previously published by Marugg et al. (1995; 
1996). By using transcriptional fusions of prtP or prtM with the E.coli E-glucuronidase gene, they showed 
that expression of prtM is higher than that of prtP. In order to exclude the possibility that a lack of the 5’-
end of prtP and prtM influences the measured values, the promoter region together with the 5’-end of 
prtP and prtM (33- and 93-bp, respectively) of strain BGMN1-5 was cloned in two orientations upstream 
of lacZ in pORI13. The constructs were introduced in L. lactis LL108. Enzyme expression was analysed 
by fluorometry during growth of the strains in CDM supplemented with 0.2% or 2% casitone. E-
galactosidase production was similar to that observed with the translational fusions presented above. 
Upon increase of the casitone concentration the E-galactosidase activity decreased and the E-
galactosidase activity was higher when the gene was under the control of prtP than when it was driven by 
the prtM promoter (data not shown).
Regulation of prtP and prtM is derepressed in a CodY-deficient strain 
The pleiotropic repressor CodY was shown to be involved in the regulation of the pepN and pepC genes 
and the opp-pepO1 operon (Guedon et al., 2001b). As these genes are regulated by medium 
components in a way similar to that of prtP, the role of CodY in prtP and prtM expression was studied. To 
this end, a CodY-deficient L. lactis MG1363 was constructed by replacing the chromosomal copy of codY
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by a mutated version by means of homologous double cross-over recombination. Plasmids pGKB11 and 
pGKB12 were introduced in this strain, L. lactis MG1363codY'1, and prtP and prtM gene expression was 
analysed in CDM media containing different amounts of casitone, and in peptide-rich M17 medium. In the 
wild type strain, the E-galactosidase activities of the prtP::lacZ and prtM::lacZ fusions were 6- and 8-fold 
lower in CDM with 2% than in CDM with 0.2% casitone, respectively (Table 2). In the codY mutant, E-
galactosidase activity in CDM with 2% casitone was less than twofold lower than that in CDM with 0.2% 
casitone. E-galactosidase activities in M17 were similar to those in CDM with 2% casitone for both 
MG1363 and MG1363codY'1. These results show that repression of these two gene fusions by medium 
peptides was almost fully abolished in the codY mutant. 
Table 2. Effect of a codY mutation on the expression of prtP::lacZ and prtM::lacZ fusions in L. lactis.
                                                  WT codY'1
Plasmid E -galactosidase activitya E-galactosidase activitya
                                  0.2                   2%           Repressionb            0.2%            2%           Repressionb
pGKB11 Pc 16.0 ± 2.0   2.5 ± 0.5  6.4  25.0 ± 3.2 12 ± 2  2.1 
pGKB12 Mc  2.5 ± 0.4  0.30 ± 0.05 8.3  4.0 ± 0.6   2.5 ± 0.5 1.6 
aE-galactosidase activity as determined by fluorescence (calculated as arbitrary fluorescence units divided per time 
and optical density (AFU x min-1 x OD595-1))
bRatio between the E-galactosidase activities in CDM with 0.2% and 2% casitone for one strain 
cP: prtP::lacZ; M: prtM::lacZ fusions 
CodY binds to the prtP/prtM intergenic region 
The prtP/prtM intergenic region of L. lactis BGMN1-5, E8, SK11 and Wg2 each contain an inverted 
repeat. As it overlaps the –10 sequence of both the prtP and prtM promoter, it could function as a binding 
site for a repressor. In order to determine whether CodY is able to bind to this DNA sequence, gel 
mobility shift assays were performed.
Figure 4. Gel mobility-shift assays 
performed with the prtP/prtM
promoter regions of L. lactis
BGMN1-5, E8, SK11 and Wg2. The 
[J-32P]-ATP-labelled DNA fragments 
(3000 cpm) were incubated for 15 
min at 30ºC with His6-CodY at 
concentrations of 0, 50, 100, 200 or
400 ng. Samples were run on a non-
denaturing 4% polyacrylamide gel. 
Free probe and single strand (SS) 
DNA are indicated.
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Histidine(6)-tagged CodY was overexpressed by using the nisin inducible gene expression system 
(Kuipers et al., 1998). The purified protein was used in a binding study with the 330-bp J-32P-labelled
PCR fragments containing the 330-bp prtP/prtM intergenic regions of L. lactis BGMN1-5, E8, SK11 and 
Wg2 as probes. Addition of His6-CodY resulted in a markedly lower electrophoretic mobility of all four 
double stranded PCR products on a polyacrylamide gel as compared to the situation in which CodY was 
not added (Fig. 4). Moreover, multiple shifted bands are present suggesting that CodY might act as a 
multimer. These results indicate that CodY binds to the prtP/prtM intergenic regions of all four lactococcal 
strains tested.
Discussion
Nucleotide sequence analysis of the intergenic regions encompassing the divergently oriented prtP and 
prtM promoters of different L. lactis strains showed that, although base-pair substitutions are present, the 
length of this region in L. lactis BGMN1-5 and E8 is identical to that in SK11 (Vos et al., 1989). 
Transcription initiation sites for the prtP and prtM genes of BGMN1-5 and E8 were mapped and found to 
be in close proximity to each other, as is the case for prtP/prtM genes of SK11 and Wg2 (Vos et al., 1989; 
van der Vossen et al., 1992).
By using transcriptional and translational fusions of the prtP and prtM promoters of L. lactis
BGMN1-5, E8, SK11 and Wg2 with promoterless reporter genes, it was shown that the prtP expression 
level was higher than that of prtM in all strains except E8. This observation is in contradiction with results 
previously published by Marugg et al. (1995; 1996). In their studies these authors used transcriptional 
fusions of the prtP and prtM promoters from L. lactis SK11 with a promotorless E-glucuronidase gene 
(gusA). As judged from the plasmid pNZ544 and pNZ554 construction (Marugg et al., 1995) and the 
published nucleotide sequence of the 0.35-kb SalI-EcoRI fragment containing the prtP and prtM
promoters (Marugg et al., 1996), the AUG start codon of prtM is not present in pNZ554: by cloning 
Klenow-treated ClaI fragment, carrying the prtP/prtM promoters, into the Klenow-treated SalI site of the 
vector, the AUG has been replaced by CGA, while the ribosome binding site of prtM was present. The 
start codon and the ribosome binding site of prtP were present in pNZ544. Nevertheless, in both gene 
fusions translation initiates at the AUG of gusA, as stop codons are present in the region upstream of the 
ribosome binding site of gusA. The differences between the two fusions could account for the observed 
PprtP::gusA/PprtM::gusA expression ratio in their study.
As is the case for the expression of peptide transport systems of L. lactis, namely DtpP (Foucaud et
al., 1995), DtpT (Kunji et al., 1996) and OppA (Detmers et al., 1998) and several peptidases e.g. PepN, 
PepC, PepO1 and PepO2 (Guedon et al., 2001b; 2001a), PrtP and PrtM were also shown to be 
repressed in cells grown in the presence of peptide-rich sources such as casein hydrolysate, casitone 
and casamino acids (Marugg et al., 1995; 1996; Guedon et al., 2001a). For the above-mentioned 
enzymes and proteins it was shown that their production is negatively regulated by the dipeptides Leu-
Pro and Pro-Leu. It was suggested that they might form (part of) a signal that mediates the regulation on 
a rich nitrogen source (Marugg et al., 1995; Guedon et al., 2001a; 2001b). Guedon et al. (2001b) showed 
that the expression of pepN, pepC and opp-pepO1 is regulated by CodY and that branched-chain amino 
acids serve as a signal for CodY activity. As almost all products involved in casein degradation are 
regulated in a similar medium-dependent way, the involvement of a common regulator was suggested. 
Here, we show that the expression of the prtP and prtM genes is approximately 10-fold repressed by 
CodY in media with a high concentration of peptides.
In the prt regulatory region of all four strains, a sequence with dyad symmetry is present which 
could form a stem-loop structure with a free energy ('G°) varying from –10.2 to –21.4 kcal/mol between 
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the strains. Marugg et al. (1996) hypothesized that specific sequences within this repeat 
structure may be involved in regulation of expression of both prt genes, since removal of half of 
this repeat in SK11 resulted in an almost constitutive expression of the prtP promoter. The dyad 
symmetry in L. lactis BGMN1-5 has the highest estimated 'G° (–21.4 kcal/mol; -89.5 kJ/mol), 
which could explain that the regulation of prt gene expression is most stringent in this strain. As 
was suggested before (Marugg et al., 1996), the palindromic sequence in the intergenic region 
between prtP and prtM could be involved in the recognition and/or binding of a repressor protein. 
By using gel retardation experiments, we confirmed that CodY binds to the prtP/prtM promoter 
region. Multiple bands are observed, suggesting that CodY might act as a multimer. Multiple 
shifted bands were also observed when the dpp (dipeptide permease) promoter region of Bacillus
subtilis was used in gel mobility shift assays with the B. subtilis CodY protein (Serror et al.,
1996b). B. subtilis CodY was also shown to bind to the srfA and comK promoters of this species, 
but no consensus sequence to which it binds could be deduced from the CodY protected regions 
(Serror et al., 1996a).  
Experimental procedures
Bacterial strains, plasmids and media 
The strains and plasmids used in this study are listed in Table 3. L. lactis was grown at 30qC in M17 broth (Terzaghi et al.,
1975) or on M17 agar plates containing 1.5% (wt/vol) agar. Chemically defined medium (CDM) (Mierau et al., 1994) 
containing 0.2% or 2% (wt/vol) casitone (Difco Laboratories, Detroid, Mich. USA) was used for the expression studies. All 
media contained 0.5% (wt/vol) glucose, while 5 Pg/ml chloramphenicol (Sigma-Aldrich, St. Louis, Missouri, USA) or 5 
Pg/ml erythromycin (Roche Molecular Biochemicals, Mannheim, Germany) were added when necessary. The 
chromogenic substrate 5-bromo-4-chloro-3-indolyl-E-D-galactopyranoside (X-Gal; Sigma-Aldrich) was used at a 
concentration of 1 mM. 
DNA techniques and transformation 
Molecular cloning techniques were performed essentially as described by Sambrook et al. (1989). Restriction enzymes, 
Klenow enzyme, T4 DNA ligase and ExpandTM High Fidelity DNA polymerase were used according to the instructions of 
the supplier (Roche Molecular Biochemicals). Synthetic oligo deoxyribonucleotides were obtained from Life Technologies 
B.V. (Breda, the Netherlands). PCR products were purified with the High pure PCR product purification kit (Roche 
Molecular Biochemicals). For nucleotide sequence analysis the dideoxy chain termination method (Sanger et al., 1977) 
was used with [D-35S]-dATP (Amersham Pharmacia Biotech, Roosendaal, the Netherlands) and the T7 sequencing kit 
(Amersham Pharmacia Biotech). L. lactis was transformed by electroporation using a gene pulser (Bio Rad Laboratories, 
Richmond, Calif.) as described by Leenhouts and Venema (1993). 
Plasmid constructions 
The prtP/prtM promoter region of L. lactis BGMN1-5 was amplified by PCR with the oligonucleotides PrA (5’-CTCGT 
GATCATCGATTCGTTCTCTTCTG) and PrB (5’-CAGGTGATCATCCAATACCCTCCACTTTCC). Oligonucleotides PrD (5’-
CAGGTGATCATCCAATATCCTCCACTTTCC) and PrC (5’-CTCGTGATCATCGATTCGGTCTCCTCTG) were used for the 
amplification of the prtP/prtM intergenic regions of L. lactis E8, SK11 and Wg2. Purified PCR products were digested with 
BclI (restriction site is underlined in the oligonucleotide sequence), and ligated into the BamHI site of pGKH10 
(Haandrikman, 1990), upstream of the promoterless D-galactosidase (Dgal) and E-galactosidase (lacZ) genes. All 
constructs were made using L. lactis MG1363 as the cloning host. The prtP and prtM promoters of BGMN1-5 were each  
transcriptionally fused to lacZ in pORI13. To this end, the PCR product obtained on BGMN1-5 template DNA with PrE (5’-
ACCAGCCAGACTAAACTGAC; annealing to the 5’-end of prtM) and PrF (5’-GGCTAACAAGATCGATAGCCC; annealing to 
the 5’-end of prtP) as oligonucleotides, was cloned into the SmaI site of pORI13. The ligation mixtures were used to transform L.
lactis LL108. This strain carries the repA gene on the chromosome, thereby allowing pORI13 derivatives to replicate. The 
orientation of the inserts was confirmed by nucleotide sequencing. 
Overproduction and purification of His6-CodY 
Chromosomaly located codY of L. lactis MG1363 was amplified by PCR with oligonucleotides HC-5 (5’-CTAGACCA 
CCATGGGGCATCACCATCACCATCACGTGGCTACATTACTTGAAAAAACACG), introducing the underlined NcoI
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restriction enzyme site upstream of the hexa-histidine tag (italic) and HC-6 (5’-CTAGTCTAGATTAGAAATTACGT 
CCAGCAAGTTTATC), introducing the underlined XbaI restriction enzyme site downstream of the stop codon (italic) of 
codY. The purified 833-bp PCR product was digested with NcoI and XbaI and ligated into the corresponding sites in 
pNZ8048, resulting in pNH6CodY. This plasmid was introduced in L. lactis NZ9000 to enable nisin induction of PnisA
upstream of his6-cody, as described by de Ruyter et al. (1996). Subsequently, His6-CodY was isolated by affinity 
chromatography in an FPLC procedure (Amersham Pharmacia Biotech) using Ni-NTA agarose (Qiagen GmbH, Hilden, 
Germany).
Table 3. Bacterial strains and plasmids used in this study. 
Strain or plasmid Relevant phenotype or genotype Source or reference 
Strains 
L. lactis subsp. cremoris
MG1363 Lac-; Prt- ; Plasmid–free derivative of NCDO712  Gasson, 1983 
MG1363codY'̷ MG1363 derivative with chromosomal deletion in codY This work 
NZ9000 MG1363 pepN::nisRK Kuipers et al., 1998 
NZ9700 Nisin producing transconjugant containing the nisin-sucrose 
transposon Tn5276
Kuipers et al., 1993 
LL108 Cmr, MG1363 derivative containing pWV01 repA gene in the 
chromosome
Leenhouts et al., 1998 
SK11 Lac+; Prt+; harbours, a.o., proteinase plasmid pSK111 de Vos et al., 1984 
Wg2 Prt+; harbours, a.o., proteinase plasmid pWV05 Otto et al., 1982 
E8 Lac+; Prt+ Kok, 1990 
L. lactis subsp. lactis   
BGMN1-5 Wild type strain, PrtP+, Bac501+, Bac513+ Gajic et al., 1999 
Plasmids
pNZ8048 Cmr, inducible expression vector carrying PnisA Kuipers et al., 1998 
pNH6CodY his6-codY of L. lactis MG1363 behind PnisA This work 
pORI280 Emr , ori+ of pWV01, replicates only in strains carrying repA in 
trans
Leenhouts et al., 1996 
pORI'codY pORI280 derivative containing 423 bp deletion in codY This work 
pVE6007 Cmr, Ts replication derivative of pWV01 Maguin et al., 1992 
pGKH10 Emr, Cmr, contains promoterless genes for D- and E-gal Haandrikman, 1990 
pGKH11 Emr, Cmr, contains genes for D-gal and E-gal, controlled by PprtM
and PprtP of Wg2, respectively 
Haandrikman, 1990 
pGKH12 Emr, Cmr, contains genes for D-gal and E-gal, controlled by PprtP
and PprtM of Wg2, respectively 
Haandrikman, 1990 
pGKB11 Emr, Cmr, contains genes for D-gal and E-gal, controlled by PprtM
and PprtP of BGMN1-5, respectively 
This work 
pGKB12 Emr, Cmr, contains genes for D-gal and E-gal, controlled by PprtP
and PprtM of BGMN1-5, respectively 
This work 
pGKE11 Emr, Cmr, contains genes for D-gal and E-gal, controlled by PprtM
and PprtP of E8, respectively 
This work 
pGKE12 Emr, Cmr, contains genes for D-gal and E-gal, controlled by PprtP
and PprtM of E8, respectively 
This work 
pGKS11 Emr, Cmr, contains genes for D-gal and E-gal, controlled by PprtM
and PprtP of SK11, respectively 
This work 
pGKS12 Emr, Cmr, contains genes for D-gal and E-gal, controlled by PprtP
and PprtM of SK11, respectively 
This work 
pORI13 Emr, Cmr, contains promoterless lacZ, repA- Sanders et al., 1998 
pORIB11 Emr, Cmr, pORI13 derivative carrying lacZ gene fused to prtP
promoter of BGMN1-5 
This work 
pORIB12 Emr, Cmr, pORI13 derivative carrying lacZ gene fused to prtM
promoter of BGMN1-5 
This work 
Emr, Cmr Apr, resistance to erythromycin, chloramphenicol and ampicilin, respectively. PnisA-inducible nisA promoter, PprtP
– prtP promoter, PprtM - prtM promoter, D-gal – D-galactosidase, E-gal – E-galactosidase.
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Construction of a codY deletion strain
A 1400 bp EcoRI/HindIII chromosomal fragment of L. lactis MG1363, containing codY, was subcloned in pUC19. The 
resulting plasmid was digested with SnaBI and subsequently selfligated. In this way, 423 bp were deleted from codY. The 
oligonucleotides cod280A (5’-GGGAATTCGGATTGTCTATCTGCCTCG) and cod280B (5’-GGGGGATCCAGATCTGACC
ATGATTACGCCAAGCTT) were used to amplify the 'codY-containing fragment. PCR product was digested with 
EcoRI/BamHI (restriction sites are underlined in the oligonucleotide sequence) and ligated into corresponding sites in 
pORI280. The resulting plasmid, pORI'codY, was introduced together with pVE6007 into L.lactis MG1363. As this strain 
does not contain the repA gene, selection for growth in the presence of erythromycin and increased temperature (37qC)
forces pORI'codY to integrate into the chromosome by homologous recombination. A number of integrants were 
subsequently grown for about 30 generations under nonselective conditions allowing a second recombination event to 
occur, which results in either the deletion or the wild-type gene codY. The 'CodY mutation was confirmed by PCR and 
Southern hybridisation experiments. 
D- and E-galactosidase activity assays 
The activities of D- and E-galactosidase were measured during growth of L. lactis in a 96 well microtiter plate (Greiner Bio-
One B.V., Alphen, the Netherlands) using the GENios microtiterplate reader and Magelan software (Tecan, Grödig, 
Austria). E-galactosidase activity was measured by determining the conversion rate of T657 substrate (trifluoromethyl 
umbelliferyl-E-D-galactopiranoside; Molecular probes, Leiden, the Netherlands) into T659 fluorescent product. D-
galactosidase activity was measured by using 4-methylumbelliferyl-D-D-galactopyranoside (Fluka Chemie, Zwijndrecht, 
the Netherlands). Fluorescence was followed using excitation and emission wavelengths of 360 and 535 nm, respectively. 
Culture optical densities (OD) were measured at 595 nm. Specific D- and E-galactosidase activities (mid exponential 
growth phase; OD~0.7) were calculated as arbitrary fluorescence units divided per time and optical absorbance (AFU x 
min-1 x OD595-1).
Primer extension analysis 
RNA was isolated from exponentially growing L. lactis cells as described by van Asseldonk et al. (1993). Synthesis of 
cDNA was performed using SUPERSCRIPT transcriptase (Life Technologies). mRNA (3.5 Pg) was reverse transcribed 
using 25 ng of the synthetic oligonucleotides PrE or PrF and 0.25 mM dATP, dGTP, dTTP, and 2PM [D-32P]dCTP 
(Amersham Pharmacia Biotech). Reactions were performed as described by Sanders et al. (1998). 
Gel retardation 
Gel retardation experiments were carried out essentially as described by Ebbole and Zalkin (1989). Oligonucleotides PrA 
and PrB were used to amplify the prtP/prtM promoter region of L. lactis BGMN1-5, while PrC and PrD were employed to 
amplify corresponding regions of L. lactis E8, SK11 and Wg2. Purified PCR products (2 Pg) were end-labelled with 
polynucleotide kinase (Amersham Pharmacia Biotech) for 1 h at 37qC using 30 PCi [J-32P]-ATP (Amersham Pharmacia 
Biotech). Reactions were stopped by incubating the mixtures for 10 min at 70qC. Binding studies were carried out in 20 Pl
reaction volumes containing 20 mM Tris-HCl (pH 8.0), 8.7 % (v/v) glycerol, 1 mM EDTA (pH 8.0), 5 mM MgCl2, 0.5 mM 
DTT, labelled DNA fragment (3000 cpm), and purified His6-CodY protein (50-400 ng). After incubation for 15 min at 30qC,
samples were loaded onto a 4% polyacrylamide gel. Electrophoresis was performed in the Protean II Minigel System (Bio 
Rad) using a gradient of TAE (Sambrook et al., 1989) buffer (0.5x to 2x) at 150 V for 1.5 h. Gels were dried and used for 
autoradiography at –80qC using Kodak XAR-5 films and intensifying screens. 
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Chapter 6
Repetition of the cell wall spanning domain of the 
lactococcal proteinase enhances cell sedimentation 




Lactococcus lactis subsp. lactis BGMN1-5 sediments after overnight growth. This 
phenomenon was dependent on the presence and expression level of the plasmid-
encoded extracellular proteinase PrtP. Although the production of its PI-type 
proteinase resulted in degradation of the major autolysin AcmA, which also gives rise 
to sedimentation due to interference with cell separation, settling of L. lactis BGMN1-5 
clearly differed from that of an L. lactis AcmA-negative strain. In contrast to an AcmA-
deficient strain, a BGMN1-5 culture re-sedimented after mixing and cells were present 
in clumps rather than long linear chains. The proteinase of L. lactis BGMN1-5, like that 
of L. lactis subsp. cremoris SK11, contains a duplication of a C-terminal cell wall 
spanning (CWS) domain, which is present once in the proteinase of L. lactis Wg2. As 
L. lactis SK11 also sediments, hybrids of the L. lactis SK11 proteinase and that of the 
non-sedimenting L. lactis Wg2 were used to determine which part is responsible for 
settling. Sedimentation appeared to be dependent on the presence of the C-terminal 
part of the L. lactis SK11 proteinase containing the duplicated CWS domain. It was 
shown that only cells producing a fusion protein with two or more CWS domains 
settled. Sedimentation is the result of a specific interaction between the CWS 
domains. Interestingly, cells producing anchored multiple CWS domains also had an 
enhanced interaction with human epithelial cancer cells of the small intestine. 
Introduction
Lactococcus lactis, like many other lactic acid bacteria, is a multiple amino acid auxotroph. Therefore, it 
has a complex proteolytic system to degrade caseins, the major milk proteins, into small peptides and 
free amino acids that are subsequently used for cell growth (Christensen et al., 1999). The initial 
breakdown of caseins is carried out by the cell wall-bound extracellular serine proteinase (CEP) PrtP. 
Several lactococcal prtP genes have been cloned and sequenced (Kok et al., 1985; 1988; de Vos et al.,
1989; Kiwaki et al., 1989). Although their deduced amino acid sequences are over 98% identical, the 
specificity of the proteinases towards caseins is quite different. On basis of their caseinolytic properties, 
the proteinases are divided into two major groups: the PrtPI-type enzymes preferentially degrade E-
casein but hardly DS1- and N-casein, and the PrtPIII-type enzymes, degrading DS1-, N-, and E-casein, but 
the latter with a specificity different from that of PrtPI (Visser et al., 1986). 
A comparative in silico analysis of the amino acid sequences of known PrtP’s and a number of 
CEPs from different lactic acid bacteria showed that PrtP has a modular, multidomain structure (Siezen, 
1999). The N-terminal part, with the pre-pro domain containing signals for secretion and activation (Kok 
et al., 1985; 1988; de Vos et al., 1989; Kiwaki et al., 1989), is followed by the subtilisin-like serine 
proteinase domain (Siezen et al., 1991; Siezen and Leunissen, 1997) and two large central domains that 
are thought to have regulatory and stabilizing functions (Siezen, 1999). The C-terminal part of PrtP 
consists of (i) a helical spacer, followed by (ii) a hydrophobic Gly/Thr/Asp-rich putative cell wall spacer 
(attachment) domain that can span the peptidoglycan layer and, (iii) a cell wall anchoring domain. The 
cell wall anchoring domain of PrtP contains the pentapeptide LPXTG, that is conserved among many 
surface proteins of Gram-positive bacteria (Fischetti et al., 1990), followed by a stretch of hydrophobic 
amino acids and a short tail of positively charged residues that remains in the cytoplasm (Schneewind et
al., 1993).
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Some of the bacterial cell wall-anchored proteins are known to have adhesive properties (Navarre 
and Schneewind, 1999). L. lactis cells can adhere to one another via the sex factor CluA, in order to allow 
conjugal transfer of DNA. The cell-to-cell binding causes a cell aggregation phenotype (Godon et al.,
1994). Cell aggregation was also found to be connected with AcmA, the major lactococcal peptidoglycan 
hydrolase. As this protein is required for cell separation, an acmA deletion mutant grows in extremely 
long chains causing settling of the culture after overnight growth (Buist et al., 1995). It has been shown 
that the cell wall-bound extracellular PI-type proteinase of L. lactis can degrade the autolysin AcmA, 
thereby influencing the rate of autolysis and cell aggregation (Buist et al., 1998).
Pathogenic Gram-positive bacteria carry cell wall-anchored surface proteins that contribute to 
virulence (Foster and McDevitt, 1994). They do so by promoting adherence to the host cells and/or tissue 
components, and by binding a variety of serum proteins including albumin, collagen, complement 
regulatory factors, soluble forms of fibronectin and fibrinogen, and the proinflammatory plasminogen and 
kininogen (Patti et al., 1994; Bensing et al., 2001; Foster and McDevitt, 1994; Signas et al., 1989; 
Lindgren et al., 1993; Navarre and Schneewind, 1999). Some streptococcal M proteins as well as 
fibrinogen binding protein (FgBP) from Streptococcus equi can also mediate bacterial autoaggregation, a 
property shown to be crucial for adherence and resistance to phagocytosis (Frick et al., 2000; Meehan et
al., 2001). 
Here, we report the direct involvement of the proteinase PrtP in cell sedimentation of L. lactis. The 
effect of different proteinase domains as well as the effect of a duplicated CWS domain on cell 
sedimentation were analysed. In addition to cell sedimentation, the enhanced interaction of lactococcal 
cells expressing this duplicated PrtP domain with cells of a human small intestine cancer cell line was 
studied.
Results
Cell sedimentation is dependent on proteinase production 
After overnight growth in GM17 or in CDM containing a low concentration (0.1%) of casitone as a 
nitrogen source, cells of L. lactis BGMN1-5 had sedimented. However, growth in CDM with a high (2%) 
casitone concentration did not result in sedimentation. The plasmid cured derivative of L. lactis BGMN1-5 
had lost the ability to produce proteinase (PrtP) and did not sediment (12). Proteinase production of L.
lactis BGMN1-5 was found to be dependent on the growth medium: proteinase production is high in 
medium containing a low concentration of casitone, and decreases with increasing casitone 
concentrations (data not shown). These results indicated a possible involvement of the plasmid-encoded 
proteinase in cell sedimentation. 
As cell sedimentation could be the result of degradation of autolysin AcmA by a PI-type proteinase 
(Buist et al., 1998), the caseinolytic specificity of the BGMN1-5 proteinase was determined. Incubation of 
L. lactis BGMN1-5 cells with different milk caseins showed that the proteinase preferentially hydrolyses E-
casein, indicating that it has a PI-type specificity (data not shown). This result was complemented by an 
immunological characterisation showing that PI-type specific monoclonal antibodies group IV and V 
(Laan et al., 1992) reacted with the proteinase (data not shown). As judged from the active degradation 
products of the 40.3-kDa AcmA obtained by zymographic analysis, the degree of AcmA degradation is 
indeed inversely correlated with the level of proteinase production (Fig.1). A high level of degradation was 
observed under conditions that resulted in high proteinase production. In accordance with these results 
the proteinase deletion mutant L. lactis BGMN1-5'prtP/M did not show any degradation of AcmA (Fig.1), 














Figure 2. (A) Cell sedimentation after vortexing of
an overnight culture of L. lactis BGMN1-5 (x) or L.
lactis MG1363acmA'1 (i) as followed by optical 
density measurements at 600 nm. (B) Light 
microscopic view of the overnight cultures in 
GM17 of L. lactis BGMN1-5 (left) and L. lactis
MG1363acmA'1 (right). Magnification, x 1,000.
Cell sedimentation of L. lactis BGMN1-5, however, can not be solely ascribed to the depletion of 
AcmA as several differences in settling were observed between an AcmA negative strain and L. lactis
BGMN1-5: (i) cells of BGMN1-5 were present in clumps instead of long linear chains as seen for L. lactis 
acmA'1 (Fig.2B), and (ii) BGMN1-5 cells sedimented again after mixing (Fig.2A), which acmA'1 cells do 
not. These results suggest a direct involvement of the proteinase in cell settling.
The C-terminal part of the proteinase is involved in cell sedimentation
Besides determining the substrate specificity, the BGMN1-5 proteinase was partially characterised at the genetic 
level. PCR analysis using oligonucleotides designed on the sequences of the SK11 and Wg2 proteinase genes 
revealed that a 180-bp DNA duplication is present in the 3’-end of prtP of strain BGMN1-5. This DNA fragment 
encodes the 60-amino-acid-residue putative cell wall spanning domain (CWS) also present in the SK11 
proteinase. Interestingly, L. lactis SK11 also sedimented after growth in CDM with a low concentration of 
casitone, albeit to a lesser extent than L. lactis BGMN1-5. In contrast, L. lactis Wg2 did not sediment. In order to 
determine which domain of the proteinase is involved in cell sedimentation, settling of the lactococcal strains 
SK11, Wg2, BGMN1-5, and four MG1363 derivatives producing hybrid proteinases was compared. In the hybrid 
proteinases, one or more of three different segments, denoted a, b and c, had been interchanged between the 
SK11 proteinase (ABCD, wild-type PIII activity) and the Wg2 (abcd, wild-type PI activity) proteinase (Vos et al.,
1991), (Fig.3). In aBcD and AbCd, the regions a/(A) and c/(C) have been replaced by the corresponding 
domains of the other proteinase. In abcD and ABCd three domains have been interchanged.
Figure 1. Zymographic analysis of
AcmA degradation in L. lactis BGMN1-
5 and BGMN1-5 'prtP/M on a 
renaturing SDS-12.5% PAA gel 
containing 0.2% Micrococcus
lysodeicticus cell wall fragments. 
Strains were grown in CDM containing 
0.2% (1), 1% (2), or 2% (3) casitone, 
and in GM17 (4). The arrow indicates 
the position of mature AcmA.
A B 
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Figure 3. Schematic representation of the hybrid proteinases specified by the plasmids used in this study (adjusted 
from (Vos et al., 1991)). White regions (A, B, C, D) represent SK11-derived sequences, Wg2-derived sequences (a, 
b, c, d) are shown as striped regions. The cell wall anchor is indicated in black. The fact that one CWS is lacking in 
Wg2 domain “d” is indicated by a thin horizontal line. Nomenclature of plasmids and proteinases is shown at the left 
and right, respectively. Sedimentation (+/-) of L. lactis MG1363 cells expressing hybrid proteinases after overnight 
growth in CDM with 0.2 % casitone is indicated.
Sedimentation of cells was only observed when they produced a hybrid proteinase that contained 
segment D of the SK11 proteinase. The differences between segment d/D of the proteinases of Wg2 and 
SK11 are 17 amino acid substitutions and the duplication of 60 amino acids in the SK11 segment. The 
presence of this duplicated CWS, as a major difference, suggested its involvement in cell sedimentation. 
The CWS domain spans the peptidoglycan layer
The CWS domain precedes the cell wall anchor and, presumably, has a function in spanning the bacterial 
cell wall to expose the mature proteinase on the outside of the cell (Siezen, 1999). Since the BGMN1-5 
proteinase contains a duplication of the CWS (2x60 residues), the cell wall thickness of the proteinase 
producing lactococcal strains BGMN1-5 and Wg2, and MG1363 (PrtP-) after growth in whey permeate 
was evaluated by electron microscopy (data not shown). For the cell wall of BGMN1-5 and Wg2 an 
overall thickness of approximately 23 nm was determined. In contrast, MG1363 has a thinner cell wall of 
approximately 18 nm.
Figure 4. Schematic representation of MSA2 fusion proteins. SS (dark grey), signal sequence of Wg2 PrtP; PS (light 
grey), pro sequence of Wg2 PrtP; MSA2 (striped), merozoite stage surface antigen MSA2 of Plasmodium falciparum;
CWS (white), cell wall spanning domain; CWA (black), cell wall anchoring domain. Nomenclature of plasmids and 
proteins is shown at the left and right, respectively. Sedimentation (+/-) of L. lactis NZ9000 cells expressing either of 
the three fusion proteins is indicated. 
In order to examine whether one CWS domain suffices to span the peptidoglycan layer, 
immunogold electron microscopy analyses were performed. One, two or three CWS domains, together 
with the PrtP cell wall anchoring domain, were C-terminally fused to a truncated form of the Plasmodium 
falciparum MSA2 antigen. Signal- and pro-sequences of PrtP of L. lactis Wg2 were used for the secretion 
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and proteolytic stabilisation of the fusion proteins (Fig.4).
The nisin controlled gene expression system, based on the L. lactis nisA promoter and nisK/R
genes (de Ruyter et al., 1996), was used to overexpress the fusion proteins in L. lactis NZ9000. After 
nisin induced production of the proteins and subsequent Western blot analysis the MSA2 antigen could 
only be detected in the cell walls of disrupted cells (data not shown). This indicated that the fusion 
proteins were covalently anchored to the peptidoglycan. Immunogold electron microscopy on intact cells 
expressing the fusion protein with one CWS domain (M::C1a) showed that the MSA2 antigen is located 
on the outside of the cell, indicating that one CWS domain is enough to cross the entire cell wall of 
MG1363 (Fig.5). 
Sedimentation due to the interaction between CWS domains
To test the involvement of the CWS domain in cell sedimentation, NZ9000 cells expressing the M::C1a, 
M::C2a or M::C3a fusion protein were used. After nisin induction cell sedimentation was observed only 
when a protein with more than one CWS domain was expressed (Fig.4). Sedimentation occurred fastest 
when three CWS domains were present (data not shown). These data suggest that CWS domain 
participate in cell-cell interactions, resulting in the formation of bacterial aggregates. 
In order to examine the type of interaction between CWS domains, derivatives of M::C1a, M::C2a 
and M::C3a fusion proteins were made in which the LPXTG sorting signal was deleted. Strain NZ9000 
secreted these anchor-less proteins, M::C1, M::C2 and M::C3, respectively into the medium. The 
Figure 5. Electron microscopy picture of immunogold
labelled L. lactis NZ9000 cells expressing the M::C1a
fusion protein, 2 hours after nisin induction. The MSA2
antigen was visualised with polyclonal anti-MSA2
antibodies.
Figure 6. Binding of anchor-less MSA2
fusion proteins to lactococcal cells 
producing the anchored fusion proteins. 
Cell wall-bound and non-bound fractions 
of L. lactis NZ9000 cells expressing an 
anchored fusion protein M::C1a, or
M::C2a, or producing the non-anchored 
MSA2 protein after incubation with the 
supernatants of NZ9000 containing the 
anchor-less proteins (1) M::C1, (2) M::C2, 
or (3) M::C3. The non-covalently bound 
proteins were released by SDS treatment. 
Protein fractions were separated on an 
SDS-10% PAA gel, after which the MSA2 
antigen was detected by Western 
analysis using anti-MSA2 antibodies. 
Molecular masses (in kDa) of reference 
proteins are shown on the right.
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supernatant of these induced strains was mixed with an equal amount of cells from cultures of NZ9000 
(pCWS1a), NZ9000 (pCWS2a) or NZ9000 (pNG304). After incubation, cells were spun down and the 
amount of cell-bound and non-bound protein was determined by Western blot analysis using anti-MSA2 
antibodies. Non-bound proteins were present in the supernatant fraction, while the bound proteins were 
obtained by SDS treatment of the cell pellet. The anchor-less proteins M::C1, M::C2 and M::C3 were 
capable of binding to cells of NZ9000 (pCWS1a) and NZ9000 (pCWS2a) (Fig.6). Binding was shown to 
be dependent on the number of CWS domain copies present in the anchored proteins. All of the anchor-
less proteins were found to bind better to the NZ9000 (pCWS2a) cells. Binding was also observed to cells 
of NZ9000 (pCWS1a) albeit to a lesser extent (Fig.6). No binding was detected to NZ9000 (pNG304) 
cells, confirming that the CWS domain does not bind to the bacterial cell per se. In conclusion, cell 
sedimentation is the result of protein-protein interaction between CWS domains. 
Enhanced interaction with human intestine 407 cells via multiple CWS domains
Some of the surface located bacterial proteins can be involved in interaction with eukaryotic cells. To test 
whether the expression of the CWS domain on the surface of the lactococcal cells can result in 
interaction with eukaryotic cells, interaction with cells of the human small intestine cancer cell line 407 
(Henle) was studied. The binding capacity of L. lactis NZ9000 cells expressing the M::C1a, M::C2a or 
M::C3a fusion protein was tested. As a control, NZ9000 cells secreting MSA2 were used. To exclude a 
possible interaction of the MSA2 protein with the human cells, L. lactis expressing an M::A fusion protein 
was used, in which MSA2 is non-covalently anchored to the peptidoglycan via AcmA repeats and thereby 
positioning it on the cell surface (Leenhouts et al., 1999). Only cells expressing proteins harbouring a 
CWS domain adhered to the Henle cells and were present in clumps in most cases (Fig.7).
Figure 7. Interaction of L. lactis NZ9000 cells expressing (A) M::A and (B) M::C3a fusion proteins with human 
intestine 407 cells. 
NZ9000 cells expressing M::A did not interact with these cells, indicating that MSA2, when exposed 
on the outside of the lactococcal cell, is not involved in adherence. The number of lactococcal cells that 
adhered to Henle cells was higher when more CWS domains were present (Table 1). 
To determine whether this interaction is caused by binding of the CWS domain to surface 
components of Henle cells, the latter were incubated with the culture supernatant of L. lactis NZ9000 
expressing M::C1, M::C2 or M::C3 fusion protein, or MSA2. After incubation, cells were spun down and 
the amount of cell-bound and non-bound protein was determined by Western blot analysis using anti-
MSA2 antibodies. After SDS treatment of the cell pellets no fusion proteins could be detected (data not 
shown). Moreover, the initial amount of fusion protein used in the binding experiment and the amount of 
fusion protein in the Henle cell supernatant fraction after 1 hour of incubation were nearly identical, 
indicating that no significant portion of the fusion proteins bind to the Henle cells. 
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Table 1. Interaction of Lactococcus lactis NZ9000 carrying plasmids pNG304, pNG3041, pCWS1a, 
pCWS2a, and pCWS2a with human intestine 407 cells. 
Strain 407 cellsa Bacteriab Mean value 
NZ9000(pNG304) 54 255 4.7 
NZ9000(pNG3041) 78 447 5.7 
NZ9000(pCWS1a) 73 1342 18.4 
NZ9000(pCWS2a) 80 2131 27.4 
NZ9000(pCWS3a) 64 1970 30.8 
aNumber of whole epithelial cells in 10 randomly chosen fields of view in light microscopy 
bNumber of lactococcal cells in contact with Henle cells 
Discussion
This study provides the first evidence that certain lactococcal proteinases are directly involved in bacterial 
cell sedimentation. Although AcmA of L. lactis BGMN1-5 is substrate for its P-I type proteinase, the 
characteristics of sedimentation of L. lactis BGMN1-5 clearly differ from those of an AcmA-minus strain. 
In contrast to the latter, a BGMN1-5 culture re-sedimented within 2 h after mixing and cells were present 
in clumps rather than long linear chains. It was concluded that cell sedimentation of strain BGMN1-5 can 
not be explained by degradation of AcmA. 
The phenomenon of cell sedimentation was shown to be positively correlated with the presence of 
the proteinase in BGMN1-5. A derivative of L. lactis BGMN1-5 that had only lost the prtP/M genes did not 
sediment. Moreover, cells sedimented after growth in CDM only when it contained a low casitone 
concentration, a situation in which the production of the BGMN1-5 proteinase, like other lactococcal 
proteinases (Marugg et al., 1995), is high. Most proteinase-producing lactococcal strains, e.g. L. lactis
Wg2, do not sediment even under conditions in which proteinase production is high. Analysis of the 
partially deduced amino acid sequence of the BGMN1-5 proteinase revealed that it contains a duplication 
of 60 amino acids in the C-terminus. The same duplication is also present in the proteinase produced by 
L. lactis strain SK11 (de Vos et al., 1989). We observed that the latter strain also sedimented under 
conditions of high proteinase production (data not shown). Analysis of the sedimentation behaviour of 
cells expressing hybrid proteinases in which domains of the SK11 and Wg2 proteinse had been 
swapped, showed that cell sedimentation is not related to the specificity of the proteinase but to the C-
terminal part of the SK11 proteinase. As, in addition to 17 amino acid differences, the major difference 
between the C-terminal parts of the SK11 and Wg2 proteinase is the duplication of 60 amino acid 
residues (de Vos et al., 1989) thought to form a cell wall spanning domain, its role in cell sedimentation 
was further examined.
The CWS domain of PrtP is tough to function as a cell wall spacer needed to display the active 
proteinase on the cell surface. Previous studies have shown that the minimum number of amino acid 
residues necessary to display a biologically active domain on the cell surface of the Gram-positive 
bacterium S. aureus is between 60 and 90 (Hartford et al., 1997; Strauss and Gotz, 1996). As the 60-
residues CWS domain in the BGMN1-5 proteinase is duplicated, we examined whether one or both 
domains are needed to span the cell wall by fusing one, two or three CWS domain(s) to the truncated 
MSA2 antigen of Plasmodium falciparum. Immunofluorescence microscopy using anti-MSA2 antibodies 
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revealed that the MSA2 antigen is displayed on the surface of cells expressing all three fusion proteins, 
indicating that one CWS domain suffices to span the peptidoglycan layer. From these results, it can be 
concluded that the additional copies of the CWS domain in the fusion proteins are most likely located on 
the outside of the cell wall.
Sedimentation analyses showed that only cells expressing a fusion protein with more than one 
CWS domain settled. The rate of sedimentation was positively correlated to the number of CWS domains 
present, indicating their involvement in settling. By mixing cell wall anchor-less derivatives of the fusion 
proteins with cells expressing their cell wall-bound forms, it was clearly shown that the CWS domain 
participate in protein-protein interaction. The anchor-less CWS domain-containing proteins did not bind to 
lactococcal cells that did not express a fusion protein with a CWS domain. One CWS domain in the 
anchored protein is sufficient to allow binding of anchor-less protein with one CWS domain, albeit to a 
lesser extent. Most likely, one copy of the anchored CWS domain is not fully accessible for protein-
protein interaction, as most of the domain will be hidden in the cell wall. This inaccessibility of the CWS 
domain, when present in the peptidoglycan, was demonstrated by a lack of interaction between, and thus 
sedimentation of, cells expressing an anchored fusion protein with only one CWS domain. The interaction 
between the CWS domains was found to be non-covalent and loose, but reversible, as gentle vortexing 
of the sedimented cells was enough to destroy it. 
L. lactis NZ9000 cells expressing the anchored fusion protein with one, two or three CWS domains 
were also shown to interact to epithelial cancer cells of the human small intestine. It was ruled out that 
the interaction is mediated by the MSA2 moiety of the fusion protein by comparing the interaction of cells 
expressing MSA2 anchored to the peptidoglycan through the peptidoglycan binding domain of AcmA 
(Leenhouts et al., 1999) with cells expressing anchor-free MSA2. No significant interaction of both 
bacterial cell lines with Henle cells was observed. The degree of interaction with Henle cells is positively 
correlated to the number of CWS domain expressed on the lactococcal cells. The underlying mechanism 
by which the L. lactis cells interact with epithelial cells is still unknown. The CWS domain did not show 
similarities with CWS domains of e.g. the surface proteins involved in adherence of pathogenic Gram-
positive bacteria to eukaryotic cells. Also, no homology was observed with other protein domains able to 
bind to certain components of epithelial cells. Since the CWS domain does not bind specifically to the 
Henle cells, it could be that lactococcal cells expressing a fusion protein with a CWS domain clump 
around extracellular material emanating from the cell surface of Henle cells. 
This study clearly demonstrates the involvement of the duplicated CWS domain of the BGMN1-5 
proteinase in the interaction with other duplicated CWS-containing lactococcal cells. At present, we can 
only speculate whether the binding characteristics constitute an additional function of the proteinase or 
that it is just coincidental. Duplication of the CWS domain could give the cells a selective advantage. It 
could constitute an extended hinge region to expose the proteinase further away from the cell surface 
and, thereby, bringing it into closer proximity to its substrate, casein. Sedimentation could also be 
advantageous, as it would specifically lead cells of the same strain to precipitate onto casein micelles. 
The (acquired) trait could also be used in advantage for their performance in other environments like the 
(human) intestinal tract by enabling colonization.
Experimental procedures 
Bacterial strains and growth conditions  
Bacterial strains and plasmids used in this study are listed in Table 2. L. lactis was grown at 30qC in M17 (Difco, West 
Molesey, United Kingdom) or ½ M17 broth (containing 0.95% E-glycerophosphate, Sigma Chemicals Co., St. Louis, Mo) 
as standing cultures or on ½ M17 agar plates containing 1.5% (wt/vol) agar. L. lactis cells were also grown in chemically 
defined medium CDM (Jensen and Hammer, 1993) supplemented with casitone (Difco) at concentrations of 0.1% to 2% 
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(wt/vol), and in milk-derived whey permeate (de Vos et al., 1989) containing 1.9% (wt/vol) E-glycerophosphate and 10 mM 
CaCl2. All media were supplemented with 0.5% (wt/vol) glucose, while 5 Pg/ml chloramphenicol (Sigma Chemicals Co), or 
5 Pg/ml erythromycin (Roche Molecular Biochemicals, Mannheim) were added when appropriate. To obtain a prtP/M
deletion derivative of L. lactis BGMN1-5, overnight cultures of this strain were diluted in fresh medium to a density of 1 to 
10 cells/ml and grown for 35 generations under non-selective conditions. Dilutions of the cultures were spread onto GM17 
agar plates with 0.004% (wt/vol) Bromocresol-purple (Merck) and a prtP/M deletion derivative was white among yellow 
wild type colonies.  
Table 2. Bacterial strains and plasmids used in this study. 
Strain or plasmid Relevant phenotype or genotype Source or reference 
Strains 
L. lactis subsp. cremoris 
MG1363 Lac-; Prt- ; Plasmid–free derivative of NCDO712  Gasson, 1983 
MG1363acmA'1 Derivative of MG1363 carrying a 701-bp SacI-SpeI deletion in 
acmA
Buist et al., 1995 
NZ9000 MG1363 pepN::nisRK Kuipers et al., 1998 
NZ9700 Nisin producing transconjugant containing the nisin-sucrose 
transposon Tn5276 
Kuipers et al., 1993 
SK11 Lac+; Prt+; harbours proteinase plasmid pSK111 de Vos and Davies, 1984 
Wg2 Prt+; harbours proteinase plasmid pWV05 Otto et al., 1982 
L. lactis subsp. lactis 
BGMN1-5 PrtP+, LcnB+, Bac513+, Bac2+, Gajic et al., 1999 
BGMN1-5'prtP/M Prt-, derivative of BGMN1-5 lacking prtP/M genes (~5,6 kb) from a 
80-kb proteinase plasmid 
This work 
BGMN1-596 PrtP-, LcnB-, Bac513-, Bac2-; Plasmid-free derivative of BGMN1-5 Gajic et al., 1999 
Plasmids
pNZ8048 Cmr, inducible expression vector carrying the nisA promoter Kuipers et al., 1998 
pNG8048E Cmr; Emr; pNZ8048 derivative Lab collection 
pNG300 Cmr; pNG8048E derivative with the pre-prosequence of PrtP of L.
lactis Wg2 
Lab collection 
pNG301 Cmr; pNG300 derivative with fused CWS and CWA of PrtP of Wg2 This work 
pNG304 Cmr; pNG300 derivative with msa2 Lab collection 
pNG3041 Cmr; pNG304 derivative with fused repeats of acmA Lab collection 
pCWS1a Cmr; pNG304 containing CWS and CWA of PrtP of Wg2 This work 
pCWS1 Cmr; pCWS1a derivative lacking CWA  This work 
pCWS2a Cmr; pCWS1a with additional copy of CWS This work 
pCWS2 Cmr; pCWS2a derivative lacking CWA This work 
pCWS3a Cmr; pCWS1a with two additional copies of CWS This work 
pCWS3 Cmr; pCWS3a derivative lacking CWA This work 
pGKV552 Emr, specifying cell wall-anchored proteinase of L. lactis Wg2  Haandrikman et al., 1991 
pGKV552abc Emr, specifying hybrid PI(Wg2)-PIII(SK11) proteinase  Vos et al., 1991 
pGKV552ac Emr, specifying hybrid PI(Wg2)-PIII(SK11) proteinase Vos et al., 1991 
pNZ521 Emr, specifying cell wall-anchored proteinase of L. lactis SK11  de Vos et al., 1989 
pNZ521abc Emr, specifying hybrid PIII(SK11)-PI(Wg2) proteinase  Vos et al., 1991 
pNZ521ac Emr, specifying hybrid PIII(SK11)-PI(Wg2) proteinase  Vos et al., 1991 
   
Emr, Cmr resistance to erythromycin and chloramphenicol, respectively 
DNA techniques and transformation
Molecular cloning techniques were performed essentially as described by Sambrook et al. (1989). Restriction enzymes, 
T4 DNA ligase and ExpandTM High Fidelity DNA polymerase were obtained from Roche Molecular Biochemicals and used 
according the instructions of the supplier. Synthetic oligo deoxynucleotides were obtained from Life Technologies B.V. 
(Breda, The Netherlands). PCR products were purified using the High pure PCR product purification kit (Roche Molecular 
Biochemicals). L. lactis NZ9000 was transformed by electroporation using a gene pulser (Bio Rad Laboratories, 
Richmond, Calif.) as described by Leenhouts and Venema (1993). Analytical grade chemicals were obtained from Merck 
(Darmstad, Germany), or BDH (Poole, United Kingdom).
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Overexpression of fusion proteins
The DNA fragment encoding the CWS domain and cell wall anchor domain of the proteinase of L. lactis Wg2 was
amplified from plasmid pGKV552 by PCR with oligonucleotides CWS1 (5'- ATATAAAGCTTGCAAAGTCTGAAAAC 
GAAGG), and CWS2 (5'- CCGTCTCAAGCTCACTATTCTTCACGTTGTTTCCG). The purified 402-bp PCR product was 
digested with HindIII/Esp3I (underlined) and ligated into the HindIII site of pNG300, resulting in pNG301. The merozoite 
surface antigen of Plasmodium falciparum strain 3D7 (MSA2) was chosen as localization reporter protein. As this protein 
contains the GPI anchor (Smythe et al., 1988), which could obstruct secretion of the fusion proteins, a truncated version of 
MSA2 (lacking this membrane-spanning domain) was used. It was amplified using the oligonucleotides MSA2-1 (5'- 
ACCATGGCAAAAAATGAAAGTAAATATAGC) and MSA2-4 (5'- CGGTCTCTAGCTTATAAGCTTAGAATTCGGGATGTT
GCTGCTCCACAG). The PCR product was digested with NcoI/HindIII (underlined) and ligated into the corresponding 
restriction enzymes sites of pNG301, resulting in pCWS1a. One or two copies of the 264-bp PCR product obtained with 
oligonucleotides CWS1 and CWS3 (5’-ATTTAAGCTTTTACCGGATGTAAGTTGACCATTACG), encoding the CWS 
domain, was/were introduced in the HindIII site of pCWS1a, resulting in pCWS2a and pCWS3a, respectively. Anchor-less 
variants of the CWS-containing fusion proteins were obtained using oligonucleotides MSA2-1 and Prt.Myc2 (5'-AAGATC 
TTCTTTGAAATAAGTTTTTGTTCCGTGCT) with pCWS1a, pCWS2a or pCWS3a as templates, respectively. The PCR 
products were digested with NcoI and XhoI and ligated into these sites of pNG300, resulting in pCWS1, pCWS2 and 
pCWS3, respectively.
Nisin induction of the nisA promoter upstream of the fusion protein-encoding fragments was performed as 
described by de Ruyter et al. (1996).
SDS-polyacrylamide (PAA) gel electrophoresis  
SDS-PAGE was carried out according to Laemmli (1970) with the Protean II Minigel System (Bio-Rad). The prestained 
high-range molecular weight marker (Bio-Rad) and the high-range SDS-PAGE rainbowTM colored protein molecular weight 
marker of Amersham Life Science Inc. (Buckinghamshire, UK) were used as protein size references.  
Proteinase isolation and activity assays 
Proteinases were isolated from L. lactis as described by Vos et al. (1991). The concentration and purity of the proteinase 
was estimated by SDS-10% PAGE. The amount of proteinase in the samples was normalized before Western blot 
analysis. Proteinase activity was measured by using the chromogenic peptide S2586 (Meo-Suc-Arg-Pro-Tyr-pNA; 
Cromatogenix AB, Sweden), as described by Mierau et al. (1996). Samples for determining the caseinolytic specificity of 
the proteinase were made as described by Hill and Gasson (1986). As substrates, E-, DS1- and N-casein (5 mg/ml; Sigma) 
were used. Samples were analysed on an SDS- 15% PAA gel.  
Detection of AcmA activity
Two ml of CDM culture samples were subjected to centrifugation for 5 min at 12000 x g. 0.5 ml of the supernatant was 
dialyzed at room temperature against several changes of demineralised water, lyophilised, and dissolved in 0.25 ml 
denaturation buffer (Beliveau et al., 1991). The cell pellets were washed with 1 ml of fresh growth medium and 
resuspended in 1 ml denaturation buffer. Cell-free extracts were prepared as described by van de Guchte et al. (1990).
AcmA activity was determined by a zymogram staining technique using SDS-12.5% PAA gels containing 0.2% autoclaved, 
lyophilised Micrococcus lysodeikticus ATCC 4698 cells (Sigma) as described before (Buist et al., 1995). 
Western blot analysis
Western blotting was performed using a semi-dry system as described by Kyhse-Andersen (1984). After separation by 
SDS-PAGE, proteins were transferred to polyvinylidene difluoride membranes (Roche). Proteins were visualised with 
specific antibodies and horseradish peroxidase goat anti-rabbit IgG conjugates (Amersham), using the ECL detection 
system of Amersham. The BGMN1-5 proteinase was detected using the monoclonal antibodies of groups IV and V that 
were raised against the PrtP of L. lactis strain Wg2 (Laan et al., 1989; 1992). The MSA2 fusion proteins were detected 
using polyclonal antibodies raised against merozoite stage surface antigen MSA2 of Plasmodium falciparum 3D7
(Ramasamy et al., 1999). 
Electron microscopy 
For determining cell wall thickness, lactococcal cells were fixed, and ultrathin sections for electron microscopy were 
prepared, as described by Waterham et al. (1994). The cell wall of 20 randomly chosen cells was measured taking into 
account only sections of whole cells. 
L. lactis cells expressing the fusion protein with one CWS domain (M::C1a) were collected and washed with 
phosphate buffered saline (PBS). Immunogold labelling was performed on whole mount preparations of glutaraldehyde 
fixed cells on Formvar-carbon coated nickel grids using Auroprobe 15 nm goat anti-rabbit IgG gold marker (Amersham). 
The primary antibodies against MSA2 were diluted 1:1000 in PBS-glycine buffer. Subsequently, the labelled samples were 
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stained with 0.1% uranyl acetate (wt/vol in water) and examined in a Philips CM10 transmission electron microscope at 
100 kV. 
Binding of CWS-containing fusion proteins to lactococcal cells
One ml of culture of L. lactis NZ9000 cells carrying either plasmid pNG304, pCWS1a or pCWS2a was taken 2 h after nisin 
induction. After centrifugation cells were resuspended in an equal volume of supernatant taken from L. lactis NZ9000 
carrying pCWS1, pCWS2, or pCWS3 and incubated for 1 h at 30qC. Subsequently, the mixtures were centrifuged for 5 
min at 10000 rpm in an Eppendorf microcentrifuge, after which the cell pellets were resuspended in 100 Pl demineralised 
water, and mixed with five times concentrated protein-gel-sample-buffer (Laemmli, 1970). Samples were boiled for 5 min 
prior to loading on an SDS- 10% PAA gel. The supernatants were concentrated 10-fold using phenol and ether as 
described by Sauyé et al. (1995).
Interaction with eukaryotic cells
Human Henle cells (Intestine 407/ATCCCCL6) were cultivated to confluence in RPMI 1640 medium (Gibco) supplemented 
with 10% fetal calf serum (Gibco), 1% L-glutamine, 1% non-essential amino acids, and penicillin-streptomycin followed by 
cultivation for two days on diagnostic glass slides (Danlab Oy, Helsinki, Finland). Before adhesion assays, the cells were 
washed once with PBS. L. lactis NZ9000 carrying either pNG304, pNG3041, pCWS1a, pCWS2a or pCWS3a was induced 
with nisin and grown overnight. After harvesting the cells by centrifugation (5 min, 12000 x g) and washing with PBS, the 
cells were resuspended in PBS. Equal amounts of bacteria (10 Pl, 2 x 108cells/ml) from each suspension were added to 
the epithelial cells followed by incubation for 1 h at 37qC in a moist chamber. After five washings with PBS at room 
temperature the slides were fixed for 10 min with methanol and the cells were stained for 5 min with 10 (v/v) Giemsa stain 
(Oy Reagena Ltd, Kuopio, Finland) and analysed by light microscopy. The number of lactococcal cells that were in contact 
with the epithelial cells was counted from ten randomly chosen fields of view taking into account only whole cells. The 
mean number of adhering bacteria was quantified. 
Interaction of CWS-containing fusion proteins with Henle cells  
Approx 2 x 106 Henle cells/ml were suspended in 0.5 ml of 10-fold concentrated supernatant of culture of L. lactis NZ9000 
cells carrying either plasmid pNG304, pCWS1 or pCWS2 or pCWS3, taken 2 h after nisin induction. After incubation for 1 
h at RT with slow shaking cells were collected at 1000 g. Equal amounts of cell fraction, supernatant and untreated 
supernatant were loaded on an SDS- 10% PAA gel and analysed by Western blotting using anti-MSA2 antibodies. 
Chemiluminescent detection was carried out with SuperSignal West Dura Extended substrate (Pierce, Rockford, USA) 
using a Molecular Imager G-525 system (BioRad). 
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Summary and concluding remarks 
The Gram-positive lactic acid bacterium Lactococcus lactis can harbour a wide variety of circular 
extrachromosomal DNA molecules, so-called plasmids. Many of the traits that make them useful for 
manufacturing of fermented food products (e.g. bacteriophage resistance, bacteriocin and proteinase 
production, lactose utilization and sucrose degradation) are plasmid encoded. Strain L. lactis BGMN1-5, 
an isolate from home made semi-hard cheese, possesses multiple plasmids with several interesting 
traits. This thesis focuses on the MDR protein, proteinase and bacteriocins produced by L. lactis BGMN1-
5. As an introduction in these topics, an overview of the state-of-the-art in these fields of research is given 
in Chapter 1.
Two peptides with antimicrobial activity, LsbA and LsbB, produced by L. lactis BGMN1-5 were 
studied in detail (chapter 2). Two novel observations with respect to the secretion of and immunity 
against these bacteriocins were made. 1) LsbA is synthesised with an N-terminal extension. The 
housekeeping surface proteinase HtrA was shown to be responsible for the cleavage of the precursor 
peptide to yield the active LsbA. This activation by HtrA, during or after translocation of the bacteriocin 
across the cytoplasmic membrane, is a processing mechanism that is distinctly different from those 
reported thus far. 2) L. lactis BGMN1-5 is resistant against LsbA and LsbB due to the action of LmrB, a 
protein localised in the cytoplasmic membrane. LmrB is a member of the ABC protein superfamily and is 
homologous to various prokaryotic- (e.g. LmrA of L. lactis MG1363) and eukaryotic- (human P-
glycoprotein) multidrug resistance (MDR) proteins. The two known lactococcal MDR proteins LmrA and 
LmrP were also shown to confer resistance to both bacteriocins. They do not render cells resistant to 
other lactococcal bacteriocins. Both bacteriocins contain a stretch of 4 or 5 positively charged amino acid 
residues that could be a diagnostic feature of peptide substrates for MDR proteins. Taking this 
observation into account, genetically engineered analogous of LsbA and LsbB can be designed that may 
be even better substrates for MDR proteins. As most substrates of MDR proteins are recognised at the 
level of the cytoplasmic membrane, and (amphiphilic) bacteriocins intercalate into these lipid bilayers, it is 
very likely that LmrB mediates bacteriocin resistance by extruding the peptides from the cytoplasmic 
membrane. In this way, MDR proteins mediate both the secretion of and resistance against the 
antimicrobial peptides.
The conservation of function and substrate specificity between LmrB and its eukaryotic 
counterpart P-glycoprotein was studied in more detail in Chapter 3. The extrusion of amphiphilic 
compounds from eukaryotic cells by the action of the human P-glycoprotein, a phenomenon known as 
multidrug resistance, is one of the causes of failure of chemotherapeutic treatment in human cancers. 
LmrB, which is a half-size version of P-glycoprotein, was shown to mediate the extrusion of amphiphilic 
compounds from the cytoplasmic membrane of lactococcal cells. In addition, LmrB secretes LsbA and 
LsbB and the eukaryotic linear antimicrobial peptides magainin II and cecropin P1, thereby conferring 
resistance to these polypeptides. Normally, P-glycoprotein excretes hydrophobic xenobiotics from the 
membrane of humane cells into bile, urine or the intestinal lumen, preventing their accumulation in critical 
organs such as the brain. Reconstituted in insect cells, P-glycoprotein was also capable of transporting 
LsbB across the cytoplasmic membrane. This observation indicates another possible physiological 
function of MDR proteins in higher eukaryotic cells: besides toxic compounds and cytotoxic drugs, the 
excretion of endogenous biologically active peptides, that belong to the host defence system commonly 
called ”innate immunity”, could be mediated by these proteins. LsbA and LsbB were shown to compete 
with transport substrates of both LmrB and P-glycoprotein. Apart from chemotherapeutic treatment of 
cancers, endogenous or acquired multidrug transporters in pathogenic microorganisms represent one of 
the major challenges in treatment of patients with infections caused by antibiotic resistant bacteria, yeast, 
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fungi, or parasites. When LsbB was added to LmrB-expressing lactococcal cells, together with a clinically 
relevant MDR antibiotic (e.g. minocycline or azytromycin), the cells were shown to be more sensitive to 
the antibiotic as compared to the situation in which only antibiotic was added. These data suggest that 
LsbB, or maybe even more potent analogues thereof made by protein- or chemical engineering, could be 
used in advantage to sensitise multi-antibiotic resistant bacterial strains, provided that their resistance is 
due to the action of a multidrug resistance transporter protein. Understanding the molecular mechanisms 
of LsbA and LsbB recognition and transport by MDR proteins is instrumental in continuous search for the 
development of new drugs that circumvent, inhibit or alter the activity of these proteins. As produced by 
the food grade microorganism L. lactis, these two peptides might be good candidates.
L. lactis BGMN1-5 also produces a small, hydrophobic and positively charged bacteriocin, that was 
shown to be lactococcin B, LcnB (Chapter 4). The cognate gene is located on a large plasmid (approx. 
80-kb) that also carries the genetic information for proteinase PrtP production. Transcription of lcnB was 
shown to be medium dependent, induced in medium with a high peptide concentration and repressed (up 
to 3.5–fold) when a limited amount of peptides is present. The actual player(s) involved in the signalling 
and regulation remain(s) to be elucidated. Moreover, the direct interaction of the regulator protein with the 
lcnB promoter region should be demonstrated and the sequence to which it binds determined. The total 
activity of secreted LcnB appeared to be post-translationaly controlled through proteolytic degradation by 
the cell wall anchored proteinase PrtP. The degradation was shown to be dependent on the caseinolytic 
specificity of the proteinase and to be rather specific for lactococcins. Apart from providing immunity that 
is genetically linked to bacteriocin production, the presence of a proteinase able to degrade certain 
bacteriocins can be advantageous for the cell.
L. lactis is an amino acids auxotroph. For growth in milk, peptides and amino acids have to be 
released from milk protein (casein) and subsequently internalised by a number of dedicated transport 
systems. The proteolytic breakdown of casein is initiated by the extracellular cell wall-bound proteinase 
PrtP. PrtP requires the action of the maturase (PrtM) to be autoproteolitically activated. In Chapter 5 the 
expression of the cognate divergently oriented prtP and prtM genes of L. lactis subsp. lactis BGMN1-5 
and a number of reference strains was studied. It was shown that the expression signals of prtP are more 
efficient than those of prtM, which is in accordance with the view that PrtM has a catalytic function in PrtP 
maturation. As also observed for the lactococcal peptide transport systems and several peptidases, it 
appeared that the production of proteinase and maturase is repressed in the presence of peptide-rich 
sources such as casein hydrolysates, casitone and casamino acids. Because of this similar, medium-
dependent way of regulation of various components involved in casein degradation and peptide/amino 
acid uptake, the involvement of a common regulator was suggested. This hypothesis was strengthened in 
this study as it was shown that the transcriptional repressor CodY, as demonstrated before for several 
peptidases, is responsible for the repression of proteinase and maturase production in peptide-rich 
media. A palindromic sequence in the intergenic region between prtP and prtM might be involved in the 
recognition and/or binding of CodY. This hypothesis can be corroborated by DNaseI footprinting studies. 
By comparing promoter regions to which CodY binds, apart from the fact that they are all AT rich, no 
consensus sequences could be discerned. This observation suggests a binding mechanism that is not 
solely dependent on a specific DNA sequence. It is likely that CodY recognises a three dimensional DNA 
structure rather than only a linear sequence.
Cells of L. lactis subsp. lactis BGMN1-5 were shown to settle in clumps after overnight growth. As 
this phenomenon, that clearly differs from the sedimentation of the extended linear chains of autolysin 
(AcmA)-negative L. lactis cells, was also shown to be dependent on the peptide concentration of the 
medium, the role of PrtP in this phenomenon was studied (Chapter 6). It appeared that a specific trait of 
the plasmid-encoded extracellular proteinase PrtP is responsible for the observed sedimentation. PrtP of 
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L. lactis BGMN1-5 and L. lactis subsp. cremoris SK11, which was also shown to settle, contain a 
duplicated 60-amino-acids-long C-terminal cell wall spanning (CWS) domain. This domain is thought to 
function as a cell wall spacer needed to display the proteinase on the cell surface. It was shown that one 
CWS domain suffices to span the peptidoglycan layer and that sedimentation is the result of the (specific) 
interaction between the additional CWS domains in the BGMN1-5 and SK11 proteinases. Proteinases 
harbouring a single CWS domain do not mediate cell sedimentation (e.g. that of L. lactis WG2). Upon the 
increase in the number of CWS domains, sedimentation becomes more pronounced as a result of a 
better accessibility of the domains for protein-protein interactions. This feature could have 
biotechnological applications, e.g. in separating cells producing a desired protein of interest from the 
heterogeneous cell population. The CWS domain is not homologous to domains in proteins of 
(pathogenic) Gram-positive bacteria that mediate the adherence to eukaryotic cells. Nevertheless, L.
lactis cells expressing proteins with more than 1 CWS domain were shown to interact with epithelial cells 
of the human small intestine. This adherence to the intestinal epithelium could prevent pathogen 
colonization by hindrance of access to epithelial receptors. L. lactis is not a member of the human gut 
intestinal flora and is unable to colonize the human intestine. However, expression of proteins with 
multiple CWS domains could be advantageous in adherence of L. lactis to human epithelial cells, making 
this lactic acid bacterium an attractive candidate as carrier of foreign proteins, e.g. as live vaccines.
In conclusion, this study clearly demonstrates that L. lactis should not only be regarded as an 
important organism for dairy-related studies. It can be used as an interesting model-organism for studying 
MDR proteins, which are the basis of a number of problems the medical world faces today. MDR proteins 
are one of the main causes of failure of chemotherapeutic treatment in human cancers and also play a 
crucial role in the antibiotic resistance of human pathogens, as observed in hospitals worldwide. The 
lactococcal MDR proteins, that have a similar function and substrate specificity as their eukaryotic 
counterparts, provide us with a tool for studying this type of transporters. The antimicrobial peptides 
produced by lactic acid bacteria, or analogues thereof, may be used advantageously in conjunction with 
existing drugs to treat infectious diseases caused by multidrug resistant microorganisms. 
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Samenvatting en conclusies 
De Gram-positieve melkzuurbacterie Lactococcus lactis bevat een grote verscheidenheid aan 
extrachromosomaal DNA in de vorm van plasmiden. De genetische informatie voor veel van de 
eigenschappen die van belang zijn voor de bereiding van gefermenteerde voedingsmiddelen (o.a. de 
resistentie tegen bacteriële virussen, de productie van antimicrobiële peptiden en eiwitafbrekende 
enzymen, de afbraak van lactose en sucrose) is gelegen op dergelijke plasmiden. De L. lactis stam 
BGMN1-5, die is geïsoleerd uit een “home-made” halfharde kaas, bezit vijf plasmiden die de informatie 
bevatten voor verschillende interessante eigenschappen. Dit proefschrift gaat voornamelijk in op de 
productie van het protease en enkele hiermee samenhangende verschijnselen alsmede de produktie en 
uitscheiding van bacteriocines. Ter introductie is in Hoofdstuk 1 een overzicht gegeven van de stand van 
zaken in gerelateerde onderzoeksgebieden. 
L. lactis BGMN1-5 produceert meerdere eiwitten met antimicrobiële activiteit, zgn. bacteriocines. 
De plasmide-gecodeerde bacteriocines LsbA en LsbB zijn in detail bestudeerd (Hoofdstuk 2). Enkele 
nieuwe inzichten werden verkregen met betrekking tot de secretie van en de immuniteit tegen deze 
bacteriocines. 1) LsbA wordt gesynthetiseerd met een N-terminale extensie. Het proteinase HtrA, dat aan 
de buitenkant van de bacterie is gesitueerd, is verantwoordelijk voor de verwijdering van deze extensie 
zodat een actief LsbA wordt verkregen. Deze activatie door HtrA, gedurende of na translocatie van het 
bacteriocine over de cel membraan, is een mechanisme van processing dat fundamenteel verschilt van 
reeds bekende mechanismen. 2) L. lactis BGMN1-5 is immuun voor LsbA en LsbB door het bezit van 
LmrB, dat gelokaliseerd is in de celmembraan. Deze representant van de ABC eiwit superfamilie is 
homoloog aan verschillende prokaryote- en eukaryote multidrug resistentie (MDR) eiwitten zoals LmrA 
van L. lactis MG1363 en het humane P-glycoproteïne. De twee reeds bekende MDR eiwitten van 
Lactococcus, LmrA en LmrP, bleken ook in staat cellen immuun te maken voor beide bacteriocines. De 
LmrA- of LmrP-bevattende cellen bleken niet resistent tegen andere bacteriocines. Zowel LsbA als LsbB 
bevat een sequentie van (respectievelijk 4 en 5) opeenvolgende positief geladen aminozuur residuen, 
een eigenschap die karakteristiek zou kunnen zijn om een substraat voor MDR eiwitten te vormen. Op 
grond van deze kennis zouden, door middel van genetische engineering, analogen van beide 
bacteriocines gemaakt kunnen worden die een beter substraat voor MDR eiwitten zouden zijn. Daar de 
meeste substraten van MDR eiwitten worden herkend op het niveau van de cytoplasmatische membraan, 
en de (amfifilische) bacteriocines intercaleren in de membraan, lijkt het aannemelijk dat LmrB de 
antimicrobiële peptiden verwijdert uit de membraan. LmrB medieert zodoende zowel de secretie van als 
de immuniteit tegen de bacteriocines. 
De conservering tussen LmrB en de eukaryote homoloog P-glycoproteïne voor wat betreft functie 
en substraat specificiteit werd in meer detail bestudeerd in Hoofdstuk 3. De uitscheiding van amfifilische 
verbindingen uit eukaryote cellen door het P-glycoproteïne, een fenomeen dat resulteert in multidrug 
resistentie (MDR), is één van de oorzaken van het falen van chemotherapie in de bestrijding van humane 
kankers. LmrB, dat half zo groot is als het P-glycoproteïne, is ook in staat verbindingen uit de 
cytoplasmatische membraan van L. lactis te verwijderen. Daarnaast bleek LmrB de uitscheiding van 
zowel prokaryote (LsbA en LsbB) als eukaryote lineaire antimicrobiële peptiden (maganaïne II en 
cecropin P1) te mediëren. Door het bezit van LmrB werden de cellen tevens resistent tegen deze 
peptiden. P-glycoproteïne verwijdert hydrofobe xenobiotica uit de membraan van humane cellen naar de 
gal, urine of het lumen van de darm. Hierdoor wordt de ophoping van deze verbindingen in vitale organen 
zoals de hersenen voorkomen. P-glycoproteïne dat was gereconstitueerd in insecten cellen, bleek in 
staat LsbB over de cytoplasmatische membraan te transporteren. Deze observatie duidt op een 
mogelijke fysiologische rol van MDR eiwitten in hogere eukarytische cellen: naast het uitscheiden van 
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toxische verbindingen and cytostatische drugs, zou het de uitscheiding van endogene biologisch actieve 
eiwitten, die behoren tot het defensieve systeem van de gastheer (de zgn. “innate immunity”), kunnen 
mediëren. LsbA en LsbB bleken in staat te competeren voor transport met andere MDR substraten. Deze 
eigenschap zou, naast het optimaliseren van de chemotherapeutische behandeling van kankers, tevens 
kunnen worden aangewend voor de behandeling van patiënten met infecties die zijn veroorzaakt door 
antibiotica resistente pathogene bacteriën, gisten, schimmels of parasieten. Wanneer LsbB samen met 
een klinisch relevant MDR antibioticum (zoals minocycline en azytromycine) aan LmrB producerende 
Lactococcus cellen werd toegevoegd, bleken deze cellen gevoeliger te zijn voor het antibioticum. Deze 
bevinding zou kunnen worden gebruikt om multi-resistente pathogene bacteriën (mits deze resistentie 
wordt veroorzaakt door MDR eiwitten) gevoeliger te maken voor een antibioticum door toevoeging van 
LsbB of meer potente analogen daarvan die verkregen zouden kunnen worden door middel van eiwit- of 
chemische engineering. Kennis van de moleculaire mechanismen die ten grondslag liggen aan de 
herkenning en transport van LsbA en LsbB door MDR eiwitten zou kunnen resulteren in de ontwikkeling 
van nieuwe drugs die de activiteit van MDR eiwitten remmen, veranderen of omzeilen. Daar LsbA en 
LsbB worden geproduceerd door het “food-grade” microorganisme L. lactis, zouden beide eiwitten goede 
kandidaten kunnen zijn. 
L. lactis BGMN1-5 produceert nog een klein, hydrofoob en positief geladen bacteriocine, dat 
identiek is aan het reeds beschreven LcnB (Hoofdstuk 4). Het corresponderende gen is gelegen op een 
groot (ongeveer 80 kbp) plasmide dat tevens de informatie bevat voor de productie van het aan de 
buitenkant van de celwand gebonden proteinase PrtP. De transcriptie van lcnB bleek te worden 
geïnduceerd bij een hoge concentratie aan peptiden. De expressie is gerepresseerd wanneer de 
concentratie aan peptiden in het medium laag is. De spelers die betrokken zijn bij het signalerings- en 
regulatiesysteem moeten nog worden geïdentificeerd. Bovendien moet nog worden aangetoond of het 
regulator eiwit een interactie aangaat met het lcnB-promoter gebied en zo ja, aan welke 
nucleotidensequentie hiervoor dan verantwoordelijk is. Eenmaal uitgescheiden wordt de totale activiteit 
van LcnB (en de andere lactococcines) beïnvloed door proteolytische afbraak door PrtP. De mate van 
afbraak bleek afhankelijk van de caseïnolytische specificiteit van het proteinase. Hoewel de mate waarin 
dit gebeurde verschilde, bleken alle lactococines te worden afgebroken. LsbA, LsbB en het lantibioticum 
nisine waren ongevoelig voor PrtP. Het immuniteit-systeem, waarvan de genetische informatie is 
gekoppeld aan die van de bacteriocine productie, bepaalt in grote mate de ongevoeligheid voor een 
bepaald bacteriocine. Daarnaast zou de productie van een proteinase dat in staat is het bacteriocine af te 
breken een voordeel voor dat organisme kunnen opleveren.
Teneinde te kunnen groeien moet L. lactis enkele essentiële aminozuren tot zich nemen. Tijdens 
groei op melk worden eiwitfragmenten (peptiden) en aminozuren uit het melkeiwit (caseïne) vrijgemaakt 
en met behulp van specifieke transportsystemen door de cellen opgenomen. De afbraak van melkeiwit, 
proteolyse, wordt geïnitieerd door het aan de buitenkant van de celwand gebonden proteinase PrtP. Dit 
eiwit moet daartoe eerst door een zgn maturase worden geactiveerd. In hoofdstuk 5 is de expressie van 
de corresponderende, tegenovergesteld georiënteerde genen prtP en prtM van o.a L. lactis BGMN1-5 
bestudeerd. Aangetoond werd dat de expressie van prtP veel efficiënter is dan die van prtM, een 
observatie die in overeenstemming is met de katalytische functie van PrtM in de maturatie van PrtP. De 
productie van het proteinase en de maturase worden, zoals reeds aangetoond voor de 
transportsystemen van Lactococcus en enkele van haar intracellulaire peptiden-afbrekende enzymen 
(peptidases), gerepresseerd in de aanwezigheid van een hoge concentratie peptiden (in de vorm van 
caseïnehydrolysaten, casiton of casaminozuren). Op grond van deze overeenkomstige, medium 
afhankelijke manier van regulatie, was het bestaan van een gemeenschappelijke regulator reeds 
gesuggereerd. Deze hypothese werd hier versterkt omdat werd aangetoond dat de transcriptionele 
Samenvatting en conclusies 
85
repressor CodY verantwoordelijk is voor de repressie van de proteinase en maturase productie in 
peptide-rijk medium. Een palindromische sequentie, gelegen in het intergene prtP/prtM  promotergebied, 
bleek verantwoordelijk voor de herkenning en/of binding van CodY. Hoewel alle gebieden waaraan CodY 
lijkt te binden AT-rijk zijn kon geen consensus sequentie worden aangetoond. Dit impliceert dat de 
binding niet slechts gebasseerd is op een specifieke nucleotidensequentie. Waarschijnlijk herkent CodY 
een 3-dimensionale structuur die aanwezig is in het DNA.
L. lactis BGMN1-5 cellen blijken, na enige tijd te hebben gegroeid, samen te klonteren. Dit 
fenomeen, dat duidelijk verschilt van de sedimentatie van de verlengde lineaire ketens van een 
autolysine (AcmA-) negatieve stam, bleek ook afhankelijk van de peptide concentratie van het medium. 
Daarom werd (in Hoofdstuk 6) de rol van PrtP in de sedimentatie onderzocht. Het bleek dat een 
specifieke eigenschap van het proteinase verantwoordelijk is voor de samenklontering. PrtP van L. lactis
BGMN1-5 alsmede dat van L. lactis SK11, een stam die ook samenklontert, bevat een gedupliceerd, C-
terminaal celwand overspannend (CWS) domein van 60 aminozuren. De veronderstelde functie van dit 
gedeelte van het eiwit is het positioneren van het actieve proteinase aan de buitenkant van de cel. Eén 
CWS domein is voldoende om de peptidoglycaan laag te overbruggen. Het samenklonteren van de cellen 
bleek het resultaat van een specifieke interactie tussen de additionele CWS domeinen. Cellen die een 
proteinase produceren met één enkel CWS domein (L. lactis WG2) bleken niet in staat samen te 
klonteren. Bij een toename van het aantal CWS domeinen was, als gevolg van een betere 
beschikbaarheid van de additionele domeinen voor eiwit-eiwit interacties, de samenklontering groter. 
Deze eigenschap zou een biotechnologische toepassing kunnen hebben in het isoleren van specifieke 
cellen die een gewenst eiwit produceren uit een heterogene populatie. Het CWS domein is niet homoloog 
aan domeinen van eiwitten van (pathogene) Gram-positieve bacteriën die in staat zijn aan eukaryote 
cellen te binden. Desalniettemin gingen cellen die CWS- bevattende eiwitten produceren ook een 
interactie aan met humane cellen van de dunne darm. Deze interactie met het epitheel van de dunne 
darm zou de binding van pathogene microorganismen aan de aanwezige receptoren kunnen verstoren 
en daarmee hun kolonisatie helpen voorkomen. L. lactis maakt normaal geen deel uit van de humane 
darmflora daar het niet in staat is de darm te koloniseren. Door het tot laten produceren eiwitten met 
meerdere CWS-domeinen zou dit  echter mogelijk gemaakt kunnen worden. Hiermee zou L. lactis een 
goede kandidaat kunnen zijn voor het fungeren als een carrier van specifieke eiwitten, bijvoorbeeld in 
een toepassing als levend vaccin. Bovenstaande zou kunnen worden gebruikt om meerdere cellen van 
dezelfde stam in caseïne micellen in een kaasmatrix te doen precipiteren. Tevens zou het vermogen om 
aan eukaryote cellen te binden kunnen worden gebruikt om de bacteriële cellen naar het humane 
darmweefsel te dirigeren teneinde, bijvoorbeeld kolonisatie te bewerkstelligen.
Uit de resultaten van dit proefschrift is duidelijk naar voren gekomen dat L. lactis niet alleen moet 
worden beschouwd als interessant voor zuivel-gerelateerd onderzoek. L. lactis zou ook kunnen dienen 
als model-organisme voor onderzoek naar MDR eiwitten, die enkele problemen waar de medische wereld 
zich voor gesteld ziet veroorzaken. De werking van MDR eiwitten is  één van de redenen van het falen 
van chemotherapie tijdens de behandeling van humane kankers en speelt tevens een cruciale rol in de 
resistentie van humane pathogenen in ziekenhuizen over de hele wereld. De MDR eiwitten van L. lactis,
die qua functie en substraatspecificiteit sterk lijken op hun eukaryote homoloog P-glycoproteïne, geven 
de mogelijkheid om dit type van transport eiwitten in detail te bestuderen. De antimicrobiële peptiden die 
door de melkzuurbacterie worden geproduceerd, of analogen daarvan, zouden kunnen worden gebruikt 
ter vervanging van of in combinatie met bestaande drugs in de bestrijding van ziektes die worden 









Ovo je deo namenjem rodbini i prijateljima, ljudima drugih profesija koji nisu upuüeni u 
terminologiju i problematiku molekularne genetike. Obiþno se kaže da se posao genetiþara
svodi na muükanje i presipanje iz jedne u drugu epruvetu. Malo se od svega toga direktno 
vidi, dok se sa druge strane puno toga dešava u üeliji. Odredjenim tehnikama se sva ta 
dešavanja ipak mogu doþarati.
Nadam se da üe vam ovo malo teksta približiti problematiku kojom sam se bavila.
Bakterije mleþne kiseline (BMK)
Lactococcus lactis je jednoüelijska bakterija, koka, nevidljiva golim okom. Zajedno sa drugim BMK, u 
obliku starter kulture se koristi za dobijanje velikog broja vrsta fermentisanih mleþnih proizvoda. Kao 
glavni produkt fermentacije šeüera laktoze, ove bakterije proizvode mleþnu kiselinu koja fermentisanom 
mleku daje prijatan nakiseo ukus. Po prskanju, BMK oslobadjaju razliþita jedinjenja koja doprinose aromi i 
zrenju sira. Pored mleþnih proizvoda, ove bakterije imaju znaþajnu ulogu u procesima proizvodnje 
mesnih preradjevina, fermentisanog povrüa i sliþno. Bakterije ove grupe proizvode i odredjene proteine 
(bakteriocini) koji spreþavaju rast kontaminanata u proizvodima i time produžavaju njihovu trajnost. 
ûelija, DNK i proteini 
Svaka bakterijska üelija poseduje dva omotaþa, spoljašnji, tzv. üelijski zid koji doprinosi þvrstoüi i 
unutrašnji, üelijska membrana. Unutrašnjost üelije þini citoplazma u kojoj se nalaze razliþiti molekuli, 
proteini i DNK (dezoksiribonukleinska kiselina) (Slika 1). DNK je molekul koji nosi naslednu materiju i 
sastoji se iz dva medjusobno pevezana, spiralno uvijena lanca nukleotida. Svaki od ova dva lanca se 
sastoji iz niza u kome se smenjuju ukupno 4 nukleotida, adenin (A), timin (T), guanin (G) i citozin (C). 
Oba lanca su komplementarna, što znaþi da A u jednom lancu stoji uvek naspram T u drugom lancu. Isto 
važi i za G i C. 
Nisu svi nukleotidi u DNK funkcionalni. Fukncionalni delovi DNK (geni) sadrže informacije za 
sintezu odredjenih proteina. Informacije sadržane u DNK se najpre uz pomoü dekodirajuüeg proteina 
(RNK polimeraze) preslikavaju na redosled nukleotida u RNK (ribonukleinska kiselina). RNK zatim 
prenosi instrukcije i informacije sa DNK na ribozom, tzv. fabriku proteina gde dolazi do formiranja 
polipeptidnih lanaca i proizvodnje proteina. Paket od 3 nukleotida u RNK predstavlja jednu amino 
kiselinu, jedinicu proteina. Svaka od 20 postojeüih amino kiselina ima svoju šifru. Veliþina i specifiþnost
napravljenog proteina zavisi od veliþine gena i redosleda nukleotida.
Moje istraživanje 
Glavnu ulogu u ovom radu ima Lactococcus lactis BGMN1-5, bakterija izolovana iz polutvrdog sira 
proizvedenog u domaüinstvu. Odredjeni proteini kao što su MDR protein, bakteriocini i proteinaza koje 
ova bakterija proizvodi su izuþavani. Opšti pregled (literarni) navedenih oblasti dat je u uvodu (Deo 1).
Deo 2. Bakteriocini LsbA i LsbB
Bakteriocini su proteini koji imaju sposobnost da inhibiraju, tj. spreþe rast drugih bakterija. Proizvode se u 
üeliji i putem transportnih proteina izbaciju iz üelije. Deluju tako što se sjedinjuju u membranu osetljivih 
üelija, formiraju pore pri þemu dolazi do izlaska sadržaja iz üelije, citoplazme i smrti bakterije. Da bi 
zaštila sebe od dejstva bakteriocina koji proizvodi, bakterija zajedno sa bakteriocinom pravi još jedan, 
takozvani imuni protein. 
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Geni za LsbA i LsbB i njihov imuni protein su klonirani. To znaþi da je iz lanca DNK izolovane iz 
jedne üelije pomoüu odredjenih enzima iseþen deo koji sadrži gen za bakteriocin i ugradjen uz pomoü
drugih enzima u lanac DNK druge, razliþite üelije. Tako dobijena üelija, sada osim sopstvenih može da 
proizvodi i bakteriocin koji do sada nije mogla. Pored toga, odredjen je i redosled nukleotida (sekvenca) u 
genima za oba bakteriocina i njihovom proteinu za imunost. Dobijeni deo pokazuje da se radi o tri 
razliþita proteina. LsbA i LsbB su mali proteini od 67 i 30 amino kiselina, dok je LmrB znatno veüi protein 
od 567 amino kiselina. Izbacivanje iz üelije i otpornost na LsbA i LsbB se ostvaruje putem LmrB 
tranporter proteina. Uprošteno reþeno, LmrB dejuje kao pumpa i izbacuje ova dva bakteriocina iz üelijske
membrane (Slika 1). 
Slika 1. Šematski prikaz gradje bakterije Lactococcus lactis ukljuþujuüi proteine iz ove priþe.
Deo 3. LmrB funkcioniše kao MDR protein. 
MDR proteini su tzv. transportni proteini koji se nalaze u üelijskoj membrani i igraju ulogu u zaštiti üelije.
Ispumpavaju otrovne, štetne materije iz membrane i na taj naþin smanjuju njihovu koncentraciju u üeliji.
Ova pojava je poznata pod nazivom ”multidrug resistance” (MDR) i jedan je od razloga neuspešnosti 
hemoterapije u leþenju raka.
Pored dva bakteriocina LsbA i LsbB, LmrB izbacuje iz üelijske membrane otrovna jedinjena i 
odredjenje antibiotike koji se normalno koriste u leþenju (Slika 1). Ova pojava predstavlja jedan od 
problema u medicini jer sužava delovanje antibiotika koji se mogu koristiti u leþenju odredjenih obolenja. 
Ova dva bakteriocina mogu da naruše funkciju MDR proteina što omoguüava antibiotiku da ispolji svoje 
dejstvo. Popred toga, funkcija jednog ljudskog MDR proteina je izuþavana i pokazano je da je on i po 
gradji i funkciji sliþan bakterijskom LmrB proteinu. 
Deo 4. Bakteriocin LcnB. 
Gen za bakteriocin LcnB je kloniran i njegov DNK deo je odredjen. Njegova proizvodnja je ispitivana u 
razliþitim medijumima za rast bakterija. Tom prilikom, deo DNK ispred gena odakle poþinje preslikavanje 
DNK u RNK (tzv. promotor) je kloniran ispred reporter gena. Reporter gen nije ništa drugo do obiþan gen 
þiji proizvod, protein može biti indirektno doþaran. Reporter protein razgradjuje jednu hemijsku supstancu 
koja se nalazi u medijimu za rast bakterija što dovodi do bojenja bakterijske kolonije u plavo. Ako reporter 
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gen nije proþitan i ako protein nije napravljen bakterije ostaju bele boje. Pored toga, uoþeno je da 
proteinaze razliþitog tipa imaju sposobnost da razgrade ovaj bakteriocin. 
Deo 5. Proteinaza. 
Obzirom da rastu u mleku, BMK imaju dobro razvijeni sistem za razgradnju proteina mleka, kazeina, kako 
bi došle do amino kiselina koje koriste za rast. Ovaj sistem þine enzim proteinaza koji se nalazi van üelije
(Slika 1), brojni drugi enzimi unutar i van üelije kao i transportni proteini koji omoguüavaju unošenje 
kratkih lanaca peptida i amino kiselina u üeliju.
Proizvodnja proteinaze je ispitivana u razliþitim medijumima za rast bakterija. U tu svrhu, promotor 
region je vezan za reporter gen (kao u delu 4). Plave kolonije (visoka proizvodnja) su primeüene u 
medijumu za rast siromašnom proteinima, dok su u medijumu obogaüenom proteinima kolonije bele boje. 
To znaþi da u bogatoj sredini bakterija pravi neki drugi protein koji uzrokuje ovo smanjenje. Taj protein, 
tzv. represor je izolovan i pokazano je da se on direktno vezuje za proteinazni promotor region kada 
bakterije rastu u sredini obogaüenoj proteinima i dovodi na taj naþin do smanjene proizvodnje proteinaze.  
Deo 6. Proteinaza i taloženje üelija.
Svaki protein ima N-terminus (poþetak) i C-terminus (kraj). Proteinaza je vanüelijski protein vezan za 
üelijski zid bakterije svojim C-terminalnim krajem (Slika 1). Kod proteinaze izuþavane u ovom radu deo 
proteina koji prolazi kroz üelijski zid je umnožen. Bakterije, ukoliko proizvode proteinazu koja sadrži dva ili 
tri ova duplikata se nakon rasta u teþnoj kulturi istalože na dnu epruvete. Duplikat proteinaze jedne üelije
se vezuje za isti duplikat proteinaze druge üelije, pri þemu dolazi do grupisanja i taloženja üelija. Brzina 
taloženja üelija je srazmerna broju ovih duplikata. Veüi broj duplikata rezultira brzim taloženjem. Pored 
toga, bakterija koja proizvodi proteinazu sa ovim duplikatima se preko njih vezuje i za üelije ljudskog 
malog creva. 
Osim u proizvodnji sira, ove bakterije mogu imati i drugu primenu. ýinjenica da su bakterijski i ljudski 
MDR protein sliþni po gradji i funkciji (deo 2), þini ove bakterije dobrim kandidatima, primernim 
organizmima, za izuþavanje ljudskih MDR proteina. Lako ih je uzgajati i tehnike za njihovu genetiþku
manipulaciju su raspoložive. Ovo istraživanje bi moglo dovesti do razrešavanja naþina delovanja ovih 
proteina i pomoüi u traženju novih lekova koji mogu da naruše funkciju MDR proteina i time doprinesu 
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